US20030014093A1 - Excisional and ultrasound medical treatment system - Google Patents

Excisional and ultrasound medical treatment system Download PDF

Info

Publication number
US20030014093A1
US20030014093A1 US10/153,510 US15351002A US2003014093A1 US 20030014093 A1 US20030014093 A1 US 20030014093A1 US 15351002 A US15351002 A US 15351002A US 2003014093 A1 US2003014093 A1 US 2003014093A1
Authority
US
United States
Prior art keywords
ultrasound
patient
end effector
lumen
medical treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/153,510
Inventor
Inder Makin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethicon Endo Surgery Inc
Original Assignee
Ethicon Endo Surgery Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Endo Surgery Inc filed Critical Ethicon Endo Surgery Inc
Priority to US10/153,510 priority Critical patent/US20030014093A1/en
Priority to PCT/US2002/016697 priority patent/WO2002096505A2/en
Priority to CA 2449068 priority patent/CA2449068A1/en
Priority to DE60233401T priority patent/DE60233401D1/en
Priority to EP20020739438 priority patent/EP1397073B1/en
Priority to AT02739438T priority patent/ATE439807T1/en
Priority to JP2002593013A priority patent/JP2004528924A/en
Assigned to ETHICON ENDO-SURGERY, INC. reassignment ETHICON ENDO-SURGERY, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MAKIN, INDER RAJ S.
Publication of US20030014093A1 publication Critical patent/US20030014093A1/en
Assigned to ETHICON ENDO-SURGERY, INC. reassignment ETHICON ENDO-SURGERY, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BARTHE, PETER G., SLAYTON, MICHAEL H.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/44Constructional features of the ultrasonic, sonic or infrasonic diagnostic device
    • A61B8/4444Constructional features of the ultrasonic, sonic or infrasonic diagnostic device related to the probe
    • A61B8/445Details of catheter construction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/12Diagnosis using ultrasonic, sonic or infrasonic waves in body cavities or body tracts, e.g. by using catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/44Constructional features of the ultrasonic, sonic or infrasonic diagnostic device
    • A61B8/4483Constructional features of the ultrasonic, sonic or infrasonic diagnostic device characterised by features of the ultrasound transducer
    • A61B8/4488Constructional features of the ultrasonic, sonic or infrasonic diagnostic device characterised by features of the ultrasound transducer the transducer being a phased array
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00Ultrasound therapy
    • A61N7/02Localised ultrasound hyperthermia
    • A61N7/022Localised ultrasound hyperthermia intracavitary
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/02Instruments for taking cell samples or for biopsy
    • A61B10/0233Pointed or sharp biopsy instruments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/22004Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
    • A61B17/22012Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/22004Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
    • A61B17/22012Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement
    • A61B17/2202Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement the ultrasound transducer being inside patient's body at the distal end of the catheter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/28Surgical forceps
    • A61B17/29Forceps for use in minimally invasive surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B17/320068Surgical cutting instruments using mechanical vibrations, e.g. ultrasonic
    • A61B17/320092Surgical cutting instruments using mechanical vibrations, e.g. ultrasonic with additional movable means for clamping or cutting tissue, e.g. with a pivoting jaw
    • A61B2017/320093Surgical cutting instruments using mechanical vibrations, e.g. ultrasonic with additional movable means for clamping or cutting tissue, e.g. with a pivoting jaw additional movable means performing cutting operation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/36Image-producing devices or illumination devices not otherwise provided for
    • A61B90/37Surgical systems with images on a monitor during operation
    • A61B2090/378Surgical systems with images on a monitor during operation using ultrasound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/36Image-producing devices or illumination devices not otherwise provided for
    • A61B90/37Surgical systems with images on a monitor during operation
    • A61B2090/378Surgical systems with images on a monitor during operation using ultrasound
    • A61B2090/3782Surgical systems with images on a monitor during operation using ultrasound transmitter or receiver in catheter or minimal invasive instrument
    • A61B2090/3784Surgical systems with images on a monitor during operation using ultrasound transmitter or receiver in catheter or minimal invasive instrument both receiver and transmitter being in the instrument or receiver being also transmitter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3925Markers, e.g. radio-opaque or breast lesions markers ultrasonic
    • A61B2090/3929Active markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/397Markers, e.g. radio-opaque or breast lesions markers electromagnetic other than visible, e.g. microwave
    • A61B2090/3975Markers, e.g. radio-opaque or breast lesions markers electromagnetic other than visible, e.g. microwave active
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00Ultrasound therapy
    • A61N2007/0078Ultrasound therapy with multiple treatment transducers

Definitions

  • the present invention relates generally to ultrasound, and more particularly to an ultrasound medical system and/or to an ultrasound medical method.
  • Known ultrasound medical systems and methods include using ultrasound imaging of patients to identify patient tissue for medical treatment and include using ultrasound to medically destroy identified patient tissue by heating the tissue. Imaging is done at lower power and medical treatment is done at higher power. Low power imaging ultrasound will not medically affect patient tissue. High power medical-treatment ultrasound, when focused at a focal zone a distance away from the ultrasound source, will substantially medically affect patient tissue in the focal zone. However, focused medical-treatment ultrasound will not substantially medically affect patient tissue outside the focal zone such as patient tissue located between the source and the focal zone.
  • a transducer assembly includes a single ultrasound transducer having a single transducer element, or an array of transducer elements acting together, to ultrasonically image the patient and to ultrasonically ablate identified patient tissue. It is known to convert ultrasound imaging data into temperature imaging data for ultrasound-treated patient tissue to monitor the ultrasound treatment.
  • a known transducer element includes a transducer element having a concave shape or an acoustic lens to focus ultrasound energy.
  • a known array of transducer elements includes a planar, concave, or convex array of transducer elements to focus ultrasound energy.
  • a known array of transducer elements includes an array whose transducer elements are electronically or mechanically controlled together to steer and focus the ultrasound emitted by the array to a focal zone (which may be large or which may be as small as, for example, a grain of rice) to provide three-dimensional medical ultrasound treatment of patient tissue.
  • the transducer is placed on the surface of patient tissue for ultrasound imaging and/or ultrasound medical treatment of areas within the patient tissue.
  • the transducer is surrounded with a balloon which is expanded to contact the surface of patient tissue by filling with a fluid such as a saline solution to provide acoustic coupling between the transducer and the patient tissue.
  • Known ultrasound medical systems and methods include deploying an end effector having an ultrasound transducer outside the body to break up kidney stones inside the body, endoscopically inserting an end effector having an ultrasound transducer in the colon to medically destroy prostate cancer, laparoscopically inserting an end effector having an ultrasound transducer in the abdominal cavity to medically destroy a cancerous liver tumor, intravenously inserting a catheter end effector having an ultrasound transducer into a vein in the arm and moving the catheter to the heart to medically destroy diseased heart tissue, and interstitially inserting a needle end effector having an ultrasound transducer needle into the tongue to medically destroy tissue to reduce tongue volume to reduce snoring.
  • Known methods for guiding an end effector within a patient include guiding the end effector from x-rays, from MRI images, and from ultrasound images obtained using the ultrasound transducer.
  • Known ultrasound imaging includes Doppler ultrasound imaging to detect blood flow, and a proposed known use of ultrasound includes using an ultrasound transducer outside the body to stop internal bleeding (by sealing ruptured blood vessels) of a patient brought to an emergency room of a hospital.
  • a Mammotome® Breast Biopsy System manufactured by Ethicon Endo-Surgery, Inc. inserts a tube into breast tissue, wherein the tube contains an end effector having a biopsy cutting tool.
  • a known electromagnetic transponder and three-receiver system for calculating the position of the transponder and for guiding the transponder (which is attached to a heart catheter for monitoring the heart) inside a patient is the CARTOTM EP Navigation System used with a NAVI-STAR® catheter manufactured by Biosense Webster (a Johnson & Johnson Company).
  • CARTOTM EP Navigation System used with a NAVI-STAR® catheter manufactured by Biosense Webster (a Johnson & Johnson Company).
  • an ultrasound medical treatment system including a tube, a first end effector, and a second end effector.
  • the tube has a distal end insertable into a patient and has a lumen.
  • the first end effector has a cutting tool, is introducible into the lumen of the inserted tube from outside the patient, and is translatable through the lumen of the inserted tube to inside the patient.
  • the second end effector has an ultrasound medical-treatment transducer assembly, is introducible into the lumen of the inserted tube from outside the patient, and is translatable through the lumen of the inserted tube to inside the patient.
  • the ultrasound medical-treatment transducer assembly is an ultrasound imaging and medical-treatment transducer assembly.
  • the cutting tool takes a biopsy sample of possibly cancerous breast tissue of a patient, and the breast receives ultrasound medical treatment from the transducer assembly to stop hemorrhaging in the breast.
  • the present invention has, without limitation, application in conventional endoscopic and open surgical instrumentation as well as application in robotic-assisted surgery.
  • FIG. 1 is a perspective view of a first embodiment of the present invention showing an ultrasound medical treatment system which includes a tissue-retaining device;
  • FIG. 2 is an enlarged view of the end effector of the ultrasound medical treatment system of FIG. 1;
  • FIG. 3 is a view of the end effector of FIG. 2 retaining an intervertebral disk of a patient
  • FIG. 4 is a perspective view of a first alternate end effector which can be used in the ultrasound medical treatment system of FIG. 1;
  • FIG. 5 is a perspective view of a second alternate end effector which can be used in the ultrasound medical treatment system of FIG. 1;
  • FIG. 6 is a perspective view of a third alternate end effector which can be used in the ultrasound medical treatment system of FIG. 1;
  • FIG. 7 is a side elevational view of a second embodiment of the present invention showing another ultrasound medical treatment system which includes a tissue-retaining device;
  • FIG. 8 is an enlarged, partially-cutaway view of the end effector of the ultrasound medical treatment system of FIG. 7;
  • FIG. 9 is a perspective view of a third embodiment of the present invention showing an ultrasound medical system which includes flexible fingers, wherein each finger includes an ultrasound transducer;
  • FIG. 10 is an enlarged view of the tube and the flexible fingers of the ultrasound medical system of FIG. 9 showing the flexible fingers in a deployed fan-like state;
  • FIG. 11 is a view of the flexible fingers of FIG. 10 shown in a stowed state
  • FIG. 12 is a perspective view of an alternate flexible finger arrangement which can be used in the ultrasound medical system of FIG. 9, showing the flexible fingers in a deployed claw-like state surrounding patient tissue;
  • FIG. 13 is a perspective view of a fourth embodiment of the present invention showing an ultrasound medical system which includes an ultrasound transducer assembly which includes at least two ultrasound transducers;
  • FIG. 14 is an enlarged view of the ultrasound transducer assembly of the ultrasound medical system of FIG. 13;
  • FIG. 15 is a cross-sectional view of the transducer assembly of FIG. 14;
  • FIG. 16 is a cross-sectional view of a first alternate transducer arrangement which can be used in place of the arrangement of FIG. 15;
  • FIG. 17 is a cross-sectional view of a second alternate transducer arrangement which can be used in place of the arrangement of FIG. 15;
  • FIG. 18 is a perspective view of a fifth embodiment of the present invention showing an ultrasound medical treatment system which includes a cutting tool and an ultrasound medical-treatment transducer assembly;
  • FIG. 19 is an enlarged, cross-sectional view of the tube of FIG. 18 showing a cutting tool that has been introduced into the lumen of the tube;
  • FIG. 20 is an enlarged, cross-sectional view of the tube of FIG. 18 showing an ultrasound medical-treatment transducer assembly that has been introduced into the lumen of the tube;
  • FIG. 21 is a block diagram of an eighth method of the present invention which includes ultrasound staging of medical treatment of patient tissue in the gastrointestinal area;
  • FIG. 22 is a block diagram of an eleventh method of the present invention which includes ultrasound medical treatment of a lesion on or in the lung of a patient;
  • FIG. 23 is a block diagram of a thirteenth method of the present invention which includes ultrasound medical treatment of a blood vessel to stop the supply of blood to a lesion from the blood vessel;
  • FIG. 24 is a perspective view of a sixth embodiment of the present invention showing a portion of an ultrasound medical treatment system which includes receivers for locating the position of the transducer assembly of the system;
  • FIG. 25 is a perspective view of a seventh embodiment of the present invention showing a portion of another ultrasound medical treatment system which includes receivers for locating the position of the transponder of the system;
  • FIG. 26 is a block diagram of a seventeenth method of the present invention which includes aiming the transducer assembly.
  • FIG. 27 is a block diagram of a twentieth method of the present invention which includes creating an image after starting medical treatment using an imaging ultrasound wave before medical treatment and an imaging ultrasound wave after starting medical treatment.
  • any one or more of the following-described embodiments, expressions of embodiments, examples, methods, etc. can be combined with any one or more of the other following-described embodiments, expressions of embodiments, examples, methods, etc.
  • any of the end effectors can be used in any of the methods
  • any of the transducer arrangements can be used in any of the end effectors
  • any appropriate methods can be combined such as combining the seventeenth and twentieth methods, etc.
  • FIGS. 1 - 3 illustrate a first embodiment of the present invention.
  • a first expression of the first embodiment of the present invention is for an ultrasound medical treatment system 10 including an end effector 12 insertable into a patient 14 .
  • the end effector 12 includes a tissue-retaining device 16 .
  • the tissue-retaining device 16 includes a first tissue-retaining member 18 having an (i.e., at least one) ultrasound medical-treatment transducer 20 (also called “transducer 20”) and includes a second tissue-retaining member 22 .
  • the first and second tissue-retaining members 18 and 22 are operatively connected together to retain patient tissue 24 between the first and second tissue-retaining members 18 and 22 and to release patient tissue 24 so retained.
  • an ultrasound medical-treatment transducer is an ultrasound transducer adapted at least for ultrasound medical treatment of a patient such as, but not limited to, a human patient.
  • An ultrasound medical-treatment transducer includes either a single ultrasound medical-treatment transducer element or an array of ultrasound medical-treatment transducer elements, as is known to those skilled in the art.
  • An ultrasound medical-treatment transducer may or may not also be adapted for ultrasound imaging of a patient.
  • an ultrasound imaging transducer is an ultrasound transducer adapted at least for ultrasound imaging of a patient and may or may not also be adapted for ultrasound medical-treatment of a patient.
  • Advantages of retaining patient tissue between two tissue-retaining members during ultrasound medical treatment by one of the tissue-retaining members include having a single instrument which ultrasonically medically treats patient tissue and at the same time immobilizes patient tissue against undesired movement during the treatment. It is also noted that in one application the tissue-retaining device is a clamp which retains and holds tissue and that in another application the tissue-retaining device retains tissue against movement, but does not hold tissue, and therefore is not a clamp.
  • the second tissue-retaining member 22 has an ultrasound imaging and/or medical treatment transducer.
  • the tissue-retaining device 16 has at least one additional tissue-retaining member.
  • Mechanisms, not shown, for remotely moving two (or more) members toward and away from each other are within the ordinary level of skill of the artisan and include, without limitation, the use of pivotal member attachments and the use of cables or motors.
  • the retained patient tissue 24 is retained between the ultrasound medical-treatment transducer 20 and the second tissue-retaining member 22 .
  • the ultrasound medical-treatment transducer 20 focuses ultrasound energy, such focusing being known to those skilled in the art.
  • the second tissue-retaining member 22 is substantially ultrasonically non-reflective.
  • a second expression of the first embodiment of the present invention is for an ultrasound medical treatment system 10 including an end effector 12 insertable into a patient 14 .
  • the end effector 12 includes a tissue-retaining device 16 .
  • the tissue-retaining device 16 includes a first tissue-retaining member 18 having an (i.e., at least one) ultrasound imaging and medical-treatment transducer 26 (also called “transducer 26”) and includes a second tissue-retaining member 22 .
  • the first and second tissue-retaining members 18 and 22 are operatively connected together to retain patient tissue 24 between the first and second tissue-retaining members 18 and 22 and to release patient tissue 24 so retained.
  • an ultrasound imaging and medical-treatment transducer is an ultrasound transducer adapted at least for both ultrasound imaging and ultrasound medical treatment of a patient.
  • An ultrasound imaging and medical-treatment transducer includes either a single ultrasound imaging and medical-treatment transducer element or an array of ultrasound medical transducer elements (including an array having at least one separate element for imaging and at least one separate element for medical treatment or an array having at least two elements each adapted for both imaging and medical treatment), as is known to those skilled in the art.
  • the retained patient tissue 24 is retained between the imaging and medical-treatment transducer 26 and the second tissue-retaining member 22 .
  • the ultrasound imaging and medical-treatment transducer 26 focuses ultrasound energy.
  • the second tissue-retaining member 22 is substantially ultrasonically non-reflective.
  • a third expression of the first embodiment shown in FIGS. 1 - 3 is for an ultrasound medical treatment system 10 including an end effector 12 insertable into a patient 14 .
  • the end effector 12 includes a tissue-retaining device 16 .
  • the tissue-retaining device 16 includes a first tissue-retaining member 18 having an (i.e., at least one) ultrasound medical-treatment transducer 20 and includes a second tissue-retaining member 22 having an (i.e., at least one) ultrasound reflector 28 .
  • the first and second tissue-retaining members 18 and 22 are operatively connected together to retain patient tissue 24 between the first and second tissue-retaining members 18 and 22 and to release patient tissue 24 so retained.
  • Advantages of retaining patient tissue between two tissue-retaining members during ultrasound medical treatment by an ultrasound medical-treatment transducer of a first tissue-retaining member and an ultrasound reflector of a second tissue-retaining member include having a single instrument which ultrasonically medically treats patient tissue by direct ultrasound, which enhances the ultrasound medical treatment by reflected ultrasound, and which at the same time immobilizes patient tissue against undesired movement during the treatment.
  • an ultrasound reflector 28 is a material which reflects ultrasound at least to a degree that would substantially medically affect patient tissue over a treatment period by direct ultrasound which is being reflected back by the ultrasound reflector.
  • Choices of ultrasound reflecting materials include, without limitation, acoustically-rigid materials such as stainless steel (which reflects about 100%) and aluminum (which reflects about 80%) and acoustically-softer materials such as corporene (which reflects about 90%).
  • An ultrasound reflecting material is contrasted with an ultrasound absorbing material such as, without limitation, rubber or plastic.
  • the retained patient tissue 24 is retained between the ultrasound medical-treatment transducer 20 and the ultrasound reflector 28 .
  • the ultrasound medical-treatment transducer 20 and the ultrasound reflector 28 each focus ultrasound energy, such ultrasound reflector focusing being accomplished by the shape of, or by shaping, the reflector surface as is within the ordinary level of skill of the artisan.
  • a fourth expression of the first embodiment shown in FIGS. 1 - 3 is for an ultrasound medical treatment system 10 including an end effector 12 insertable into a patient 14 .
  • the end effector 12 includes a tissue-retaining device 16 .
  • the tissue-retaining device 16 includes a first tissue-retaining member 18 having an (i.e., at least one) ultrasound imaging and medical-treatment transducer 26 and includes a second tissue-retaining member 22 having an (i.e., at least one) ultrasound reflector 28 .
  • the first and second tissue-retaining members 18 and 22 are operatively connected together to retain patient tissue 24 between the first and second tissue-retaining members 18 and 22 and to release patient tissue 24 so retained.
  • the retained patient tissue 24 is retained between the ultrasound imaging and medical-treatment transducer 26 and the ultrasound reflector 28 .
  • the ultrasound imaging and medical-treatment transducer 26 and the ultrasound reflector 28 each focus ultrasound energy.
  • the ultrasound reflector 28 is disposed to receive ultrasound energy from the transducer 20 and 26 and is oriented to reflect the received ultrasound energy back into patient tissue 24 retained by the tissue-retaining device 16 .
  • the ultrasound reflector 28 is oriented to reflect the received ultrasound energy away from the transducer 20 and 26 when the patient tissue 14 is retained by the tissue-retaining device 16 .
  • one of the first and second tissue-retaining members 18 and 22 is controllably orientatable relative to the other of the first and second tissue-retaining members 18 and 22 such as, without limitation, by being orientatable along the double-headed arrows shown in FIG. 2.
  • the second tissue-retaining member 22 is controllably orientatable relative to the first tissue-retaining member 18 to reflect the received ultrasound energy back along different directions.
  • a first alternate end effector 30 is shown in FIG. 4 wherein the second tissue-retaining member 32 is controllably orientatable relative to the first tissue-retaining member 34 as shown by the double-headed arrows in FIG. 4.
  • Mechanisms, not shown, for remotely controlling the orientation of one member relative to another member are within the ordinary level of skill of the artisan and include, without limitation, the use of pivotal member attachments and the use of cables or motors.
  • the transducer 20 and 26 generates wide-focused ultrasound (shown by the two single-headed arrows coming from the first tissue-retaining member 18 in FIG. 3) and the ultrasound reflector 28 generates narrow-focused ultrasound (shown by the two single-headed arrows coming from the second tissue-retaining member 22 in FIG. 3).
  • the end effector 12 is an open-surgery end effector, an endoscopic end effector, a laparoscopic end effector (as shown in FIG. 1), a catheter end effector (such as, but not limited to, an intravascular catheter end effector), or a needle end effector, as can be appreciated by those skilled in the art.
  • the end effector 12 is used to retain a blood vessel and then to ultrasonically treat the blood vessel to seal the blood vessel stopping the flow of blood in the retained blood vessel.
  • the end effector 12 is used to retain patient tissue and then to ultrasonically ablate at least a portion of the retained patient tissue.
  • the end effector 12 has a longitudinal axis 35 , and one of the first and second tissue-retaining members 18 and 22 at all times faces along a direction which is substantially perpendicular to the longitudinal axis 35 . If the one tissue-retaining member were planar, this means that the longitudinal axis would be substantially parallel to the plane of the one tissue-retaining member. In one enablement, the one tissue-retaining member is the first tissue-retaining member 18 .
  • a second alternate end effector 36 has first and second tissue-retaining members 38 and 40 which are hinged together to relatively move as indicated by the double-headed arrow and which are shown in a partially open configuration in FIG. 5.
  • the second alternate end effector 36 has a longitudinal axis 42 , and one of the first and second tissue-retaining members 38 and 40 at all times faces along a direction which is substantially parallel to the longitudinal axis 42 . If the one tissue-retaining member were planar, this means that the longitudinal axis would be substantially perpendicular to the plane of the one tissue-retaining member. In one enablement, the one tissue-retaining member is the first tissue-retaining member 38 .
  • a third alternate end effector 37 having first and second tissue-retaining members 39 and 41 with one member longitudinally movable with respect to the other member (as indicated by the double-headed arrow) is shown in FIG. 6.
  • the third alternate end effector 37 has a longitudinal axis 43 , and one of the first and second tissue-retaining members 39 and 41 at all times faces along a direction which is substantially parallel to the longitudinal axis 43 .
  • the one tissue-retaining member is the first tissue-retaining member 39 .
  • the ultrasound medical treatment system 10 also includes a handpiece 44 operatively connected to the end effector 12 and to an ultrasound controller 46 operatively connected to a foot-pedal power switch 47 , as can be appreciated by those skilled in the art.
  • a first method of the invention is for ultrasound medical treatment of a patient and uses the ultrasound medical treatment system as previously described in the first, second, third or fourth expression of the first embodiment with or without the previously-described variations, etc. thereof.
  • the first method includes steps a) through e).
  • Step a) includes endoscopically inserting the end effector into an ear, nose, or throat of the patient.
  • Step b) includes guiding the end effector in the patient.
  • Step c) includes identifying patient tissue for medical treatment such as optionally at least in part from ultrasound imaging using the transducer.
  • Other ways of identifying patient tissue for medical treatment include, without limitation, using x-rays and/or MRI imaging, as are known to the artisan.
  • Step d) includes retaining the identified patient tissue using the tissue-retaining device.
  • Step e) includes medically treating the retained patient tissue with ultrasound using the transducer or using the transducer and the ultrasound reflector.
  • one tissue-retaining member at all times faces along a direction which is substantially parallel to the longitudinal axis of the end effector (as seen in FIGS. 5 and 6).
  • a second method of the invention is for ultrasound medical treatment of a patient and uses the ultrasound medical treatment system as previously described in the first, second, third or fourth expression of the first embodiment with or without the previously-described variations, etc. thereof.
  • the second method includes steps a) through c).
  • Step a) includes inserting the end effector 12 into the patient.
  • Step b) includes retaining an intervertebral disk 48 (see FIG. 3) of the patient with the tissue-retaining device, wherein the intervertebral disk 48 includes tissue.
  • Step c) includes medically treating the retained intervertebral disk 48 with ultrasound to shrink the tissue using the transducer or using the transducer and the ultrasound reflector.
  • one tissue-retaining member at all times faces along a direction which is substantially perpendicular to the longitudinal axis of the end effector (as seen in FIGS. 2 and 4).
  • the intervertebral disk 48 includes connective and nerve tissue.
  • a third method of the invention is for ultrasound medical treatment of a patient and uses the ultrasound medical treatment system as previously described in the first, second, third or fourth expression of the first embodiment with or without the previously-described variations, etc. thereof.
  • the third method includes steps a) through c).
  • Step a) includes inserting the end effector into the patient.
  • Step b) includes retaining a joint of the patient with the tissue-retaining device, wherein the joint includes tissue.
  • Step c) includes medically treating the retained joint with ultrasound to shrink the tissue using the transducer or using the transducer and the ultrasound reflector.
  • one tissue-retaining member at all times faces along a direction which is substantially perpendicular to the longitudinal axis of the end effector (as seen in FIGS. 2 and 4).
  • the joint includes connective and nerve tissue.
  • one application of the ultrasound medical treatment system 10 of the previously-described first through fourth expressions of the first embodiment uses the tissue-retaining device to retain a blood vessel and uses the transducer, or the transducer and the ultrasound reflector, to substantially stop the flow of blood within the blood vessel.
  • FIGS. 7 - 8 illustrate a second embodiment of the present invention which is an ultrasound medical treatment system 50 including an end effector 52 insertable into a patient.
  • the end effector 52 includes a tissue-retaining device 54 .
  • the tissue-retaining device 54 includes a first tissue-retaining member 56 having an ultrasound imaging and medical-treatment transducer 58 and includes a second tissue-retaining member 60 having an ultrasound reflector 62 .
  • the first and second tissue-retaining members 56 and 60 are operatively connected together to retain patient tissue between the first and second tissue-restraining members and to release patient tissue so retained.
  • the first and second tissue-retaining members 56 and 60 always maintain a substantially parallel alignment.
  • Advantages of having a substantially parallel alignment between the tissue-retaining members include, in one example, having the transducer and the ultrasound reflector maintain a substantially parallel alignment for improved reflected ultrasound medical treatment enhancement for any thickness of patient tissue retained by the tissue-retaining members.
  • the first tissue-retaining member 56 is a distal end portion 64 of a first tube 66 .
  • the ultrasound medical treatment system 50 also includes a second tube 68 , first and second link members 70 and 72 , and a cable 74 .
  • the second tube 68 is oriented substantially parallel to the first tube 66 .
  • the first and second link members 70 and 72 are pivotally attached to the second tissue-retaining member 60 and to the second tube 68 at pivot points 76 - 82 creating a hinged parallelogram defined by a proximal portion 84 of the second tissue-retaining member 60 , a distal portion 86 of the second tube 68 , and the first and second link members 70 and 72 .
  • the ultrasound reflector 62 is disposed at a distal portion 88 of the second tissue-retaining member 60 and faces the transducer 58 .
  • the cable 74 is operatively connected to the hinged parallelogram to move the second tissue-retaining member 60 toward and away from the first tissue-retaining member 56 .
  • the ultrasound medical treatment system 50 also includes an outer tube 90 .
  • the cable 74 and the first and second tubes 66 and 68 are disposed in the outer tube 90 .
  • the ultrasound medical treatment system 50 also includes a handpiece 92 .
  • the cable 74 and the first, second, and outer tubes 66 , 68 and 90 are operatively connected to the handpiece 92 .
  • the orientation of the first tube 66 about the longitudinal axis of the first tube 66 is controlled by a step motor (not shown) disposed in, and actuated by, the handpiece 92 .
  • the first tube 66 is a hollow tube allowing for transducer wiring (not shown), and the second tube is a solid tube (not shown).
  • the tubes 66 , 68 , and 90 may be rigid or flexible which also is true for any tube arrangement (specifically disclosed as rigid or flexible, or not so specifically disclosed) of any end effector and for any end effector itself of any of the previous or following embodiments of the invention.
  • FIGS. 9 - 11 illustrate a third embodiment of the present invention.
  • a first expression of the third embodiment of the present invention is for an ultrasound medical system 94 including a tube 96 and a plurality of resiliently flexible fingers 98 .
  • the tube 96 has a distal end 100 insertable into a patient and has a lumen 102 with a distal opening 104 .
  • the fingers 98 are extendable out of the distal opening 104 of the lumen 102 creating a deployed state (seen in FIG. 10) and which are at-least-partially retractable into the distal opening 104 of the lumen 102 creating a stowed state (seen in FIG. 11).
  • Each finger 98 includes an ultrasound transducer 106 .
  • the distance between the ultrasound transducers 106 of adjacent fingers 98 is greater in the deployed state than in the stowed state.
  • an ultrasound medical system is a medical system which at least provides ultrasound imaging or ultrasound medical treatment of a patient.
  • Advantages of the tube and extendable/retractable flexible-finger array arrangement include, when the transducers are ultrasound medical-treatment transducers having a common focal zone in the deployed state, providing faster medical treatment times by allowing for more transducer ultrasound-emitting surface area which can be simply stowed into a compact shape for transport within a patient to and from the site of patient tissue receiving ultrasound medical treatment.
  • the fingers 98 are only partially retracted into the distal opening 104 of the lumen 102 in the stowed state (as seen in FIG. 11). In another variation, not shown, the fingers 98 are completely retracted into the distal opening 104 of the lumen 102 in the stowed state.
  • the fingers 98 being extendable out of the distal opening 104 of the lumen 102 creating the deployed state and being at-least-partially retractable into the distal opening 104 of the lumen 102 creating the stowed state means the fingers 98 protrude more out of the distal opening 104 of the lumen 102 in the extended state than (if at all) in the stowed state.
  • Mechanisms, not shown, for remotely extending and retracting fingers in a tube include, without limitation, a common shaft attached to the proximal ends of the fingers, disposed in the lumen of the tube, and spring-biased to move forward upon squeezing of a handpiece and to return backward upon relaxing of the handpiece, as is within the ordinary level of skill of the artisan.
  • the distal opening 104 of the lumen 102 coincides with the distal end 100 of the tube 96 .
  • the distal opening of the lumen is spaced apart from the distal end of the tube.
  • the distal opening 104 of the lumen 102 faces in the same direction as the distal end 100 of the tube 96 .
  • At least one of the transducers 106 is an ultrasound imaging transducer. In the same or a different example, at least one of the transducers 106 is an ultrasound medical-treatment transducer. In the same or a different example, at least one of the transducers 106 is an ultrasound imaging and medical-treatment transducer.
  • a second expression of the third embodiment is for an ultrasound medical treatment system 108 including a tube 96 and including an end effector 110 having a plurality of fingers 98 .
  • the tube 96 has a distal end 100 insertable into a patient and has a lumen 102 with a distal opening 104 .
  • the fingers 98 are extendable out of the distal opening 104 of the lumen 102 creating a deployed state (seen in FIG. 10) and are at-least-partially retractable into the distal opening 104 of the lumen 102 creating a stowed state (seen in FIG. 11).
  • Each finger 98 includes an ultrasound medical-treatment transducer 112 . The distance between the ultrasound medical-treatment transducers 112 of adjacent fingers 98 is greater in the deployed state than in the stowed state.
  • a third expression of the third embodiment is for an ultrasound medical treatment system 108 including a tube 96 and including an end effector 110 having a plurality of fingers 98 .
  • the tube 96 has a distal end 100 insertable into a patient and has a lumen 102 with a distal opening 104 .
  • the fingers 98 are extendable out of the distal opening 104 of the lumen 102 creating a deployed state (seen in FIG. 10) and are at-least-partially retractable into the distal opening 104 of the lumen 102 creating a stowed state (seen in FIG. 11).
  • Each finger 98 includes an ultrasound imaging and medical-treatment transducer 114 . The distance between the ultrasound imaging and medical-treatment transducers 114 of adjacent fingers 98 is greater in the deployed state than in the stowed state.
  • the transducers 106 , 112 and 114 each have an ultrasound-emitting concave surface 116 .
  • the transducers have a planar ultrasound-emitting surface.
  • each concave surface 116 is concave as one moves along the corresponding finger 98 (as best seen in FIG. 10).
  • each concave surface is concave as one moves across the corresponding finger or is concave as one moves both along and across the corresponding finger (such as, for example, with a hemispherically-concave surface).
  • the concave surfaces 116 together have a substantially common focal zone when the fingers 98 are in the deployed state.
  • the end effector 110 is seen with its fingers 98 facing the patient tissue 119 in FIG. 10.
  • the focal zones are not common.
  • the fingers 98 define an open-hand finger array 118 in the deployed state.
  • An alternate flexible finger arrangement in the form of a substitute end effector 120 is shown in FIG. 12, wherein the fingers 122 define a clawed-hand finger array 124 in the deployed state.
  • the substitute end effector 120 is seen with its fingers 122 surrounding the patient tissue 126 for imaging and/or medical treatment by the ultrasound transducers 128 in FIG. 12. In other transducer arrangements, not shown, one or more or all of the ultrasound transducers face outward rather than facing inward.
  • the fingers 98 are at least four in number.
  • the end effector 110 (as well as the substitute end effector 120 ) is an open-surgery end effector, an endoscopic end effector, a laparoscopic end effector (as shown in FIG. 9), a catheter end effector (such as, but not limited to, an intravascular catheter end effector), or a needle end effector, as can be appreciated by those skilled in the art.
  • the ultrasound medical treatment system 108 also includes a handpiece 130 operatively connected to the end effector 110 and to an ultrasound controller 132 operatively connected to a foot-pedal power switch 133 , as can be appreciated by those skilled in the art.
  • a fourth embodiment of the present invention is shown in FIGS. 13 - 15 .
  • a first expression of the fourth embodiment of the present invention is for an ultrasound medical system 134 including an ultrasound transducer assembly 136 insertable into a patient.
  • the ultrasound transducer assembly 136 has a longitudinal axis 138 .
  • the ultrasound transducer assembly 136 includes a plurality P of ultrasound transducers 140 .
  • Each transducer 140 has an ultrasound-emitting surface 142 oriented at an angle of substantially 360/P degrees apart from the ultrasound-emitting surface 142 of an adjacent transducer 140 when viewed in a cross section (see FIG. 15) of the transducer assembly 136 taken by a cutting plane which is perpendicular to the longitudinal axis 138 .
  • Advantages of such a transducer configuration include, in one example, providing directed or focused medical-treatment ultrasound which is not possible with a cylindrical ultrasound transducer, as can be appreciated by those skilled in the art.
  • an ultrasound transducer assembly 136 insertable into a patient is an ultrasound imaging transducer assembly, an ultrasound medical-treatment transducer assembly, or an ultrasound imaging and medical-treatment transducer assembly.
  • An ultrasound imaging transducer assembly has at least one ultrasound imaging transducer, and an ultrasound medical-treatment transducer assembly has at least one ultrasound medical-treatment transducer.
  • An ultrasound imaging and medical-treatment transducer assembly has at least one ultrasound imaging transducer and at least one ultrasound medical-treatment transducer or has at least one ultrasound imaging and medical-treatment transducer.
  • a second expression of the fourth embodiment of the present invention is for an ultrasound medical-treatment system 144 including an end effector 146 insertable into a patient.
  • the end effector 146 includes an ultrasound medical-treatment transducer assembly 148 .
  • the ultrasound medical-treatment transducer assembly 148 has a longitudinal axis 138 .
  • the ultrasound medical-treatment transducer assembly 148 includes a plurality P of ultrasound medical-treatment transducers 150 .
  • Each transducer 150 has an ultrasound-emitting surface 142 which faces away from the longitudinal axis 138 and which is oriented at an angle of substantially 360/P degrees apart from the ultrasound-emitting surface 142 of an adjacent transducer 150 when viewed in a cross section (see FIG. 15) of the transducer assembly 148 taken by a cutting plane which is perpendicular to the longitudinal axis 138 .
  • at least one of the ultrasound medical-treatment transducers 150 is also adapted for ultrasound imaging.
  • a fourth method of the present invention is for ultrasound medical treatment of a patient and uses the ultrasound medical treatment system 144 as previously described in the second expression of the fourth embodiment.
  • the fourth method includes steps a) through b).
  • Step a) includes inserting the end effector 146 into the liver of the patient.
  • Step b) includes medically treating a lesion in the liver with ultrasound from the ultrasound medical-treatment transducer assembly 148 .
  • step a) interstially inserts the end effector 146 into the lesion.
  • step a) endoscopically inserts the end effector 146 into the liver through the hepato-biliary duct system.
  • a third expression of the fourth embodiment of the present invention is for an ultrasound medical treatment system 144 including an end effector 146 insertable into a patient.
  • the end effector 146 includes an ultrasound imaging and medical-treatment transducer assembly 152 .
  • the ultrasound imaging and medical-treatment transducer assembly 152 has a longitudinal axis 138 .
  • the ultrasound imaging and medical-treatment transducer assembly 152 includes a plurality P of ultrasound imaging and medical-treatment transducers 154 .
  • Each transducer 154 has an ultrasound-emitting surface 142 which faces away from the longitudinal axis 138 and which is oriented at an angle of substantially 360/P degrees apart from the ultrasound-emitting surface 142 of an adjacent transducer 154 when viewed in a cross section (see FIG. 15) of the transducer assembly 152 taken by a cutting plane which is perpendicular to the longitudinal axis 138 .
  • a fifth method of the present invention is for ultrasound medical treatment of a patient and uses the ultrasound medical-treatment system 144 as previously described in the third expression of the fourth embodiment.
  • the fourth method includes steps a) through c).
  • Step a) includes inserting the end effector 146 into the liver of the patient.
  • Step b) includes identifying a lesion in the liver for medical treatment at least in part from ultrasound imaging using the ultrasound imaging and medical-treatment transducer assembly 152 .
  • Step c) includes medically treating the lesion with ultrasound from the ultrasound imaging and medical-treatment transducer assembly 152 .
  • step a) interstially inserts the end effector 146 into the lesion.
  • step a) endoscopically inserts the end effector 146 into the liver through the hepato-biliary duct system.
  • the transducer assembly 136 , 148 , and 152 has a distal tip 156 and has a tip transducer 158 .
  • the tip transducer is a forward facing tip transducer.
  • the tip transducer is a sideways facing tip transducer.
  • the tip transducer is an ultrasound imaging tip transducer.
  • the tip transducer is an ultrasound medical-treatment tip transducer.
  • the tip transducer is an ultrasound imaging and medical-treatment tip transducer.
  • the tip transducer is a transponder which emits electromagnetic waves or mechanical waves or both.
  • each ultrasound-emitting surface 142 is substantially straight when viewed in the cross section, as seen in FIG. 15.
  • each ultrasound-emitting surface 142 has a substantially concave shape as one moves along the ultrasound-emitting surface 142 in a direction parallel to the longitudinal axis 138 , and each ultrasound-emitting surface 142 has a focal zone.
  • each ultrasound-emitting surface 162 has a substantially planar shape.
  • each ultrasound-emitting surface 164 has a substantially concave shape when viewed in the cross section, and each ultrasound-emitting surface 164 has a focal zone.
  • each ultrasound-emitting surface 164 also has a substantially concave shape as one moves along the ultrasound-emitting surface 164 in a direction parallel to the longitudinal axis (such as, for example, by the ultrasound-emitting surface 164 having a hemispherically-concave shape).
  • Such ultrasound-emitting surface shapes are equally applicable to any ultrasound transducer mentioned in any other embodiment of the invention.
  • P is no greater than four. In one variation, P equals three as seen in FIGS. 15 and 17. In another variation, P equals two as seen in FIG. 16.
  • the end effector 146 is an open-surgery end effector, an endoscopic end effector, a laparoscopic end effector (as shown in FIG. 13), a catheter end effector (such as, but not limited to, an intravascular catheter end effector), or a needle end effector, as can be appreciated by those skilled in the art.
  • the ultrasound medical treatment system 144 also includes a handpiece 166 operatively connected to the end effector 146 and to an ultrasound controller 168 operatively connected to a foot-pedal power switch 169 , as can be appreciated by the artisan.
  • an ultrasound medical treatment system 170 includes a tube 172 , a first end effector 174 , and a second end effector 176 .
  • the tube 172 has a distal end 178 insertable into a patient 180 and has a lumen 182 .
  • the first end effector 174 has a cutting tool 184 , is introducible into the lumen 182 of the inserted tube 172 from outside the patient 180 , and is translatable through the lumen 182 of the inserted tube 172 to inside the patient 180 .
  • the second end effector 176 has an ultrasound medical-treatment transducer assembly 186 , is introducible into the lumen 182 of the inserted tube 172 from outside the patient 180 , and is translatable through the lumen 182 of the inserted tube 172 to inside the patient 180 .
  • the first and second end effectors are introduced into the lumen through separate openings in the lumen or through separate branch channels leading to the lumen.
  • the first and second end effectors are introduced into the lumen through the same opening in the lumen.
  • a lumen opening is disposed at the end of the tube.
  • a lumen opening is spaced apart from the end of the tube.
  • a second expression of the fifth embodiment of the present invention is for an ultrasound medical treatment system 170 including a tube 172 , a first end effector 174 , and a second end effector 176 .
  • the tube has a distal end 178 insertable into a patient 180 and has a lumen 182 with a distal opening 188 and a proximal opening 190 .
  • the first end effector 174 has a cutting tool 184 , is introducible into the proximal opening 190 , and is translatable through the lumen 182 to the distal opening 188 .
  • the second end effector 176 has an ultrasound medical-treatment transducer assembly 186 , is introducible into the proximal opening 190 , and is translatable through the lumen 182 to the distal opening 188 .
  • the lumen 182 is sized to allow introduction of only one of the first and second end effectors 174 and 176 at a time.
  • the distal end 178 of the tube 172 is interstitially insertable into patient tissue 192 of the patient 180 .
  • the cutting tool 184 is a biopsy cutting tool 194 or other excisional cutting tool.
  • a third expression of the fifth embodiment of the present invention is for an ultrasound medical treatment system 170 including a tube 172 , a first end effector 174 , and a second end effector 176 .
  • the tube 172 has a distal end 178 interstitially insertable into breast tissue 196 of a patient 180 and has a lumen 182 with a distal opening 188 and a proximal opening 190 .
  • the first end effector 174 has a biopsy cutting tool 194 (or other excisional cutting tool), is introducible into the proximal opening 190 , and is translatable through the lumen 182 to the distal opening 188 .
  • the second end effector 176 has an ultrasound medical-treatment transducer assembly 186 , is introducible into the proximal opening 190 , and is translatable through the lumen 182 to the distal opening 188 .
  • the lumen 182 is sized to allow introduction of only one of the first and second end effectors 174 and 176 at a time.
  • the first end effector also includes a suction mechanism to draw in patient tissue to be biopsied by the biopsy cutting tool 194 .
  • the tube 172 and the first end effector 174 (with the biopsy cutting tool 194 including a suction mechanism) are based on components of a Mammotome® Breast Biopsy System manufactured by Ethicon Endo-Surgery, Inc. (a Johnson & Johnson Company).
  • a sixth method of the invention is for ultrasound medical treatment of a patient 180 and uses the ultrasound medical treatment system 170 as previously described in the third expression of the fifth embodiment of the present invention.
  • the sixth method includes steps a) through h).
  • Step a) includes identifying possibly cancerous breast tissue 196 of the patient.
  • Step b) includes interstitially inserting the distal end 178 of the tube 172 into the patient 180 with the distal opening 188 disposed proximate the breast tissue 196 and with the proximal opening 190 disposed outside the patient.
  • Step c) includes introducing the first end effector 174 into the proximal opening 190 and translating the first end effector 174 through the lumen 182 to the distal opening 188 .
  • Step d) includes obtaining a biopsy sample of the breast tissue 196 with the biopsy cutting tool 194 .
  • Step e) includes removing the first end effector 174 from the lumen 182
  • Step f) includes introducing the second end effector 176 into the proximal opening 190 and translating the second end effector 176 through the lumen 182 to the distal opening 188 .
  • Step g) includes identifying an area of hemorrhaging in the breast tissue where the biopsy sample was obtained.
  • Step h) includes medically treating the identified area with ultrasound using the transducer assembly 186 to substantially stop the hemorrhaging.
  • the sixth method of the invention also includes the steps of testing the biopsy sample for cancer and substantially ablating any remaining cancer in the breast tissue with ultrasound using the transducer assembly 186 .
  • Advantages of such an ultrasound medical treatment system and method include the ease of obtaining a breast biopsy and the control of hemorrhaging caused by the biopsy procedure coupled together in a minimally invasive manner.
  • an ultrasound medical treatment system 170 includes a tube 172 , a first end effector 174 , and a second end effector 176 .
  • the tube 172 has a distal end 178 insertable into a patient 180 and has a lumen 182 .
  • the first end effector 174 has a cutting tool 184 , is introducible into the lumen 182 of the inserted tube 172 from outside the patient 180 , and is translatable through the lumen 182 of the inserted tube 172 to inside the patient 180 .
  • the second end effector 176 has an ultrasound imaging and medical-treatment transducer assembly 198 , is introducible into the lumen 182 of the inserted tube 172 from outside the patient 180 , and is translatable through the lumen 182 of the inserted tube 172 to inside the patient 180 .
  • the first and second end effectors are introduced into the lumen through separate openings in the lumen or through separate branch channels leading to the lumen.
  • the first and second end effectors are introduced into the lumen through the same opening in the lumen.
  • a lumen opening is disposed at the end of the tube.
  • a lumen opening is spaced apart from the end of the tube.
  • a fifth expression of the fifth embodiment of the present invention is for an ultrasound medical treatment system 170 including a tube 172 , a first end effector 174 , and a second end effector 176 .
  • the tube has a distal end 178 insertable into a patient 180 and has a lumen 182 with a distal opening 188 and a proximal opening 190 .
  • the first end effector 174 has a cutting tool 184 , is introducible into the proximal opening 190 , and is translatable through the lumen 182 to the distal opening 188 .
  • the second end effector 176 has an ultrasound imaging and medical-treatment transducer assembly 198 , is introducible into proximal opening 190 , and is translatable through the lumen 182 to the distal opening 188 .
  • the lumen 182 is sized to allow introduction of only one of the first and second end effectors 174 and 176 at a time.
  • the distal end 178 of the tube 172 is interstitially insertable into patient tissue 192 of the patient 180 .
  • the cutting tool 184 is a biopsy cutting tool 194 or other excisional cutting tool.
  • a sixth expression of the fifth embodiment of the present invention is for an ultrasound medical treatment system 170 including a tube 172 , a first end effector 174 , and a second end effector 176 .
  • the tube 172 has a distal end 178 interstitially insertable into breast tissue 196 of a patient 180 and has a lumen 182 with a distal opening 188 and a proximal opening 190 .
  • the first end effector 174 has a biopsy cutting tool 194 (or other excisional cutting tool), is introducible into the proximal opening 190 , and is translatable through the lumen 182 to the distal opening 188 .
  • the second end effector 176 has an ultrasound imaging and medical-treatment transducer assembly 196 , is introducible into the proximal opening 190 , and is translatable through the lumen 182 to the distal opening 188 .
  • the lumen 182 is sized to allow introduction of only one of the first and second end effectors 174 and 176 at a time.
  • the tube 172 and the first end effector 174 are based on components of a Mammotome® Breast Biopsy System manufactured by Ethicon Endo-Surgery, Inc. (a Johnson & Johnson Company).
  • a seventh method of the invention is for ultrasound medical treatment of a patient 180 and uses the ultrasound medical treatment system 170 as previously described in the sixth expression of the fifth embodiment of the present invention.
  • the seventh method includes steps a) through h).
  • Step a) includes identifying possibly cancerous breast tissue 196 of the patient.
  • Step b) includes interstitially inserting the distal end 178 of the tube 172 into the patient 180 with the distal opening 188 disposed proximate the breast tissue 196 and with the proximal opening 190 disposed outside the patient.
  • Step c) includes introducing the first end effector 174 into the proximal opening 190 and translating the first end effector 174 through the lumen 182 to the distal opening 188 .
  • Step d) includes obtaining a biopsy sample of the breast tissue 196 with the biopsy cutting tool 194 .
  • Step e) includes removing the first end effector 174 from the lumen 182
  • Step f) includes introducing the second end effector 176 into the proximal opening 190 and translating the second end effector 176 through the lumen 182 to the distal opening 188 .
  • Step g) includes identifying an area of hemorrhaging in the breast tissue where the biopsy sample was obtained from ultrasound imaging using the transducer assembly 198 .
  • Step h) includes medically treating the identified area with ultrasound using the transducer assembly 198 to substantially stop the hemorrhaging.
  • the seventh method of the invention also includes the steps of testing the biopsy sample for cancer and substantially ablating any remaining cancer in the breast tissue with ultrasound using the transducer assembly 198 .
  • Advantages of such an ultrasound medical treatment system and method include the ease of obtaining a breast biopsy and the imaging and control of hemorrhaging caused by the biopsy procedure coupled together in a minimally invasive manner.
  • the ultrasound medical treatment system 170 also includes a handpiece 199 which is attached to the tube 172 , which contains the first end effector 174 for extending the cutting tool 184 into, and withdrawing it from, the lumen 182 , and which is operatively connected to an ultrasound controller 201 via a first cable 203 .
  • the second end effector 176 in this enablement, is operatively connected to the ultrasound controller 201 via a second cable 205 and is inserted into the lumen 182 from outside the handpiece 199 as shown in FIG. 18.
  • An eighth method of the invention is shown in block diagram form in FIG. 21 and is for medical treatment of a patient.
  • the eighth method includes steps a) through f).
  • Step a) is labeled “Obtain Transducer Assembly” in block 200 of FIG. 21.
  • Step a) includes obtaining an ultrasound imaging transducer assembly.
  • Step b) is labeled “Insert Assembly Into Gastrointestinal Area” in block 202 of FIG. 21.
  • Step b) includes inserting the transducer assembly into a gastrointestinal area of the patient.
  • Step c) is labeled “Guide Assembly” in block 204 of FIG. 21.
  • Step c) includes guiding the transducer assembly within the gastrointestinal area.
  • Step d) is labeled “Identify Patient Tissue For Treatment” in block 206 of FIG. 21.
  • Step d) includes identifying patient tissue in the gastrointestinal area for medical treatment.
  • Step e) is labeled “Stage Treatment From Ultrasound Imaging” in block 208 of FIG. 21.
  • Step e) includes staging the medical treatment from ultrasound imaging using the transducer assembly.
  • Step f) is labeled as “Medically Treat Patient” in block 210 of FIG. 21.
  • Step f) includes medically treating the patient tissue according to the staging of step e). It is pointed out that in the eighth method the medical treatment need not include ultrasound medical treatment with the transducer assembly used for staging and/or need not include ultrasound medical treatment with any other ultrasound transducer assembly.
  • a first transducer assembly is used endoscopically to stage the medical treatment in step e) and a second transducer assembly is used laparoscopically to medically treat the patient tissue with ultrasound in step f).
  • the first transducer assembly is used laparoscopically to stage the medical treatment in step e) and the second transducer assembly is used endoscopically to medically treat the patient tissue with ultrasound in step f).
  • the medical treatment in step f) is radio-frequency, laser, microwave, or chemical ablation medical treatment. Other types of medical treatment are left to the artisan.
  • the gastrointestinal (GI) area of a human patient includes, without limitation, the esophagus and the stomach of the upper GI area and the rectum and the colon of the lower GI area. It further is noted that the liver is also considered to be in the GI area for purposes of this method.
  • GI tumors can be visualized with high frequency (6-30 MHz) ultrasound imaging using a cylindrical, side-firing, or half-convex ultrasound array or single-element transducer introduced endoscopically into the GI tract. All layers of the GI tract can be visualized including all layers of the esophagus, stomach, duodenum, colon, etc.
  • a three-dimensional representation of the GI structures is created by collating a series of two-dimensional scans generated by axially advancing the ultrasound transducer. Any neoplastic growth, its morphological characteristics, as well as the tumor's size and shape can easily be determined from the three-dimensional representation.
  • Advantages of such medical-treatment staging from ultrasound imaging include, in one example, providing a non-invasive medical-treatment staging technique which has greater resolution and which is more practical compared to conventional extracorporeal medical-treatment staging techniques such as using x-rays or MRI imaging or compared to using conventional endoscopic optical techniques.
  • a ninth method of the invention is for ultrasound medical treatment of a patient and includes steps a) through f).
  • the ninth method uses the same block diagram of FIG. 21 as does the eighth method but with “end effector” replacing “transducer assembly” in block 200 and with “end effector” replacing “assembly” in blocks 202 and 204 .
  • Step a) includes obtaining an end effector having an ultrasound imaging and medical-treatment transducer assembly.
  • Step b) includes inserting the end effector into a gastrointestinal area of the patient.
  • Step c) includes guiding the transducer assembly within the gastrointestinal area.
  • Step d) includes identifying patient tissue in the gastrointestinal area for medical treatment.
  • Step e) includes staging the medical treatment from ultrasound imaging using the transducer assembly.
  • Step f) includes medically treating the patient tissue with ultrasound using the transducer assembly according to the staging of step e).
  • a tenth method of the invention is for ultrasound medical treatment of a patient and includes steps a) through f).
  • the tenth method uses the same block diagram of FIG. 21 as does the eighth method but with “end effector” replacing “transducer assembly” in block 200 and with “end effector” replacing “assembly” in blocks 202 and 204 .
  • Step a) includes obtaining an end effector having an ultrasound imaging and medical-treatment transducer assembly.
  • Step b) includes inserting the end effector into a gastrointestinal area of the patient.
  • Step c) includes guiding the transducer assembly within the gastrointestinal area.
  • Step d) includes identifying patient tissue in the gastrointestinal area for medical treatment at least in part from ultrasound imaging using the transducer assembly.
  • Step e) includes staging the medical treatment from ultrasound imaging using the transducer assembly.
  • Step f) includes medically treating the patient tissue with ultrasound using the transducer assembly according to the staging of step e).
  • large GI tumors are staged through a laparoscopic access to the GI area, whereby the tumors are identified, staged and treated using an end effector having an ultrasound imaging and medical-treatment transducer assembly.
  • the patient tissue is gastroesophageal tissue containing a lesion, and step f) ultrasonically substantially ablates the lesion.
  • the gastroesophageal tissue contains a blood vessel supplying blood to the lesion, and step f) ultrasonically treats the blood vessel to substantially stop the supply of blood to the lesion from the blood vessel.
  • the patient tissue is liver tissue containing a lesion and a blood vessel supplying blood to the lesion
  • step f) ultrasonically treats the blood vessel to substantially stop the supply of blood to the lesion from the blood vessel.
  • the patient tissue is liver tissue containing a lesion, and step f) ultrasonically substantially ablates the lesion.
  • the liver tissue contains a blood vessel supplying blood to the lesion, and step f) also ultrasonically treats the blood vessel to substantially stop the supply of blood to the lesion from the blood vessel.
  • an end effector having an ultrasound imaging and medical-treatment transducer assembly is introduced endoscopically into the GI tract, is advanced retrogradely through the ampulla of Vater up the common bile duct, and is advanced further into the hepatic duct system where liver parenchyma requiring medical treatment (such as cholangio-carcinomas) are identified, staged, and treated using the end effector.
  • An eleventh method of the invention is shown in block diagram form in FIG. 22 and is for ultrasound medical treatment of a patient.
  • the eleventh method includes steps a) through f).
  • Step a) is labeled “Obtain End Effector” in block 212 of FIG. 22.
  • Step a) includes obtaining an end effector having an ultrasound medical-treatment transducer assembly.
  • Step b) is labeled “Insert End Effector” in block 214 of FIG. 22.
  • Step b) includes inserting the end effector into the patient.
  • Step c) is labeled “Guide End Effector To Lung” in block 216 of FIG. 22.
  • Step c) includes guiding the end effector within the patient to a lung of the patient.
  • Step d) is labeled “Identify Lesion” in block 218 of FIG. 22.
  • Step d) includes identifying a lesion on or in the lung for medical treatment.
  • Step e) is labeled “Position Transducer Assembly” in block 220 of FIG. 22.
  • Step e) includes positioning the transducer assembly on or in the lesion.
  • Step f) is labeled “Medically Treat Lesion” in block 222 of FIG. 22.
  • Step f) includes medically treating the lesion with ultrasound using the transducer assembly.
  • a twelfth method of the invention is for ultrasound medical treatment of a patient and includes steps a) through f).
  • the twelfth method uses the same block diagram of FIG. 22 as does the eleventh method.
  • Step a) includes obtaining an end effector having an ultrasound imaging and medical-treatment transducer assembly.
  • Step b) includes inserting the end effector into the patient.
  • Step c) includes guiding the end effector within the patient to a lung of the patient.
  • Step d) includes identifying a lesion on or in the lung for medical treatment at least in part from ultrasound imaging using the transducer assembly.
  • Step e) includes positioning the transducer assembly on or in the lesion.
  • Step f) includes medically treating the lesion with ultrasound using the transducer assembly.
  • step f) ultrasonically substantially ablates the lesion.
  • the end effector is an endoscopic end effector and step b) transbronchial-endoscopically inserts the end effector into the patient.
  • the end effector is a needle end effector and step b) interstitially inserts the end effector into the patient.
  • step e) positions the transducer assembly on the lesion.
  • step e) positions the transducer assembly in the lesion.
  • a bronchoscope is used to guide the end effector to a lung of the patient.
  • Ultrasound medical treatment of the lung has conventionally been avoided because such ultrasound is prevented from reaching a lesion within the lung by the alveoli of the lung which contain air which reflect back most of the ultrasound preventing the ultrasound from effectively penetrating the lung to the lesion.
  • Using higher power ultrasound for effective penetration of the lung to reach the lesion would injure or destroy the alveoli which are needed for breathing.
  • positioning the ultrasound transducer on or in a lesion of the lung would allow ultrasound medical treatment of the lesion (such as a tumor or an infarct) without injury to the alveoli.
  • Applicants' method is applicable to surface lesions as well as non-surface lesions.
  • Advantages of Applicants' eleventh and twelfth methods for ultrasound medical treatment include, in one example, the destruction of lung cancer lesions in cases which otherwise would be inoperable or incurable.
  • a thirteenth method of the invention is shown in block diagram form in FIG. 23 and is for ultrasound medical treatment of a patient.
  • the thirteenth method includes steps a) through e).
  • Step a) is labeled “Obtain End Effector” in block 224 of FIG. 23.
  • Step a) includes obtaining an end effector having an ultrasound medical-treatment transducer assembly.
  • Step b) is labeled “Insert End Effector” in block 226 of FIG. 23.
  • Step b) includes inserting the end effector into the patient.
  • Step c) is labeled “Guide End Effector” in block 228 of FIG. 23.
  • Step c) includes guiding the end effector within the patient to a region of patient tissue containing a lesion.
  • Step d) is labeled “Identify Blood Vessel Supplying Lesion” in block 230 of FIG. 23.
  • Step d) includes identifying a blood vessel in the region which supplies blood to the lesion.
  • Step e) is labeled “Stop Blood Supply Using Ultrasound” in block 232 of FIG. 23.
  • Step e) includes medically treating the blood vessel with ultrasound from the transducer assembly to substantially seal the blood vessel to stop the supply of blood to the lesion from the blood vessel.
  • One implementation of the thirteenth method of the invention also includes the step of medically treating the lesion with ultrasound from the transducer assembly to substantially ablate the lesion.
  • a fourteenth method of the invention is for ultrasound medical treatment of a patient and includes steps a) through g).
  • the fourteenth method is similar to the thirteenth method.
  • Step a) includes obtaining an end effector having an ultrasound imaging and medical-treatment transducer assembly.
  • Step b) includes inserting the end effector into the patient.
  • Step c) includes guiding the end effector within the patient to a region of patient tissue containing a lesion.
  • Step d) includes identifying the lesion at least in part from ultrasound imaging using the transducer assembly.
  • Step e) includes identifying a blood vessel in the region which supplies blood to the lesion from ultrasound imaging using the transducer assembly.
  • Step f) includes medically treating the blood vessel with ultrasound from the transducer assembly to substantially seal the blood vessel to substantially stop the supply of blood to the lesion from the blood vessel.
  • Step g) includes medically treating the lesion with ultrasound from the transducer assembly to substantially ablate the lesion. It is noted that Doppler ultrasound imaging alone, gray-scale ultrasound imaging alone, and a combination of Doppler and gray-scale ultrasound imaging are known ultrasound techniques to image blood flow in blood vessels.
  • the end effector is an open-surgery end effector.
  • the end effector is an endoscopic end effector.
  • the end effector is a laparoscopic end effector.
  • the end effector is a catheter end effector (such as, but not limited to, an intravascular catheter end effector).
  • the end effector is a needle end effector.
  • a broadened thirteenth method of the invention eliminates the inserting into and guiding within steps of the above-described thirteenth method and includes steps a) through c).
  • Step a) includes obtaining an end effector having an ultrasound medical-treatment transducer assembly.
  • Step b) includes identifying a blood vessel in the patient which supplies blood to a lesion.
  • Step c) includes medically treating the blood vessel with ultrasound from the transducer assembly to substantially seal the blood vessel to substantially stop the supply of blood to the lesion from the blood vessel.
  • a broadened fourteenth method of the invention eliminates the inserting into and guiding within steps of the above-described fourteenth method and includes steps a) through e).
  • Step a) includes obtaining an end effector having an ultrasound imaging and medical-treatment transducer assembly.
  • Step b) includes identifying a lesion in the patient at least in part from ultrasound imaging using the transducer assembly.
  • Step c) includes identifying a blood vessel which supplies blood to the lesion from ultrasound imaging using the transducer assembly.
  • Step d) includes medically treating the blood vessel with ultrasound from the transducer assembly to substantially seal the blood vessel to substantially stop the supply of blood to the lesion from the blood vessel.
  • Step e) includes medically treating the lesion with ultrasound from the transducer assembly to substantially ablate the lesion.
  • the end effector is an extracorporeal end effector.
  • the end effector is an intracorporeal end effector.
  • the end effector can be used in both an extracorporeal mode and in an intracorporeal mode.
  • Advantages of Applicants' thirteenth and broadened thirteenth methods for ultrasound medical treatment include, in one example, the indirect destruction of cancer lesions by ultrasound hemostasis in blood vessels supplying the cancer lesions in cases which otherwise would be inoperable or incurable because the location of the cancer lesions prevents medical treatment of the lesions themselves.
  • Advantages of Applicants' fourteenth and broadened fourteenth methods for ultrasound treatment include, in one example, direct destruction of cancer lesions by ultrasound ablation of the cancer lesions together with the indirect destruction of any cancer lesions missed in the ultrasound ablation step by ultrasound hemostasis in blood vessels supplying blood to the missed cancer lesions.
  • an ultrasound medical treatment system 234 (only a portion of which is shown in FIG. 24) includes an end effector 236 and at least three receivers 238 .
  • the end effector 236 has a transducer assembly 240 including a transducer 242 having at least one transducer element 244 adapted for emitting medical-treatment ultrasound waves and for emitting mechanical waves.
  • mechanical waves includes ultrasound and non-ultrasound compression (acoustic) waves and ultrasound and non-ultrasound shear waves, and that waves include wave pulses.
  • the receivers 238 are spaced apart from the transducer assembly 240 , and the receivers 238 are adapted to receive the emitted mechanical waves for use in locating the position of the transducer assembly 240 .
  • Conventional methods for locating the position of a transponder emitting waves which are received by three receivers are well known.
  • a second expression of the sixth embodiment is identical to the first expression of the sixth embodiment except that the at-least-one transducer element 244 is also adapted for emitting imaging ultrasound waves.
  • the end effector and the receivers are disposable outside (including in one modification on) the patient.
  • the end effector is insertable into the patient and the receivers are disposable outside (including in one modification on) the patient.
  • an ultrasound medical treatment system 246 (only a portion of which is shown in FIG. 25) includes an end effector 248 and at least three receivers 250 .
  • the end effector 248 has an ultrasound medical-treatment transducer assembly 252 and has a transponder 254
  • the transponder 254 is adapted to emit waves, and the waves include electromagnetic waves or mechanical waves or both.
  • the receivers 250 are spaced apart from the transducer assembly 252 , and the receivers 250 are adapted to receive the emitted waves for use in locating the position of the transponder 254 .
  • the ultrasound medical-treatment transducer assembly 252 is an ultrasound imaging and medical-treatment transducer assembly 256 .
  • the end effector 248 is insertable into a patient, the transponder 254 is adapted to emit electromagnetic waves, and the receivers 250 are disposable outside the patient.
  • the receivers 250 are disposable on the patient.
  • the end effector is disposable outside (including in one modification on) the patient and the receivers are disposable outside (including in one modification on) the patient.
  • the end effector 248 is an endoscopic end effector, a laparoscopic end effector, a catheter end effector (such as, but not limited to, an intravascular catheter end effector), or a needle end effector.
  • the end effector 248 has a distal tip 260
  • the transponder 254 is disposed at the distal tip 260 of the end effector 248 .
  • the transducer assembly 252 and 256 is disposed proximate the transponder 254 .
  • a fifteenth method of the invention uses the ultrasound medical treatment system of the first expression of the seventh embodiment and includes steps a) through h).
  • Step a) includes inserting the end effector 248 into the patient.
  • Step b) includes disposing the receivers 250 outside the patient.
  • Step c) includes emitting electromagnetic waves from the transponder 254 .
  • Step d) includes receiving the electromagnetic waves with the disposed receivers 250 .
  • Step e) includes calculating the position of the transponder 254 from the received electromagnetic waves.
  • Step f) includes guiding the end effector within the patient to a desired location from the calculated position of the transponder 254 .
  • Step g) includes, after step f), identifying patient tissue for medical treatment.
  • Step h) includes medically treating the identified patient tissue with ultrasound using the transducer assembly 252 .
  • a sixteenth method of the invention uses the ultrasound medical treatment system of the second expression of the seventh embodiment and includes steps a) through h).
  • Step a) includes inserting the end effector 248 into the patient.
  • Step b) includes disposing the receivers 250 outside the patient.
  • Step c) includes emitting electromagnetic waves from the transponder 254 .
  • Step d) includes receiving the electromagnetic waves with the disposed receivers 250 .
  • Step e) includes calculating the position of the transponder 254 from the received electromagnetic waves.
  • Step f) includes guiding the end effector within the patient to a desired location from the calculated position of the transponder 254 .
  • Step g) includes, after step f), identifying patient tissue for medical treatment at least in part from ultrasound imaging using the transducer assembly 256 .
  • Step h) includes medically treating the identified patient tissue with ultrasound using the transducer assembly 256 .
  • a known electromagnetic transponder and three-receiver system for calculating the position of the transponder and for guiding the transponder (which is attached to a heart catheter for monitoring the heart) inside a patient is the CARTOTM EP Navigation System used with a NAVI-STAR® catheter manufactured by Biosense Webster (a Johnson & Johnson Company).
  • Advantages of an end effector with ultrasound medical treatment and position-location capabilities include, in one example, more accurately guiding the end effector inside a patient to patient tissue for ultrasound medical treatment of the patient tissue.
  • a seventeenth method of the invention is shown in block diagram form in FIG. 26 and is for ultrasound medical treatment of a patient.
  • the seventeenth method includes steps a) through f).
  • Step a) is labeled “Obtain End Effector” in block 262 of FIG. 26.
  • Step a) includes obtaining an end effector having an ultrasound medical-treatment transducer assembly.
  • Step b) is labeled “Aim Transducer Assembly” in block 264 of FIG. 26.
  • Step b) includes aiming the transducer assembly to focus ultrasound energy at a desired focal zone of patient tissue. It is noted that, in one example, to aim a transducer assembly means to focus ultrasound energy at a particular distance from the transducer assembly and along a particular direction.
  • Step c) is labeled “Activate Transducer Assembly” in block 266 of FIG. 26.
  • Step c) includes activating the aimed transducer assembly to emit ultrasound energy sufficient to achieve a temperature increase in the patient tissue essentially without medically affecting the patient tissue.
  • Step d) is labeled “Detect Actual Focal Zone” in block 268 of FIG. 26.
  • Step d) includes after step c) detecting, from reflected ultrasound energy, an actual focal zone of patient tissue having a temperature increase.
  • Step e) is labeled “Correct For Any Aiming Error” in block 269 of FIG. 26.
  • Step e) includes correcting for any error between the desired focal zone and the actual focal zone.
  • Step f) is labeled “Medically Treat Patient Tissue” in block 270 of FIG. 26.
  • Step f) includes after step e), medically treating the patient tissue with ultrasound using the transducer assembly.
  • step d) uses one or more additional ultrasound transducer assemblies, separate from the ultrasound transducer assembly used in steps a) through c) and e) through f), to detect, from reflected ultrasound energy, the actual focal zone.
  • the same ultrasound transducer assembly is used for steps a) through f).
  • the end effector is an extracorporeal end effector.
  • the end effector is an intracorporeal end effector.
  • the end effector can be used in both an extracorporeal mode and in an intracorporeal mode.
  • An eighteenth method of the invention is for ultrasound medical treatment of a patient and includes steps a) through f).
  • the eighteenth method uses the same block diagram of FIG. 26 as does the seventeenth method.
  • Step a) includes obtaining an end effector having an ultrasound imaging and medical-treatment transducer assembly.
  • Step b) includes aiming the transducer assembly to focus ultrasound energy at a desired focal zone of patient tissue.
  • Step c) includes activating the aimed transducer assembly to emit ultrasound energy sufficient to achieve a temperature increase in the patient tissue essentially without medically affecting the patient tissue.
  • Step d) includes after step c) detecting, from reflected ultrasound energy using the transducer assembly, an actual focal zone of patient tissue having a temperature increase.
  • Step e) includes correcting for any error between the desired focal zone and the actual focal zone.
  • Step f) includes after step e), medically treating the patient tissue with ultrasound using the transducer assembly.
  • the end effector is an extracorporeal end effector.
  • the end effector is an intracorporeal end effector.
  • the end effector can be used in both an extracorporeal mode and in an intracorporeal mode.
  • a nineteenth method of the invention is for ultrasound medical treatment of a patient and includes steps a) through i).
  • the nineteenth method uses the same block diagram of FIG. 26 as does the seventeenth method but with three extra steps added between block 262 's step a) and block 264 's step b) of the seventeenth method.
  • step a) includes obtaining an end effector having an ultrasound imaging and medical-treatment transducer assembly.
  • step b) includes inserting the end effector into the patient.
  • Step c) includes guiding the end effector inside the patient.
  • Step d) includes identifying a desired focal zone of patient tissue at least in part from ultrasound imaging using the transducer assembly.
  • Step e) includes aiming the transducer assembly to focus ultrasound energy at the desired focal zone of patient tissue.
  • Step f) includes activating the aimed transducer assembly to emit ultrasound energy sufficient to achieve a temperature increase in the patient tissue essentially without medically affecting the patient tissue.
  • Step g) includes after step f) detecting, from reflected ultrasound energy using the transducer assembly, an actual focal zone of patient tissue having a temperature increase.
  • Step h) includes correcting for any error between the desired focal zone and the actual focal zone.
  • Step i) includes after step h), medically treating the patient tissue with ultrasound using the transducer assembly.
  • the end effector is an endoscopic end effector.
  • the end effector is a laparoscopic end effector.
  • the end effector is a catheter end effector (such as, but not limited to, an intravascular catheter end effector).
  • the end effector is a needle end effector.
  • the achieved temperature increase will decrease over time so that the detected temperature increase may not exactly equal the achieved temperature increase.
  • the temperature increase detected in the detecting step is equal substantially to the temperature increase achieved in the activating step.
  • the detected temperature increase is not greater than about five degrees Celsius. In one variation, the detected temperature increase is not greater than about two degrees Celsius.
  • the correcting step is performed automatically by a feedback control on the same mechanism used to aim the transducer assembly in the aiming step, as can be appreciated by the artisan.
  • mechanisms for aiming an ultrasound medical-treatment transducer assembly include conventional electronic and/or mechanical techniques as are known to those skilled in the art.
  • Advantages of correcting for any error between the desired and actual focal zones before medical treatment include more precise ultrasound medical treatment of patient tissue.
  • better targeting maximizes the ablation of a lesion (and any appropriate margin) while minimizing medical treatment of patient tissue outside the lesion (and outside any appropriate margin).
  • a twentieth method of the invention is shown in block diagram form in FIG. 27 and is for ultrasound imaging of patient tissue of a patient.
  • the twentieth method includes steps a) through c).
  • Step a) is labeled “Obtain A First Signal From A Location At A First Time” in block 272 of FIG. 27.
  • Step a) includes obtaining a first signal of a first imaging ultrasound wave which has been reflected back from a location in the patient tissue at a first time.
  • Step b) is labeled “Obtain A Second Signal From The Location At A Later Second Time” in block 274 of FIG. 27.
  • Step b) includes obtaining a second signal of a second imaging ultrasound wave which has been reflected back from the location in the patient tissue at a later second time wherein the patient has received at least some medical treatment by the second time.
  • Step c) is labeled “Create An Image Of The Location Using The Two Signals” in block 276 of FIG. 27.
  • Step c) includes creating an image of the location using the first signal and the second signal. It is understood that the terminology “creating an image” includes, without limitation, creating an image in visual form displayed, for example, on a monitor and creating an image in electronic form which, for example, is used by a computer without being displayed in visual form on a monitor. In one enablement of the twentieth method of the invention, the image of the location is visually displayed at a pixel location on a monitor.
  • step c) includes creating an image of the location using at least the amplitude of the first signal and the amplitude of the second signal.
  • step c) calculates the difference in the amplitudes between the first and second signals.
  • step c) uses the calculated amplitude difference and uses one of the amplitudes of one of the first and second signals.
  • step c) calculates the sum of the one amplitude and a function of the calculated amplitude difference.
  • step c) calculates the amplitude difference, adds the difference to the second signal amplitude creating a processed amplitude of 8, and creates the image of the location using the processed amplitude.
  • Other algorithms for using the amplitude of the first and second signals to enhance any amplitude difference in creating the image of the location after medical treatment are left to the artisan.
  • step c) includes creating an image of the location using at least the phase of the first signal and the phase of the second signal.
  • step c) calculates the difference in the phase between the first and second signals.
  • step c) uses the calculated phase difference and uses one of the phases of one of the first and second signals.
  • step c) calculates the sum of the one phase and a function of the calculated phase difference. In one illustration of a first signal phase of 6 degrees and a second signal phase of 7 degrees, step c) calculates the phase difference, adds the difference to the second signal phase creating a processed phase of 8 degrees, and creates the image of the location using the processed phase.
  • Other algorithms for using the phase of the first and second signals to enhance any phase difference in creating the image after medical treatment are left to the artisan.
  • step c) includes creating an image of the location using at least the amplitude and the phase of the first signal and the amplitude and phase of the second signal.
  • step c) combines the discussions in the previous two paragraphs, as is within the ordinary level of skill of the artisan.
  • the first signal of step a) has a first frequency (e.g., a first center frequency having a sigma) and the second signal of step b) has a second frequency (e.g., a second center frequency having a sigma) which is different from the first frequency (meaning, for example, that the center frequencies are different).
  • the medical treatment is ultrasound medical treatment.
  • steps a) through c) are repeated for different locations to image the patient tissue, wherein the image of the patient tissue includes medically-treated locations and medically-untreated locations.
  • the image of the patient tissue is visually displayed on a monitor.
  • the image remains as an image map in a computer without being displayed on a monitor.
  • additional signals are obtained between steps a) and b) which are also used in creating the image of the location in step c).
  • Applicants were the first to realize that changes in patient tissue because of medical treatment of patient tissue, such as ultrasound medical treatment, which affect the amplitude and/or phase of ultrasound imaging signals can be used to enhance the ultrasound image differences of medically-treated patient tissue from surrounding untreated tissue.
  • Applicants have theorized that using different frequencies for the two signals can enhance amplitude and/or phase differences for medically treated and untreated tissue and can be used to enhance the ultrasound image differences of medically-treated patient tissue from surrounding untreated tissue.
  • Advantages of the twentieth method and examples, etc. thereof include, in one application, better ultrasound image contrast between treated and untreated patient tissue providing better monitoring during patient treatment.
  • Other medical treatments applicable to the twentieth method include, without limitation, other thermal ablation techniques such as radio-frequency, laser, and microwave medical treatments and chemical ablation techniques such as ethanol and chemo-therapeutics (including anti-cancer drugs).
  • Other optional steps in the twentieth method include using signal smoothing techniques, as are known to those skilled in the art.
  • any one or more of the previously-described embodiments, expressions of embodiments, examples, methods, etc. can be combined with any one or more of the other previously-described embodiments, expressions of embodiments, examples, methods, etc.
  • any of the end effectors can be used in any of the methods
  • any of the transducer arrangements can be used in any of the end effectors
  • any appropriate methods can be combined such as combining the seventeenth and twentieth methods, etc.

Abstract

An ultrasound medical treatment system includes a tube and first and second end effectors. The tube has a distal end insertable into a patient and has a lumen. The first end effector has a cutting tool, is introducible into the lumen of the inserted tube from outside the patient, and is translatable through the lumen of the inserted tube to inside the patient. The second end effector has an ultrasound medical-treatment transducer assembly, is introducible into the lumen of the inserted tube from outside the patient, and is translatable through the lumen of the inserted tube to inside the patient. In one example, the ultrasound medical-treatment transducer assembly is an ultrasound imaging and medical-treatment transducer assembly. In one use, the cutting tool takes a biopsy sample of possibly cancerous breast tissue of a patient, and the breast receives ultrasound medical treatment from the transducer assembly to stop hemorrhaging.

Description

  • The present application claims priority of U.S. Provisional Application Serial No. 60/294,135 filed May 29, 2001, the entire disclosure of which is incorporated herein by reference.[0001]
  • FIELD OF THE INVENTION
  • The present invention relates generally to ultrasound, and more particularly to an ultrasound medical system and/or to an ultrasound medical method. [0002]
  • BACKGROUND OF THE INVENTION
  • Known ultrasound medical systems and methods include using ultrasound imaging of patients to identify patient tissue for medical treatment and include using ultrasound to medically destroy identified patient tissue by heating the tissue. Imaging is done at lower power and medical treatment is done at higher power. Low power imaging ultrasound will not medically affect patient tissue. High power medical-treatment ultrasound, when focused at a focal zone a distance away from the ultrasound source, will substantially medically affect patient tissue in the focal zone. However, focused medical-treatment ultrasound will not substantially medically affect patient tissue outside the focal zone such as patient tissue located between the source and the focal zone. [0003]
  • In one known example, a transducer assembly includes a single ultrasound transducer having a single transducer element, or an array of transducer elements acting together, to ultrasonically image the patient and to ultrasonically ablate identified patient tissue. It is known to convert ultrasound imaging data into temperature imaging data for ultrasound-treated patient tissue to monitor the ultrasound treatment. A known transducer element includes a transducer element having a concave shape or an acoustic lens to focus ultrasound energy. A known array of transducer elements includes a planar, concave, or convex array of transducer elements to focus ultrasound energy. A known array of transducer elements includes an array whose transducer elements are electronically or mechanically controlled together to steer and focus the ultrasound emitted by the array to a focal zone (which may be large or which may be as small as, for example, a grain of rice) to provide three-dimensional medical ultrasound treatment of patient tissue. In some applications, the transducer is placed on the surface of patient tissue for ultrasound imaging and/or ultrasound medical treatment of areas within the patient tissue. In other applications, the transducer is surrounded with a balloon which is expanded to contact the surface of patient tissue by filling with a fluid such as a saline solution to provide acoustic coupling between the transducer and the patient tissue. [0004]
  • Known ultrasound medical systems and methods include deploying an end effector having an ultrasound transducer outside the body to break up kidney stones inside the body, endoscopically inserting an end effector having an ultrasound transducer in the colon to medically destroy prostate cancer, laparoscopically inserting an end effector having an ultrasound transducer in the abdominal cavity to medically destroy a cancerous liver tumor, intravenously inserting a catheter end effector having an ultrasound transducer into a vein in the arm and moving the catheter to the heart to medically destroy diseased heart tissue, and interstitially inserting a needle end effector having an ultrasound transducer needle into the tongue to medically destroy tissue to reduce tongue volume to reduce snoring. Known methods for guiding an end effector within a patient include guiding the end effector from x-rays, from MRI images, and from ultrasound images obtained using the ultrasound transducer. Known ultrasound imaging includes Doppler ultrasound imaging to detect blood flow, and a proposed known use of ultrasound includes using an ultrasound transducer outside the body to stop internal bleeding (by sealing ruptured blood vessels) of a patient brought to an emergency room of a hospital. [0005]
  • A Mammotome® Breast Biopsy System manufactured by Ethicon Endo-Surgery, Inc. (a Johnson & Johnson Company) inserts a tube into breast tissue, wherein the tube contains an end effector having a biopsy cutting tool. A known electromagnetic transponder and three-receiver system for calculating the position of the transponder and for guiding the transponder (which is attached to a heart catheter for monitoring the heart) inside a patient is the CARTO™ EP Navigation System used with a NAVI-STAR® catheter manufactured by Biosense Webster (a Johnson & Johnson Company). Further, it is known that changes in patient tissue because of medical treatment of patient tissue, such as ultrasound medical treatment, affect the amplitude and/or phase of ultrasound imaging signals. [0006]
  • What is needed is an improved ultrasound medical system and/or an improved ultrasound medical method. This invention addresses those needs lacking in an ultrasonic medical system and/or an ultrasonic medical method. [0007]
  • SUMMARY OF THE INVENTION
  • One expression of an embodiment of the invention is an ultrasound medical treatment system including a tube, a first end effector, and a second end effector. The tube has a distal end insertable into a patient and has a lumen. The first end effector has a cutting tool, is introducible into the lumen of the inserted tube from outside the patient, and is translatable through the lumen of the inserted tube to inside the patient. The second end effector has an ultrasound medical-treatment transducer assembly, is introducible into the lumen of the inserted tube from outside the patient, and is translatable through the lumen of the inserted tube to inside the patient. In one example, the ultrasound medical-treatment transducer assembly is an ultrasound imaging and medical-treatment transducer assembly. In one use, the cutting tool takes a biopsy sample of possibly cancerous breast tissue of a patient, and the breast receives ultrasound medical treatment from the transducer assembly to stop hemorrhaging in the breast. [0008]
  • The present invention has, without limitation, application in conventional endoscopic and open surgical instrumentation as well as application in robotic-assisted surgery.[0009]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a perspective view of a first embodiment of the present invention showing an ultrasound medical treatment system which includes a tissue-retaining device; [0010]
  • FIG. 2 is an enlarged view of the end effector of the ultrasound medical treatment system of FIG. 1; [0011]
  • FIG. 3 is a view of the end effector of FIG. 2 retaining an intervertebral disk of a patient; [0012]
  • FIG. 4 is a perspective view of a first alternate end effector which can be used in the ultrasound medical treatment system of FIG. 1; [0013]
  • FIG. 5 is a perspective view of a second alternate end effector which can be used in the ultrasound medical treatment system of FIG. 1; [0014]
  • FIG. 6 is a perspective view of a third alternate end effector which can be used in the ultrasound medical treatment system of FIG. 1; [0015]
  • FIG. 7 is a side elevational view of a second embodiment of the present invention showing another ultrasound medical treatment system which includes a tissue-retaining device; [0016]
  • FIG. 8 is an enlarged, partially-cutaway view of the end effector of the ultrasound medical treatment system of FIG. 7; [0017]
  • FIG. 9 is a perspective view of a third embodiment of the present invention showing an ultrasound medical system which includes flexible fingers, wherein each finger includes an ultrasound transducer; [0018]
  • FIG. 10 is an enlarged view of the tube and the flexible fingers of the ultrasound medical system of FIG. 9 showing the flexible fingers in a deployed fan-like state; [0019]
  • FIG. 11 is a view of the flexible fingers of FIG. 10 shown in a stowed state; [0020]
  • FIG. 12 is a perspective view of an alternate flexible finger arrangement which can be used in the ultrasound medical system of FIG. 9, showing the flexible fingers in a deployed claw-like state surrounding patient tissue; [0021]
  • FIG. 13 is a perspective view of a fourth embodiment of the present invention showing an ultrasound medical system which includes an ultrasound transducer assembly which includes at least two ultrasound transducers; [0022]
  • FIG. 14 is an enlarged view of the ultrasound transducer assembly of the ultrasound medical system of FIG. 13; [0023]
  • FIG. 15 is a cross-sectional view of the transducer assembly of FIG. 14; [0024]
  • FIG. 16 is a cross-sectional view of a first alternate transducer arrangement which can be used in place of the arrangement of FIG. 15; [0025]
  • FIG. 17 is a cross-sectional view of a second alternate transducer arrangement which can be used in place of the arrangement of FIG. 15; [0026]
  • FIG. 18 is a perspective view of a fifth embodiment of the present invention showing an ultrasound medical treatment system which includes a cutting tool and an ultrasound medical-treatment transducer assembly; [0027]
  • FIG. 19 is an enlarged, cross-sectional view of the tube of FIG. 18 showing a cutting tool that has been introduced into the lumen of the tube; [0028]
  • FIG. 20 is an enlarged, cross-sectional view of the tube of FIG. 18 showing an ultrasound medical-treatment transducer assembly that has been introduced into the lumen of the tube; [0029]
  • FIG. 21 is a block diagram of an eighth method of the present invention which includes ultrasound staging of medical treatment of patient tissue in the gastrointestinal area; [0030]
  • FIG. 22 is a block diagram of an eleventh method of the present invention which includes ultrasound medical treatment of a lesion on or in the lung of a patient; [0031]
  • FIG. 23 is a block diagram of a thirteenth method of the present invention which includes ultrasound medical treatment of a blood vessel to stop the supply of blood to a lesion from the blood vessel; [0032]
  • FIG. 24 is a perspective view of a sixth embodiment of the present invention showing a portion of an ultrasound medical treatment system which includes receivers for locating the position of the transducer assembly of the system; [0033]
  • FIG. 25 is a perspective view of a seventh embodiment of the present invention showing a portion of another ultrasound medical treatment system which includes receivers for locating the position of the transponder of the system; [0034]
  • FIG. 26 is a block diagram of a seventeenth method of the present invention which includes aiming the transducer assembly; and [0035]
  • FIG. 27 is a block diagram of a twentieth method of the present invention which includes creating an image after starting medical treatment using an imaging ultrasound wave before medical treatment and an imaging ultrasound wave after starting medical treatment.[0036]
  • DETAILED DESCRIPTION OF THE INVENTION
  • Before explaining the present invention in detail, it should be noted that the invention is not limited in its application or use to the details of construction and arrangement of parts illustrated in the accompanying drawings and description. The illustrative embodiments of the invention may be implemented or incorporated in other embodiments, variations and modifications, and may be practiced or carried out in various ways. Furthermore, unless otherwise indicated, the terms and expressions employed herein have been chosen for the purpose of describing the illustrative embodiments of the present invention for the convenience of the reader and are not for the purpose of limiting the invention. [0037]
  • It is understood that any one or more of the following-described embodiments, expressions of embodiments, examples, methods, etc. can be combined with any one or more of the other following-described embodiments, expressions of embodiments, examples, methods, etc. For example, and without limitation, any of the end effectors can be used in any of the methods, any of the transducer arrangements can be used in any of the end effectors, and any appropriate methods can be combined such as combining the seventeenth and twentieth methods, etc. [0038]
  • Ultrasound Medical Treatment Using Tissue-Retaining Devices
  • Tissue-Retaining System for Ultrasound Medical Treatment [0039]
  • Referring now to the drawings, FIGS. [0040] 1-3 illustrate a first embodiment of the present invention. A first expression of the first embodiment of the present invention is for an ultrasound medical treatment system 10 including an end effector 12 insertable into a patient 14. The end effector 12 includes a tissue-retaining device 16. The tissue-retaining device 16 includes a first tissue-retaining member 18 having an (i.e., at least one) ultrasound medical-treatment transducer 20 (also called “transducer 20”) and includes a second tissue-retaining member 22. The first and second tissue-retaining members 18 and 22 are operatively connected together to retain patient tissue 24 between the first and second tissue-retaining members 18 and 22 and to release patient tissue 24 so retained.
  • It is noted that an ultrasound medical-treatment transducer is an ultrasound transducer adapted at least for ultrasound medical treatment of a patient such as, but not limited to, a human patient. An ultrasound medical-treatment transducer includes either a single ultrasound medical-treatment transducer element or an array of ultrasound medical-treatment transducer elements, as is known to those skilled in the art. An ultrasound medical-treatment transducer may or may not also be adapted for ultrasound imaging of a patient. Likewise, an ultrasound imaging transducer is an ultrasound transducer adapted at least for ultrasound imaging of a patient and may or may not also be adapted for ultrasound medical-treatment of a patient. [0041]
  • Advantages of retaining patient tissue between two tissue-retaining members during ultrasound medical treatment by one of the tissue-retaining members include having a single instrument which ultrasonically medically treats patient tissue and at the same time immobilizes patient tissue against undesired movement during the treatment. It is also noted that in one application the tissue-retaining device is a clamp which retains and holds tissue and that in another application the tissue-retaining device retains tissue against movement, but does not hold tissue, and therefore is not a clamp. [0042]
  • In one variation, not shown, the second tissue-retaining [0043] member 22 has an ultrasound imaging and/or medical treatment transducer. In the same or a different variation, not shown, the tissue-retaining device 16 has at least one additional tissue-retaining member. Mechanisms, not shown, for remotely moving two (or more) members toward and away from each other are within the ordinary level of skill of the artisan and include, without limitation, the use of pivotal member attachments and the use of cables or motors. In the same or a different variation, the retained patient tissue 24 is retained between the ultrasound medical-treatment transducer 20 and the second tissue-retaining member 22. In the same or a different variation, the ultrasound medical-treatment transducer 20 focuses ultrasound energy, such focusing being known to those skilled in the art. In the same or a different variation, not shown, the second tissue-retaining member 22 is substantially ultrasonically non-reflective.
  • A second expression of the first embodiment of the present invention is for an ultrasound [0044] medical treatment system 10 including an end effector 12 insertable into a patient 14. The end effector 12 includes a tissue-retaining device 16. The tissue-retaining device 16 includes a first tissue-retaining member 18 having an (i.e., at least one) ultrasound imaging and medical-treatment transducer 26 (also called “transducer 26”) and includes a second tissue-retaining member 22. The first and second tissue-retaining members 18 and 22 are operatively connected together to retain patient tissue 24 between the first and second tissue-retaining members 18 and 22 and to release patient tissue 24 so retained.
  • It is noted that an ultrasound imaging and medical-treatment transducer is an ultrasound transducer adapted at least for both ultrasound imaging and ultrasound medical treatment of a patient. An ultrasound imaging and medical-treatment transducer includes either a single ultrasound imaging and medical-treatment transducer element or an array of ultrasound medical transducer elements (including an array having at least one separate element for imaging and at least one separate element for medical treatment or an array having at least two elements each adapted for both imaging and medical treatment), as is known to those skilled in the art. In one variation, the retained [0045] patient tissue 24 is retained between the imaging and medical-treatment transducer 26 and the second tissue-retaining member 22. In the same or a different variation, the ultrasound imaging and medical-treatment transducer 26 focuses ultrasound energy. In the same or a different variation, not shown, the second tissue-retaining member 22 is substantially ultrasonically non-reflective.
  • A third expression of the first embodiment shown in FIGS. [0046] 1-3 is for an ultrasound medical treatment system 10 including an end effector 12 insertable into a patient 14. The end effector 12 includes a tissue-retaining device 16. The tissue-retaining device 16 includes a first tissue-retaining member 18 having an (i.e., at least one) ultrasound medical-treatment transducer 20 and includes a second tissue-retaining member 22 having an (i.e., at least one) ultrasound reflector 28. The first and second tissue-retaining members 18 and 22 are operatively connected together to retain patient tissue 24 between the first and second tissue-retaining members 18 and 22 and to release patient tissue 24 so retained.
  • Advantages of retaining patient tissue between two tissue-retaining members during ultrasound medical treatment by an ultrasound medical-treatment transducer of a first tissue-retaining member and an ultrasound reflector of a second tissue-retaining member include having a single instrument which ultrasonically medically treats patient tissue by direct ultrasound, which enhances the ultrasound medical treatment by reflected ultrasound, and which at the same time immobilizes patient tissue against undesired movement during the treatment. [0047]
  • It is noted that an [0048] ultrasound reflector 28 is a material which reflects ultrasound at least to a degree that would substantially medically affect patient tissue over a treatment period by direct ultrasound which is being reflected back by the ultrasound reflector. Choices of ultrasound reflecting materials include, without limitation, acoustically-rigid materials such as stainless steel (which reflects about 100%) and aluminum (which reflects about 80%) and acoustically-softer materials such as corporene (which reflects about 90%). An ultrasound reflecting material is contrasted with an ultrasound absorbing material such as, without limitation, rubber or plastic. In one variation, the retained patient tissue 24 is retained between the ultrasound medical-treatment transducer 20 and the ultrasound reflector 28. In the same or a different variation, the ultrasound medical-treatment transducer 20 and the ultrasound reflector 28 each focus ultrasound energy, such ultrasound reflector focusing being accomplished by the shape of, or by shaping, the reflector surface as is within the ordinary level of skill of the artisan.
  • A fourth expression of the first embodiment shown in FIGS. [0049] 1-3 is for an ultrasound medical treatment system 10 including an end effector 12 insertable into a patient 14. The end effector 12 includes a tissue-retaining device 16. The tissue-retaining device 16 includes a first tissue-retaining member 18 having an (i.e., at least one) ultrasound imaging and medical-treatment transducer 26 and includes a second tissue-retaining member 22 having an (i.e., at least one) ultrasound reflector 28. The first and second tissue-retaining members 18 and 22 are operatively connected together to retain patient tissue 24 between the first and second tissue-retaining members 18 and 22 and to release patient tissue 24 so retained. In one variation, the retained patient tissue 24 is retained between the ultrasound imaging and medical-treatment transducer 26 and the ultrasound reflector 28. In the same or a different variation, the ultrasound imaging and medical-treatment transducer 26 and the ultrasound reflector 28 each focus ultrasound energy.
  • In one example of the previously-described third and fourth expressions of the first embodiment, the [0050] ultrasound reflector 28 is disposed to receive ultrasound energy from the transducer 20 and 26 and is oriented to reflect the received ultrasound energy back into patient tissue 24 retained by the tissue-retaining device 16. In the same or a different example, the ultrasound reflector 28 is oriented to reflect the received ultrasound energy away from the transducer 20 and 26 when the patient tissue 14 is retained by the tissue-retaining device 16. An advantage of this arrangement is that it avoids damage to the transducer from the reflected ultrasound. In the same or a different example, one of the first and second tissue-retaining members 18 and 22 is controllably orientatable relative to the other of the first and second tissue-retaining members 18 and 22 such as, without limitation, by being orientatable along the double-headed arrows shown in FIG. 2. In one modification, the second tissue-retaining member 22 is controllably orientatable relative to the first tissue-retaining member 18 to reflect the received ultrasound energy back along different directions. A first alternate end effector 30 is shown in FIG. 4 wherein the second tissue-retaining member 32 is controllably orientatable relative to the first tissue-retaining member 34 as shown by the double-headed arrows in FIG. 4. Mechanisms, not shown, for remotely controlling the orientation of one member relative to another member are within the ordinary level of skill of the artisan and include, without limitation, the use of pivotal member attachments and the use of cables or motors. In one application, the transducer 20 and 26 generates wide-focused ultrasound (shown by the two single-headed arrows coming from the first tissue-retaining member 18 in FIG. 3) and the ultrasound reflector 28 generates narrow-focused ultrasound (shown by the two single-headed arrows coming from the second tissue-retaining member 22 in FIG. 3).
  • In one example of the previously-described first through fourth expressions of the first embodiment, the [0051] end effector 12 is an open-surgery end effector, an endoscopic end effector, a laparoscopic end effector (as shown in FIG. 1), a catheter end effector (such as, but not limited to, an intravascular catheter end effector), or a needle end effector, as can be appreciated by those skilled in the art. In one application, the end effector 12 is used to retain a blood vessel and then to ultrasonically treat the blood vessel to seal the blood vessel stopping the flow of blood in the retained blood vessel. In another application, the end effector 12 is used to retain patient tissue and then to ultrasonically ablate at least a portion of the retained patient tissue.
  • In one design of the previously-described first through fourth expressions of the first embodiment, the [0052] end effector 12 has a longitudinal axis 35, and one of the first and second tissue-retaining members 18 and 22 at all times faces along a direction which is substantially perpendicular to the longitudinal axis 35. If the one tissue-retaining member were planar, this means that the longitudinal axis would be substantially parallel to the plane of the one tissue-retaining member. In one enablement, the one tissue-retaining member is the first tissue-retaining member 18. A second alternate end effector 36 has first and second tissue-retaining members 38 and 40 which are hinged together to relatively move as indicated by the double-headed arrow and which are shown in a partially open configuration in FIG. 5. The second alternate end effector 36 has a longitudinal axis 42, and one of the first and second tissue-retaining members 38 and 40 at all times faces along a direction which is substantially parallel to the longitudinal axis 42. If the one tissue-retaining member were planar, this means that the longitudinal axis would be substantially perpendicular to the plane of the one tissue-retaining member. In one enablement, the one tissue-retaining member is the first tissue-retaining member 38. A third alternate end effector 37 having first and second tissue-retaining members 39 and 41 with one member longitudinally movable with respect to the other member (as indicated by the double-headed arrow) is shown in FIG. 6. The third alternate end effector 37 has a longitudinal axis 43, and one of the first and second tissue-retaining members 39 and 41 at all times faces along a direction which is substantially parallel to the longitudinal axis 43. In one enablement, the one tissue-retaining member is the first tissue-retaining member 39.
  • In one enablement, as shown in FIG. 1, the ultrasound [0053] medical treatment system 10 also includes a handpiece 44 operatively connected to the end effector 12 and to an ultrasound controller 46 operatively connected to a foot-pedal power switch 47, as can be appreciated by those skilled in the art.
  • A first method of the invention is for ultrasound medical treatment of a patient and uses the ultrasound medical treatment system as previously described in the first, second, third or fourth expression of the first embodiment with or without the previously-described variations, etc. thereof. The first method includes steps a) through e). Step a) includes endoscopically inserting the end effector into an ear, nose, or throat of the patient. Step b) includes guiding the end effector in the patient. Step c) includes identifying patient tissue for medical treatment such as optionally at least in part from ultrasound imaging using the transducer. Other ways of identifying patient tissue for medical treatment include, without limitation, using x-rays and/or MRI imaging, as are known to the artisan. Step d) includes retaining the identified patient tissue using the tissue-retaining device. Step e) includes medically treating the retained patient tissue with ultrasound using the transducer or using the transducer and the ultrasound reflector. In one implementation, one tissue-retaining member at all times faces along a direction which is substantially parallel to the longitudinal axis of the end effector (as seen in FIGS. 5 and 6). [0054]
  • A second method of the invention is for ultrasound medical treatment of a patient and uses the ultrasound medical treatment system as previously described in the first, second, third or fourth expression of the first embodiment with or without the previously-described variations, etc. thereof. The second method includes steps a) through c). Step a) includes inserting the [0055] end effector 12 into the patient. Step b) includes retaining an intervertebral disk 48 (see FIG. 3) of the patient with the tissue-retaining device, wherein the intervertebral disk 48 includes tissue. Step c) includes medically treating the retained intervertebral disk 48 with ultrasound to shrink the tissue using the transducer or using the transducer and the ultrasound reflector. In one implementation, one tissue-retaining member at all times faces along a direction which is substantially perpendicular to the longitudinal axis of the end effector (as seen in FIGS. 2 and 4). In one application of the second method of the invention, the intervertebral disk 48 includes connective and nerve tissue.
  • A third method of the invention is for ultrasound medical treatment of a patient and uses the ultrasound medical treatment system as previously described in the first, second, third or fourth expression of the first embodiment with or without the previously-described variations, etc. thereof. The third method includes steps a) through c). Step a) includes inserting the end effector into the patient. Step b) includes retaining a joint of the patient with the tissue-retaining device, wherein the joint includes tissue. Step c) includes medically treating the retained joint with ultrasound to shrink the tissue using the transducer or using the transducer and the ultrasound reflector. In one implementation, one tissue-retaining member at all times faces along a direction which is substantially perpendicular to the longitudinal axis of the end effector (as seen in FIGS. 2 and 4). In one application of the third method of the invention, the joint includes connective and nerve tissue. [0056]
  • As previously mentioned, one application of the ultrasound [0057] medical treatment system 10 of the previously-described first through fourth expressions of the first embodiment uses the tissue-retaining device to retain a blood vessel and uses the transducer, or the transducer and the ultrasound reflector, to substantially stop the flow of blood within the blood vessel.
  • Referring again to the drawings, FIGS. [0058] 7-8 illustrate a second embodiment of the present invention which is an ultrasound medical treatment system 50 including an end effector 52 insertable into a patient. The end effector 52 includes a tissue-retaining device 54. The tissue-retaining device 54 includes a first tissue-retaining member 56 having an ultrasound imaging and medical-treatment transducer 58 and includes a second tissue-retaining member 60 having an ultrasound reflector 62. The first and second tissue-retaining members 56 and 60 are operatively connected together to retain patient tissue between the first and second tissue-restraining members and to release patient tissue so retained. The first and second tissue-retaining members 56 and 60 always maintain a substantially parallel alignment.
  • Advantages of having a substantially parallel alignment between the tissue-retaining members include, in one example, having the transducer and the ultrasound reflector maintain a substantially parallel alignment for improved reflected ultrasound medical treatment enhancement for any thickness of patient tissue retained by the tissue-retaining members. [0059]
  • In one example of the second embodiment, the first tissue-retaining [0060] member 56 is a distal end portion 64 of a first tube 66. The ultrasound medical treatment system 50 also includes a second tube 68, first and second link members 70 and 72, and a cable 74. The second tube 68 is oriented substantially parallel to the first tube 66. The first and second link members 70 and 72 are pivotally attached to the second tissue-retaining member 60 and to the second tube 68 at pivot points 76-82 creating a hinged parallelogram defined by a proximal portion 84 of the second tissue-retaining member 60, a distal portion 86 of the second tube 68, and the first and second link members 70 and 72. The ultrasound reflector 62 is disposed at a distal portion 88 of the second tissue-retaining member 60 and faces the transducer 58. The cable 74 is operatively connected to the hinged parallelogram to move the second tissue-retaining member 60 toward and away from the first tissue-retaining member 56.
  • In one variation, the ultrasound [0061] medical treatment system 50 also includes an outer tube 90. The cable 74 and the first and second tubes 66 and 68 are disposed in the outer tube 90. In one modification, the ultrasound medical treatment system 50 also includes a handpiece 92. The cable 74 and the first, second, and outer tubes 66, 68 and 90 are operatively connected to the handpiece 92. In one design, the orientation of the first tube 66 about the longitudinal axis of the first tube 66 is controlled by a step motor (not shown) disposed in, and actuated by, the handpiece 92. In the same or another design, the first tube 66 is a hollow tube allowing for transducer wiring (not shown), and the second tube is a solid tube (not shown). Depending on use, the tubes 66, 68, and 90 may be rigid or flexible which also is true for any tube arrangement (specifically disclosed as rigid or flexible, or not so specifically disclosed) of any end effector and for any end effector itself of any of the previous or following embodiments of the invention.
  • Ultrasound Medical Treatment Using Specific Transducer Arrangements [0062]
  • Deployable Ultrasound Medical Transducers [0063]
  • Referring to the drawings, FIGS. [0064] 9-11 illustrate a third embodiment of the present invention. A first expression of the third embodiment of the present invention is for an ultrasound medical system 94 including a tube 96 and a plurality of resiliently flexible fingers 98. The tube 96 has a distal end 100 insertable into a patient and has a lumen 102 with a distal opening 104. The fingers 98 are extendable out of the distal opening 104 of the lumen 102 creating a deployed state (seen in FIG. 10) and which are at-least-partially retractable into the distal opening 104 of the lumen 102 creating a stowed state (seen in FIG. 11). Each finger 98 includes an ultrasound transducer 106. The distance between the ultrasound transducers 106 of adjacent fingers 98 is greater in the deployed state than in the stowed state. It is noted that an ultrasound medical system is a medical system which at least provides ultrasound imaging or ultrasound medical treatment of a patient.
  • Advantages of the tube and extendable/retractable flexible-finger array arrangement include, when the transducers are ultrasound medical-treatment transducers having a common focal zone in the deployed state, providing faster medical treatment times by allowing for more transducer ultrasound-emitting surface area which can be simply stowed into a compact shape for transport within a patient to and from the site of patient tissue receiving ultrasound medical treatment. [0065]
  • In one variation, the [0066] fingers 98 are only partially retracted into the distal opening 104 of the lumen 102 in the stowed state (as seen in FIG. 11). In another variation, not shown, the fingers 98 are completely retracted into the distal opening 104 of the lumen 102 in the stowed state. By the fingers 98 being extendable out of the distal opening 104 of the lumen 102 creating the deployed state and being at-least-partially retractable into the distal opening 104 of the lumen 102 creating the stowed state means the fingers 98 protrude more out of the distal opening 104 of the lumen 102 in the extended state than (if at all) in the stowed state. Mechanisms, not shown, for remotely extending and retracting fingers in a tube include, without limitation, a common shaft attached to the proximal ends of the fingers, disposed in the lumen of the tube, and spring-biased to move forward upon squeezing of a handpiece and to return backward upon relaxing of the handpiece, as is within the ordinary level of skill of the artisan. In one modification, the distal opening 104 of the lumen 102 coincides with the distal end 100 of the tube 96. In another modification, not shown, the distal opening of the lumen is spaced apart from the distal end of the tube. In one implementation, the distal opening 104 of the lumen 102 faces in the same direction as the distal end 100 of the tube 96. Other implementations are left to the artisan, such as, without limitation, the distal opening of the lumen facing perpendicular to the distal end of the tube. In one example, at least one of the transducers 106 is an ultrasound imaging transducer. In the same or a different example, at least one of the transducers 106 is an ultrasound medical-treatment transducer. In the same or a different example, at least one of the transducers 106 is an ultrasound imaging and medical-treatment transducer.
  • A second expression of the third embodiment is for an ultrasound [0067] medical treatment system 108 including a tube 96 and including an end effector 110 having a plurality of fingers 98. The tube 96 has a distal end 100 insertable into a patient and has a lumen 102 with a distal opening 104. The fingers 98 are extendable out of the distal opening 104 of the lumen 102 creating a deployed state (seen in FIG. 10) and are at-least-partially retractable into the distal opening 104 of the lumen 102 creating a stowed state (seen in FIG. 11). Each finger 98 includes an ultrasound medical-treatment transducer 112. The distance between the ultrasound medical-treatment transducers 112 of adjacent fingers 98 is greater in the deployed state than in the stowed state.
  • A third expression of the third embodiment is for an ultrasound [0068] medical treatment system 108 including a tube 96 and including an end effector 110 having a plurality of fingers 98. The tube 96 has a distal end 100 insertable into a patient and has a lumen 102 with a distal opening 104. The fingers 98 are extendable out of the distal opening 104 of the lumen 102 creating a deployed state (seen in FIG. 10) and are at-least-partially retractable into the distal opening 104 of the lumen 102 creating a stowed state (seen in FIG. 11). Each finger 98 includes an ultrasound imaging and medical-treatment transducer 114. The distance between the ultrasound imaging and medical-treatment transducers 114 of adjacent fingers 98 is greater in the deployed state than in the stowed state.
  • It is noted that the variations, modifications, and implementations, etc. previously discussed for the first expression of the third embodiment are equally applicable to the second and third expressions of the third embodiment. [0069]
  • In one example of the first, second and third expressions of the third embodiment, the [0070] transducers 106, 112 and 114 each have an ultrasound-emitting concave surface 116. In another example, not shown, the transducers have a planar ultrasound-emitting surface. In one arrangement, each concave surface 116 is concave as one moves along the corresponding finger 98 (as best seen in FIG. 10). In another arrangement, not shown, each concave surface is concave as one moves across the corresponding finger or is concave as one moves both along and across the corresponding finger (such as, for example, with a hemispherically-concave surface). In one design, the concave surfaces 116 together have a substantially common focal zone when the fingers 98 are in the deployed state. The end effector 110 is seen with its fingers 98 facing the patient tissue 119 in FIG. 10. In another design, not shown, the focal zones are not common. In one configuration, the fingers 98 define an open-hand finger array 118 in the deployed state. An alternate flexible finger arrangement in the form of a substitute end effector 120 is shown in FIG. 12, wherein the fingers 122 define a clawed-hand finger array 124 in the deployed state. The substitute end effector 120 is seen with its fingers 122 surrounding the patient tissue 126 for imaging and/or medical treatment by the ultrasound transducers 128 in FIG. 12. In other transducer arrangements, not shown, one or more or all of the ultrasound transducers face outward rather than facing inward.
  • In the same or another example of the first, second and third expressions of the third embodiment, the [0071] fingers 98 are at least four in number. In the same or yet another example of the second and third expressions of the third embodiment, the end effector 110 (as well as the substitute end effector 120) is an open-surgery end effector, an endoscopic end effector, a laparoscopic end effector (as shown in FIG. 9), a catheter end effector (such as, but not limited to, an intravascular catheter end effector), or a needle end effector, as can be appreciated by those skilled in the art.
  • In one enablement, as shown in FIG. 9, the ultrasound [0072] medical treatment system 108 also includes a handpiece 130 operatively connected to the end effector 110 and to an ultrasound controller 132 operatively connected to a foot-pedal power switch 133, as can be appreciated by those skilled in the art.
  • Faceted Ultrasound Medical Transducer Assembly [0073]
  • A fourth embodiment of the present invention is shown in FIGS. [0074] 13-15. A first expression of the fourth embodiment of the present invention is for an ultrasound medical system 134 including an ultrasound transducer assembly 136 insertable into a patient. The ultrasound transducer assembly 136 has a longitudinal axis 138. The ultrasound transducer assembly 136 includes a plurality P of ultrasound transducers 140. Each transducer 140 has an ultrasound-emitting surface 142 oriented at an angle of substantially 360/P degrees apart from the ultrasound-emitting surface 142 of an adjacent transducer 140 when viewed in a cross section (see FIG. 15) of the transducer assembly 136 taken by a cutting plane which is perpendicular to the longitudinal axis 138.
  • Advantages of such a transducer configuration include, in one example, providing directed or focused medical-treatment ultrasound which is not possible with a cylindrical ultrasound transducer, as can be appreciated by those skilled in the art. [0075]
  • It is noted that an [0076] ultrasound transducer assembly 136 insertable into a patient is an ultrasound imaging transducer assembly, an ultrasound medical-treatment transducer assembly, or an ultrasound imaging and medical-treatment transducer assembly. An ultrasound imaging transducer assembly has at least one ultrasound imaging transducer, and an ultrasound medical-treatment transducer assembly has at least one ultrasound medical-treatment transducer. An ultrasound imaging and medical-treatment transducer assembly has at least one ultrasound imaging transducer and at least one ultrasound medical-treatment transducer or has at least one ultrasound imaging and medical-treatment transducer.
  • A second expression of the fourth embodiment of the present invention is for an ultrasound medical-[0077] treatment system 144 including an end effector 146 insertable into a patient. The end effector 146 includes an ultrasound medical-treatment transducer assembly 148. The ultrasound medical-treatment transducer assembly 148 has a longitudinal axis 138. The ultrasound medical-treatment transducer assembly 148 includes a plurality P of ultrasound medical-treatment transducers 150. Each transducer 150 has an ultrasound-emitting surface 142 which faces away from the longitudinal axis 138 and which is oriented at an angle of substantially 360/P degrees apart from the ultrasound-emitting surface 142 of an adjacent transducer 150 when viewed in a cross section (see FIG. 15) of the transducer assembly 148 taken by a cutting plane which is perpendicular to the longitudinal axis 138. In one example, at least one of the ultrasound medical-treatment transducers 150 is also adapted for ultrasound imaging.
  • A fourth method of the present invention is for ultrasound medical treatment of a patient and uses the ultrasound [0078] medical treatment system 144 as previously described in the second expression of the fourth embodiment. The fourth method includes steps a) through b). Step a) includes inserting the end effector 146 into the liver of the patient. Step b) includes medically treating a lesion in the liver with ultrasound from the ultrasound medical-treatment transducer assembly 148. In one example, step a) interstially inserts the end effector 146 into the lesion. In another example, step a) endoscopically inserts the end effector 146 into the liver through the hepato-biliary duct system.
  • A third expression of the fourth embodiment of the present invention is for an ultrasound [0079] medical treatment system 144 including an end effector 146 insertable into a patient. The end effector 146 includes an ultrasound imaging and medical-treatment transducer assembly 152. The ultrasound imaging and medical-treatment transducer assembly 152 has a longitudinal axis 138. The ultrasound imaging and medical-treatment transducer assembly 152 includes a plurality P of ultrasound imaging and medical-treatment transducers 154. Each transducer 154 has an ultrasound-emitting surface 142 which faces away from the longitudinal axis 138 and which is oriented at an angle of substantially 360/P degrees apart from the ultrasound-emitting surface 142 of an adjacent transducer 154 when viewed in a cross section (see FIG. 15) of the transducer assembly 152 taken by a cutting plane which is perpendicular to the longitudinal axis 138.
  • A fifth method of the present invention is for ultrasound medical treatment of a patient and uses the ultrasound medical-[0080] treatment system 144 as previously described in the third expression of the fourth embodiment. The fourth method includes steps a) through c). Step a) includes inserting the end effector 146 into the liver of the patient. Step b) includes identifying a lesion in the liver for medical treatment at least in part from ultrasound imaging using the ultrasound imaging and medical-treatment transducer assembly 152. Step c) includes medically treating the lesion with ultrasound from the ultrasound imaging and medical-treatment transducer assembly 152. In one example, step a) interstially inserts the end effector 146 into the lesion. In another example, step a) endoscopically inserts the end effector 146 into the liver through the hepato-biliary duct system.
  • In one example of the previously-described first, second and third expressions of the fourth embodiment, the [0081] transducer assembly 136, 148, and 152 has a distal tip 156 and has a tip transducer 158. In one design, the tip transducer is a forward facing tip transducer. In another design, the tip transducer is a sideways facing tip transducer. In one variation, the tip transducer is an ultrasound imaging tip transducer. In another variation, the tip transducer is an ultrasound medical-treatment tip transducer. In a further variation, the tip transducer is an ultrasound imaging and medical-treatment tip transducer. In an additional variation, the tip transducer is a transponder which emits electromagnetic waves or mechanical waves or both.
  • In the same or a different example of the previously-described first, second and third expressions of the third embodiment, each ultrasound-emitting [0082] surface 142 is substantially straight when viewed in the cross section, as seen in FIG. 15. In one variation, as seen in FIG. 14, each ultrasound-emitting surface 142 has a substantially concave shape as one moves along the ultrasound-emitting surface 142 in a direction parallel to the longitudinal axis 138, and each ultrasound-emitting surface 142 has a focal zone. In a first alternate transducer arrangement seen FIG. 16, each ultrasound-emitting surface 162 has a substantially planar shape. In a second alternate transducer arrangement seen in FIG. 17, each ultrasound-emitting surface 164 has a substantially concave shape when viewed in the cross section, and each ultrasound-emitting surface 164 has a focal zone. In one modification, each ultrasound-emitting surface 164 also has a substantially concave shape as one moves along the ultrasound-emitting surface 164 in a direction parallel to the longitudinal axis (such as, for example, by the ultrasound-emitting surface 164 having a hemispherically-concave shape). Such ultrasound-emitting surface shapes are equally applicable to any ultrasound transducer mentioned in any other embodiment of the invention.
  • In the same or a different example of the previously-described first, second and third expressions of the third embodiment, P is no greater than four. In one variation, P equals three as seen in FIGS. 15 and 17. In another variation, P equals two as seen in FIG. 16. [0083]
  • In the same or a different example of the previously-described second and third expressions of the third embodiment, the [0084] end effector 146 is an open-surgery end effector, an endoscopic end effector, a laparoscopic end effector (as shown in FIG. 13), a catheter end effector (such as, but not limited to, an intravascular catheter end effector), or a needle end effector, as can be appreciated by those skilled in the art. In one enablement, as shown in FIG. 13, the ultrasound medical treatment system 144 also includes a handpiece 166 operatively connected to the end effector 146 and to an ultrasound controller 168 operatively connected to a foot-pedal power switch 169, as can be appreciated by the artisan.
  • Ultrasound Medical Treatment Applications
  • Excisional and Ultrasound Medical Treatment System [0085]
  • A fifth embodiment of the present invention is shown in FIGS. [0086] 18-20. In a first expression of the fifth embodiment of the present invention, an ultrasound medical treatment system 170 includes a tube 172, a first end effector 174, and a second end effector 176. The tube 172 has a distal end 178 insertable into a patient 180 and has a lumen 182. The first end effector 174 has a cutting tool 184, is introducible into the lumen 182 of the inserted tube 172 from outside the patient 180, and is translatable through the lumen 182 of the inserted tube 172 to inside the patient 180. The second end effector 176 has an ultrasound medical-treatment transducer assembly 186, is introducible into the lumen 182 of the inserted tube 172 from outside the patient 180, and is translatable through the lumen 182 of the inserted tube 172 to inside the patient 180. In one variation, the first and second end effectors are introduced into the lumen through separate openings in the lumen or through separate branch channels leading to the lumen. In another variation, the first and second end effectors are introduced into the lumen through the same opening in the lumen. In one modification, a lumen opening is disposed at the end of the tube. In another modification, a lumen opening is spaced apart from the end of the tube.
  • A second expression of the fifth embodiment of the present invention is for an ultrasound [0087] medical treatment system 170 including a tube 172, a first end effector 174, and a second end effector 176. The tube has a distal end 178 insertable into a patient 180 and has a lumen 182 with a distal opening 188 and a proximal opening 190. The first end effector 174 has a cutting tool 184, is introducible into the proximal opening 190, and is translatable through the lumen 182 to the distal opening 188. The second end effector 176 has an ultrasound medical-treatment transducer assembly 186, is introducible into the proximal opening 190, and is translatable through the lumen 182 to the distal opening 188.
  • In one example of the first and second expressions of the fifth embodiment of the present invention, the [0088] lumen 182 is sized to allow introduction of only one of the first and second end effectors 174 and 176 at a time. In the same or another example, the distal end 178 of the tube 172 is interstitially insertable into patient tissue 192 of the patient 180. In the same or a different example, the cutting tool 184 is a biopsy cutting tool 194 or other excisional cutting tool.
  • A third expression of the fifth embodiment of the present invention is for an ultrasound [0089] medical treatment system 170 including a tube 172, a first end effector 174, and a second end effector 176. The tube 172 has a distal end 178 interstitially insertable into breast tissue 196 of a patient 180 and has a lumen 182 with a distal opening 188 and a proximal opening 190. The first end effector 174 has a biopsy cutting tool 194 (or other excisional cutting tool), is introducible into the proximal opening 190, and is translatable through the lumen 182 to the distal opening 188. The second end effector 176 has an ultrasound medical-treatment transducer assembly 186, is introducible into the proximal opening 190, and is translatable through the lumen 182 to the distal opening 188. The lumen 182 is sized to allow introduction of only one of the first and second end effectors 174 and 176 at a time. In one design, the first end effector also includes a suction mechanism to draw in patient tissue to be biopsied by the biopsy cutting tool 194. In one application, the tube 172 and the first end effector 174 (with the biopsy cutting tool 194 including a suction mechanism) are based on components of a Mammotome® Breast Biopsy System manufactured by Ethicon Endo-Surgery, Inc. (a Johnson & Johnson Company).
  • A sixth method of the invention is for ultrasound medical treatment of a [0090] patient 180 and uses the ultrasound medical treatment system 170 as previously described in the third expression of the fifth embodiment of the present invention. The sixth method includes steps a) through h). Step a) includes identifying possibly cancerous breast tissue 196 of the patient. Step b) includes interstitially inserting the distal end 178 of the tube 172 into the patient 180 with the distal opening 188 disposed proximate the breast tissue 196 and with the proximal opening 190 disposed outside the patient. Step c) includes introducing the first end effector 174 into the proximal opening 190 and translating the first end effector 174 through the lumen 182 to the distal opening 188. Step d) includes obtaining a biopsy sample of the breast tissue 196 with the biopsy cutting tool 194. Step e) includes removing the first end effector 174 from the lumen 182, Step f) includes introducing the second end effector 176 into the proximal opening 190 and translating the second end effector 176 through the lumen 182 to the distal opening 188. Step g) includes identifying an area of hemorrhaging in the breast tissue where the biopsy sample was obtained. Step h) includes medically treating the identified area with ultrasound using the transducer assembly 186 to substantially stop the hemorrhaging. In one application, the sixth method of the invention also includes the steps of testing the biopsy sample for cancer and substantially ablating any remaining cancer in the breast tissue with ultrasound using the transducer assembly 186. Advantages of such an ultrasound medical treatment system and method include the ease of obtaining a breast biopsy and the control of hemorrhaging caused by the biopsy procedure coupled together in a minimally invasive manner.
  • In a fourth expression of the fifth embodiment of the present invention, an ultrasound [0091] medical treatment system 170 includes a tube 172, a first end effector 174, and a second end effector 176. The tube 172 has a distal end 178 insertable into a patient 180 and has a lumen 182. The first end effector 174 has a cutting tool 184, is introducible into the lumen 182 of the inserted tube 172 from outside the patient 180, and is translatable through the lumen 182 of the inserted tube 172 to inside the patient 180. The second end effector 176 has an ultrasound imaging and medical-treatment transducer assembly 198, is introducible into the lumen 182 of the inserted tube 172 from outside the patient 180, and is translatable through the lumen 182 of the inserted tube 172 to inside the patient 180. In one variation, the first and second end effectors are introduced into the lumen through separate openings in the lumen or through separate branch channels leading to the lumen. In another variation, the first and second end effectors are introduced into the lumen through the same opening in the lumen. In one modification, a lumen opening is disposed at the end of the tube. In another modification, a lumen opening is spaced apart from the end of the tube.
  • A fifth expression of the fifth embodiment of the present invention is for an ultrasound [0092] medical treatment system 170 including a tube 172, a first end effector 174, and a second end effector 176. The tube has a distal end 178 insertable into a patient 180 and has a lumen 182 with a distal opening 188 and a proximal opening 190. The first end effector 174 has a cutting tool 184, is introducible into the proximal opening 190, and is translatable through the lumen 182 to the distal opening 188. The second end effector 176 has an ultrasound imaging and medical-treatment transducer assembly 198, is introducible into proximal opening 190, and is translatable through the lumen 182 to the distal opening 188.
  • In one example of the fourth and fifth expressions of the fifth embodiment of the present invention, the [0093] lumen 182 is sized to allow introduction of only one of the first and second end effectors 174 and 176 at a time. In the same or another example, the distal end 178 of the tube 172 is interstitially insertable into patient tissue 192 of the patient 180. In the same or a different example, the cutting tool 184 is a biopsy cutting tool 194 or other excisional cutting tool.
  • A sixth expression of the fifth embodiment of the present invention is for an ultrasound [0094] medical treatment system 170 including a tube 172, a first end effector 174, and a second end effector 176. The tube 172 has a distal end 178 interstitially insertable into breast tissue 196 of a patient 180 and has a lumen 182 with a distal opening 188 and a proximal opening 190. The first end effector 174 has a biopsy cutting tool 194 (or other excisional cutting tool), is introducible into the proximal opening 190, and is translatable through the lumen 182 to the distal opening 188. The second end effector 176 has an ultrasound imaging and medical-treatment transducer assembly 196, is introducible into the proximal opening 190, and is translatable through the lumen 182 to the distal opening 188. The lumen 182 is sized to allow introduction of only one of the first and second end effectors 174 and 176 at a time. In one application, the tube 172 and the first end effector 174 (with the biopsy cutting tool 194 including a suction mechanism) are based on components of a Mammotome® Breast Biopsy System manufactured by Ethicon Endo-Surgery, Inc. (a Johnson & Johnson Company).
  • A seventh method of the invention is for ultrasound medical treatment of a [0095] patient 180 and uses the ultrasound medical treatment system 170 as previously described in the sixth expression of the fifth embodiment of the present invention. The seventh method includes steps a) through h). Step a) includes identifying possibly cancerous breast tissue 196 of the patient. Step b) includes interstitially inserting the distal end 178 of the tube 172 into the patient 180 with the distal opening 188 disposed proximate the breast tissue 196 and with the proximal opening 190 disposed outside the patient. Step c) includes introducing the first end effector 174 into the proximal opening 190 and translating the first end effector 174 through the lumen 182 to the distal opening 188. Step d) includes obtaining a biopsy sample of the breast tissue 196 with the biopsy cutting tool 194. Step e) includes removing the first end effector 174 from the lumen 182, Step f) includes introducing the second end effector 176 into the proximal opening 190 and translating the second end effector 176 through the lumen 182 to the distal opening 188. Step g) includes identifying an area of hemorrhaging in the breast tissue where the biopsy sample was obtained from ultrasound imaging using the transducer assembly 198. Step h) includes medically treating the identified area with ultrasound using the transducer assembly 198 to substantially stop the hemorrhaging. In one application, the seventh method of the invention also includes the steps of testing the biopsy sample for cancer and substantially ablating any remaining cancer in the breast tissue with ultrasound using the transducer assembly 198. Advantages of such an ultrasound medical treatment system and method include the ease of obtaining a breast biopsy and the imaging and control of hemorrhaging caused by the biopsy procedure coupled together in a minimally invasive manner.
  • In one enablement, as shown in FIG. 18, the ultrasound [0096] medical treatment system 170 also includes a handpiece 199 which is attached to the tube 172, which contains the first end effector 174 for extending the cutting tool 184 into, and withdrawing it from, the lumen 182, and which is operatively connected to an ultrasound controller 201 via a first cable 203. The second end effector 176, in this enablement, is operatively connected to the ultrasound controller 201 via a second cable 205 and is inserted into the lumen 182 from outside the handpiece 199 as shown in FIG. 18.
  • Staging Medical Treatment Using Ultrasound [0097]
  • An eighth method of the invention is shown in block diagram form in FIG. 21 and is for medical treatment of a patient. The eighth method includes steps a) through f). Step a) is labeled “Obtain Transducer Assembly” in [0098] block 200 of FIG. 21. Step a) includes obtaining an ultrasound imaging transducer assembly. Step b) is labeled “Insert Assembly Into Gastrointestinal Area” in block 202 of FIG. 21. Step b) includes inserting the transducer assembly into a gastrointestinal area of the patient. Step c) is labeled “Guide Assembly” in block 204 of FIG. 21. Step c) includes guiding the transducer assembly within the gastrointestinal area. Step d) is labeled “Identify Patient Tissue For Treatment” in block 206 of FIG. 21. Step d) includes identifying patient tissue in the gastrointestinal area for medical treatment. Step e) is labeled “Stage Treatment From Ultrasound Imaging” in block 208 of FIG. 21. Step e) includes staging the medical treatment from ultrasound imaging using the transducer assembly. Step f) is labeled as “Medically Treat Patient” in block 210 of FIG. 21. Step f) includes medically treating the patient tissue according to the staging of step e). It is pointed out that in the eighth method the medical treatment need not include ultrasound medical treatment with the transducer assembly used for staging and/or need not include ultrasound medical treatment with any other ultrasound transducer assembly. In one procedure depending on the pathology size and site, a first transducer assembly is used endoscopically to stage the medical treatment in step e) and a second transducer assembly is used laparoscopically to medically treat the patient tissue with ultrasound in step f). In one variation, the first transducer assembly is used laparoscopically to stage the medical treatment in step e) and the second transducer assembly is used endoscopically to medically treat the patient tissue with ultrasound in step f). In another procedure, the medical treatment in step f) is radio-frequency, laser, microwave, or chemical ablation medical treatment. Other types of medical treatment are left to the artisan.
  • It is noted that the gastrointestinal (GI) area of a human patient includes, without limitation, the esophagus and the stomach of the upper GI area and the rectum and the colon of the lower GI area. It further is noted that the liver is also considered to be in the GI area for purposes of this method. [0099]
  • By “staging the medical treatment from ultrasound imaging” is meant at least using ultrasound images to determine the three-dimensional size and shape of the patient tissue that is to receive medical treatment. For example, and without limitation, upper and lower GI tumors can be visualized with high frequency (6-30 MHz) ultrasound imaging using a cylindrical, side-firing, or half-convex ultrasound array or single-element transducer introduced endoscopically into the GI tract. All layers of the GI tract can be visualized including all layers of the esophagus, stomach, duodenum, colon, etc. In one procedure, a three-dimensional representation of the GI structures is created by collating a series of two-dimensional scans generated by axially advancing the ultrasound transducer. Any neoplastic growth, its morphological characteristics, as well as the tumor's size and shape can easily be determined from the three-dimensional representation. [0100]
  • Advantages of such medical-treatment staging from ultrasound imaging include, in one example, providing a non-invasive medical-treatment staging technique which has greater resolution and which is more practical compared to conventional extracorporeal medical-treatment staging techniques such as using x-rays or MRI imaging or compared to using conventional endoscopic optical techniques. [0101]
  • A ninth method of the invention is for ultrasound medical treatment of a patient and includes steps a) through f). The ninth method uses the same block diagram of FIG. 21 as does the eighth method but with “end effector” replacing “transducer assembly” in [0102] block 200 and with “end effector” replacing “assembly” in blocks 202 and 204. Step a) includes obtaining an end effector having an ultrasound imaging and medical-treatment transducer assembly. Step b) includes inserting the end effector into a gastrointestinal area of the patient. Step c) includes guiding the transducer assembly within the gastrointestinal area. Step d) includes identifying patient tissue in the gastrointestinal area for medical treatment. Step e) includes staging the medical treatment from ultrasound imaging using the transducer assembly. Step f) includes medically treating the patient tissue with ultrasound using the transducer assembly according to the staging of step e).
  • A tenth method of the invention is for ultrasound medical treatment of a patient and includes steps a) through f). The tenth method uses the same block diagram of FIG. 21 as does the eighth method but with “end effector” replacing “transducer assembly” in [0103] block 200 and with “end effector” replacing “assembly” in blocks 202 and 204. Step a) includes obtaining an end effector having an ultrasound imaging and medical-treatment transducer assembly. Step b) includes inserting the end effector into a gastrointestinal area of the patient. Step c) includes guiding the transducer assembly within the gastrointestinal area. Step d) includes identifying patient tissue in the gastrointestinal area for medical treatment at least in part from ultrasound imaging using the transducer assembly. Step e) includes staging the medical treatment from ultrasound imaging using the transducer assembly. Step f) includes medically treating the patient tissue with ultrasound using the transducer assembly according to the staging of step e). In one procedure, large GI tumors are staged through a laparoscopic access to the GI area, whereby the tumors are identified, staged and treated using an end effector having an ultrasound imaging and medical-treatment transducer assembly.
  • In one example of the ninth and tenth methods of the invention, the patient tissue is gastroesophageal tissue containing a lesion, and step f) ultrasonically substantially ablates the lesion. In one modification, the gastroesophageal tissue contains a blood vessel supplying blood to the lesion, and step f) ultrasonically treats the blood vessel to substantially stop the supply of blood to the lesion from the blood vessel. [0104]
  • In another example of the ninth and tenth methods of the invention, the patient tissue is liver tissue containing a lesion and a blood vessel supplying blood to the lesion, and step f) ultrasonically treats the blood vessel to substantially stop the supply of blood to the lesion from the blood vessel. [0105]
  • In an additional example of the ninth and tenth methods of the invention, the patient tissue is liver tissue containing a lesion, and step f) ultrasonically substantially ablates the lesion. In one modification, the liver tissue contains a blood vessel supplying blood to the lesion, and step f) also ultrasonically treats the blood vessel to substantially stop the supply of blood to the lesion from the blood vessel. In one procedure, an end effector having an ultrasound imaging and medical-treatment transducer assembly is introduced endoscopically into the GI tract, is advanced retrogradely through the ampulla of Vater up the common bile duct, and is advanced further into the hepatic duct system where liver parenchyma requiring medical treatment (such as cholangio-carcinomas) are identified, staged, and treated using the end effector. [0106]
  • Treatment of Lung Lesions Using Ultrasound [0107]
  • An eleventh method of the invention is shown in block diagram form in FIG. 22 and is for ultrasound medical treatment of a patient. The eleventh method includes steps a) through f). Step a) is labeled “Obtain End Effector” in [0108] block 212 of FIG. 22. Step a) includes obtaining an end effector having an ultrasound medical-treatment transducer assembly. Step b) is labeled “Insert End Effector” in block 214 of FIG. 22. Step b) includes inserting the end effector into the patient. Step c) is labeled “Guide End Effector To Lung” in block 216 of FIG. 22. Step c) includes guiding the end effector within the patient to a lung of the patient. Step d) is labeled “Identify Lesion” in block 218 of FIG. 22. Step d) includes identifying a lesion on or in the lung for medical treatment. Step e) is labeled “Position Transducer Assembly” in block 220 of FIG. 22. Step e) includes positioning the transducer assembly on or in the lesion. Step f) is labeled “Medically Treat Lesion” in block 222 of FIG. 22. Step f) includes medically treating the lesion with ultrasound using the transducer assembly.
  • A twelfth method of the invention is for ultrasound medical treatment of a patient and includes steps a) through f). The twelfth method uses the same block diagram of FIG. 22 as does the eleventh method. Step a) includes obtaining an end effector having an ultrasound imaging and medical-treatment transducer assembly. Step b) includes inserting the end effector into the patient. Step c) includes guiding the end effector within the patient to a lung of the patient. Step d) includes identifying a lesion on or in the lung for medical treatment at least in part from ultrasound imaging using the transducer assembly. Step e) includes positioning the transducer assembly on or in the lesion. Step f) includes medically treating the lesion with ultrasound using the transducer assembly. [0109]
  • In one example of the eleventh and twelfth methods, step f) ultrasonically substantially ablates the lesion. In one application, the end effector is an endoscopic end effector and step b) transbronchial-endoscopically inserts the end effector into the patient. In another application, the end effector is a needle end effector and step b) interstitially inserts the end effector into the patient. In one implementation, step e) positions the transducer assembly on the lesion. In another implementation, step e) positions the transducer assembly in the lesion. In one practice of the eleventh and twelfth methods, step c) a bronchoscope is used to guide the end effector to a lung of the patient. [0110]
  • Ultrasound medical treatment of the lung has conventionally been avoided because such ultrasound is prevented from reaching a lesion within the lung by the alveoli of the lung which contain air which reflect back most of the ultrasound preventing the ultrasound from effectively penetrating the lung to the lesion. Using higher power ultrasound for effective penetration of the lung to reach the lesion would injure or destroy the alveoli which are needed for breathing. Applicants theorized that positioning the ultrasound transducer on or in a lesion of the lung would allow ultrasound medical treatment of the lesion (such as a tumor or an infarct) without injury to the alveoli. It is noted that Applicants' method is applicable to surface lesions as well as non-surface lesions. Advantages of Applicants' eleventh and twelfth methods for ultrasound medical treatment include, in one example, the destruction of lung cancer lesions in cases which otherwise would be inoperable or incurable. [0111]
  • Ultrasound-Based Occlusive Procedure for Medical Treatment [0112]
  • A thirteenth method of the invention is shown in block diagram form in FIG. 23 and is for ultrasound medical treatment of a patient. The thirteenth method includes steps a) through e). Step a) is labeled “Obtain End Effector” in [0113] block 224 of FIG. 23. Step a) includes obtaining an end effector having an ultrasound medical-treatment transducer assembly. Step b) is labeled “Insert End Effector” in block 226 of FIG. 23. Step b) includes inserting the end effector into the patient. Step c) is labeled “Guide End Effector” in block 228 of FIG. 23. Step c) includes guiding the end effector within the patient to a region of patient tissue containing a lesion. Step d) is labeled “Identify Blood Vessel Supplying Lesion” in block 230 of FIG. 23. Step d) includes identifying a blood vessel in the region which supplies blood to the lesion. Step e) is labeled “Stop Blood Supply Using Ultrasound” in block 232 of FIG. 23. Step e) includes medically treating the blood vessel with ultrasound from the transducer assembly to substantially seal the blood vessel to stop the supply of blood to the lesion from the blood vessel. One implementation of the thirteenth method of the invention also includes the step of medically treating the lesion with ultrasound from the transducer assembly to substantially ablate the lesion.
  • A fourteenth method of the invention is for ultrasound medical treatment of a patient and includes steps a) through g). The fourteenth method is similar to the thirteenth method. Step a) includes obtaining an end effector having an ultrasound imaging and medical-treatment transducer assembly. Step b) includes inserting the end effector into the patient. Step c) includes guiding the end effector within the patient to a region of patient tissue containing a lesion. Step d) includes identifying the lesion at least in part from ultrasound imaging using the transducer assembly. Step e) includes identifying a blood vessel in the region which supplies blood to the lesion from ultrasound imaging using the transducer assembly. Step f) includes medically treating the blood vessel with ultrasound from the transducer assembly to substantially seal the blood vessel to substantially stop the supply of blood to the lesion from the blood vessel. Step g) includes medically treating the lesion with ultrasound from the transducer assembly to substantially ablate the lesion. It is noted that Doppler ultrasound imaging alone, gray-scale ultrasound imaging alone, and a combination of Doppler and gray-scale ultrasound imaging are known ultrasound techniques to image blood flow in blood vessels. [0114]
  • In one application of the thirteenth and fourteenth methods, the end effector is an open-surgery end effector. In another application, the end effector is an endoscopic end effector. In a further application, the end effector is a laparoscopic end effector. In an additional application, the end effector is a catheter end effector (such as, but not limited to, an intravascular catheter end effector). In a different application, the end effector is a needle end effector. [0115]
  • A broadened thirteenth method of the invention eliminates the inserting into and guiding within steps of the above-described thirteenth method and includes steps a) through c). Step a) includes obtaining an end effector having an ultrasound medical-treatment transducer assembly. Step b) includes identifying a blood vessel in the patient which supplies blood to a lesion. Step c) includes medically treating the blood vessel with ultrasound from the transducer assembly to substantially seal the blood vessel to substantially stop the supply of blood to the lesion from the blood vessel. [0116]
  • A broadened fourteenth method of the invention eliminates the inserting into and guiding within steps of the above-described fourteenth method and includes steps a) through e). Step a) includes obtaining an end effector having an ultrasound imaging and medical-treatment transducer assembly. Step b) includes identifying a lesion in the patient at least in part from ultrasound imaging using the transducer assembly. Step c) includes identifying a blood vessel which supplies blood to the lesion from ultrasound imaging using the transducer assembly. Step d) includes medically treating the blood vessel with ultrasound from the transducer assembly to substantially seal the blood vessel to substantially stop the supply of blood to the lesion from the blood vessel. Step e) includes medically treating the lesion with ultrasound from the transducer assembly to substantially ablate the lesion. [0117]
  • In one example of the broadened thirteenth and fourteenth methods, the end effector is an extracorporeal end effector. In another example, the end effector is an intracorporeal end effector. In a further example, the end effector can be used in both an extracorporeal mode and in an intracorporeal mode. [0118]
  • Advantages of Applicants' thirteenth and broadened thirteenth methods for ultrasound medical treatment include, in one example, the indirect destruction of cancer lesions by ultrasound hemostasis in blood vessels supplying the cancer lesions in cases which otherwise would be inoperable or incurable because the location of the cancer lesions prevents medical treatment of the lesions themselves. Advantages of Applicants' fourteenth and broadened fourteenth methods for ultrasound treatment include, in one example, direct destruction of cancer lesions by ultrasound ablation of the cancer lesions together with the indirect destruction of any cancer lesions missed in the ultrasound ablation step by ultrasound hemostasis in blood vessels supplying blood to the missed cancer lesions. [0119]
  • Guiding and Targeting Ultrasound End Effectors
  • Guiding Ultrasound End Effector for Medical Treatment [0120]
  • A sixth embodiment of the present invention is shown in FIG. 24. In a first expression of the sixth embodiment of the present invention, an ultrasound medical treatment system [0121] 234 (only a portion of which is shown in FIG. 24) includes an end effector 236 and at least three receivers 238. The end effector 236 has a transducer assembly 240 including a transducer 242 having at least one transducer element 244 adapted for emitting medical-treatment ultrasound waves and for emitting mechanical waves. It is noted that the terminology “mechanical waves” includes ultrasound and non-ultrasound compression (acoustic) waves and ultrasound and non-ultrasound shear waves, and that waves include wave pulses. The receivers 238 are spaced apart from the transducer assembly 240, and the receivers 238 are adapted to receive the emitted mechanical waves for use in locating the position of the transducer assembly 240. Conventional methods (including triangulation methods) for locating the position of a transponder emitting waves which are received by three receivers are well known. A second expression of the sixth embodiment is identical to the first expression of the sixth embodiment except that the at-least-one transducer element 244 is also adapted for emitting imaging ultrasound waves. In one variation of the first and second expressions of the sixth embodiment, the end effector and the receivers are disposable outside (including in one modification on) the patient. In another variation, the end effector is insertable into the patient and the receivers are disposable outside (including in one modification on) the patient.
  • A seventh embodiment of the present invention is shown in FIG. 25. In a first expression of the seventh embodiment of the present invention, an ultrasound medical treatment system [0122] 246 (only a portion of which is shown in FIG. 25) includes an end effector 248 and at least three receivers 250. The end effector 248 has an ultrasound medical-treatment transducer assembly 252 and has a transponder 254 The transponder 254 is adapted to emit waves, and the waves include electromagnetic waves or mechanical waves or both. The receivers 250 are spaced apart from the transducer assembly 252, and the receivers 250 are adapted to receive the emitted waves for use in locating the position of the transponder 254. In a second expression of the seventh embodiment, the ultrasound medical-treatment transducer assembly 252 is an ultrasound imaging and medical-treatment transducer assembly 256.
  • In one application of the first and second expressions of the seventh embodiment, the [0123] end effector 248 is insertable into a patient, the transponder 254 is adapted to emit electromagnetic waves, and the receivers 250 are disposable outside the patient. In one variation, the receivers 250 are disposable on the patient. In another application, the end effector is disposable outside (including in one modification on) the patient and the receivers are disposable outside (including in one modification on) the patient.
  • In one example of the first and second expressions of the seventh embodiment, the [0124] end effector 248 is an endoscopic end effector, a laparoscopic end effector, a catheter end effector (such as, but not limited to, an intravascular catheter end effector), or a needle end effector. In one design of the first and second expressions of the seventh embodiment, the end effector 248 has a distal tip 260, and the transponder 254 is disposed at the distal tip 260 of the end effector 248. In one variation, the transducer assembly 252 and 256 is disposed proximate the transponder 254.
  • A fifteenth method of the invention uses the ultrasound medical treatment system of the first expression of the seventh embodiment and includes steps a) through h). Step a) includes inserting the [0125] end effector 248 into the patient. Step b) includes disposing the receivers 250 outside the patient. Step c) includes emitting electromagnetic waves from the transponder 254. Step d) includes receiving the electromagnetic waves with the disposed receivers 250. Step e) includes calculating the position of the transponder 254 from the received electromagnetic waves. Step f) includes guiding the end effector within the patient to a desired location from the calculated position of the transponder 254. Step g) includes, after step f), identifying patient tissue for medical treatment. Step h) includes medically treating the identified patient tissue with ultrasound using the transducer assembly 252.
  • A sixteenth method of the invention uses the ultrasound medical treatment system of the second expression of the seventh embodiment and includes steps a) through h). Step a) includes inserting the [0126] end effector 248 into the patient. Step b) includes disposing the receivers 250 outside the patient. Step c) includes emitting electromagnetic waves from the transponder 254. Step d) includes receiving the electromagnetic waves with the disposed receivers 250. Step e) includes calculating the position of the transponder 254 from the received electromagnetic waves. Step f) includes guiding the end effector within the patient to a desired location from the calculated position of the transponder 254. Step g) includes, after step f), identifying patient tissue for medical treatment at least in part from ultrasound imaging using the transducer assembly 256. Step h) includes medically treating the identified patient tissue with ultrasound using the transducer assembly 256.
  • A known electromagnetic transponder and three-receiver system for calculating the position of the transponder and for guiding the transponder (which is attached to a heart catheter for monitoring the heart) inside a patient is the CARTO™ EP Navigation System used with a NAVI-STAR® catheter manufactured by Biosense Webster (a Johnson & Johnson Company). [0127]
  • Advantages of an end effector with ultrasound medical treatment and position-location capabilities include, in one example, more accurately guiding the end effector inside a patient to patient tissue for ultrasound medical treatment of the patient tissue. [0128]
  • Method for Aiming Ultrasound for Medical Treatment [0129]
  • A seventeenth method of the invention is shown in block diagram form in FIG. 26 and is for ultrasound medical treatment of a patient. The seventeenth method includes steps a) through f). Step a) is labeled “Obtain End Effector” in [0130] block 262 of FIG. 26. Step a) includes obtaining an end effector having an ultrasound medical-treatment transducer assembly. Step b) is labeled “Aim Transducer Assembly” in block 264 of FIG. 26. Step b) includes aiming the transducer assembly to focus ultrasound energy at a desired focal zone of patient tissue. It is noted that, in one example, to aim a transducer assembly means to focus ultrasound energy at a particular distance from the transducer assembly and along a particular direction. Step c) is labeled “Activate Transducer Assembly” in block 266 of FIG. 26. Step c) includes activating the aimed transducer assembly to emit ultrasound energy sufficient to achieve a temperature increase in the patient tissue essentially without medically affecting the patient tissue. Step d) is labeled “Detect Actual Focal Zone” in block 268 of FIG. 26. Step d) includes after step c) detecting, from reflected ultrasound energy, an actual focal zone of patient tissue having a temperature increase. Step e) is labeled “Correct For Any Aiming Error” in block 269 of FIG. 26. Step e) includes correcting for any error between the desired focal zone and the actual focal zone. Step f) is labeled “Medically Treat Patient Tissue” in block 270 of FIG. 26. Step f) includes after step e), medically treating the patient tissue with ultrasound using the transducer assembly. In one application, step d) uses one or more additional ultrasound transducer assemblies, separate from the ultrasound transducer assembly used in steps a) through c) and e) through f), to detect, from reflected ultrasound energy, the actual focal zone. In another application, the same ultrasound transducer assembly is used for steps a) through f). In one example of the seventeenth method, the end effector is an extracorporeal end effector. In another example, the end effector is an intracorporeal end effector. In a further example, the end effector can be used in both an extracorporeal mode and in an intracorporeal mode.
  • An eighteenth method of the invention is for ultrasound medical treatment of a patient and includes steps a) through f). The eighteenth method uses the same block diagram of FIG. 26 as does the seventeenth method. Step a) includes obtaining an end effector having an ultrasound imaging and medical-treatment transducer assembly. Step b) includes aiming the transducer assembly to focus ultrasound energy at a desired focal zone of patient tissue. Step c) includes activating the aimed transducer assembly to emit ultrasound energy sufficient to achieve a temperature increase in the patient tissue essentially without medically affecting the patient tissue. Step d) includes after step c) detecting, from reflected ultrasound energy using the transducer assembly, an actual focal zone of patient tissue having a temperature increase. Step e) includes correcting for any error between the desired focal zone and the actual focal zone. Step f) includes after step e), medically treating the patient tissue with ultrasound using the transducer assembly. In one example, the end effector is an extracorporeal end effector. In another example, the end effector is an intracorporeal end effector. In a further example, the end effector can be used in both an extracorporeal mode and in an intracorporeal mode. [0131]
  • A nineteenth method of the invention is for ultrasound medical treatment of a patient and includes steps a) through i). The nineteenth method uses the same block diagram of FIG. 26 as does the seventeenth method but with three extra steps added between [0132] block 262's step a) and block 264's step b) of the seventeenth method. In the nineteenth method, step a) includes obtaining an end effector having an ultrasound imaging and medical-treatment transducer assembly. Step b) includes inserting the end effector into the patient. Step c) includes guiding the end effector inside the patient. Step d) includes identifying a desired focal zone of patient tissue at least in part from ultrasound imaging using the transducer assembly. Step e) includes aiming the transducer assembly to focus ultrasound energy at the desired focal zone of patient tissue. Step f) includes activating the aimed transducer assembly to emit ultrasound energy sufficient to achieve a temperature increase in the patient tissue essentially without medically affecting the patient tissue. Step g) includes after step f) detecting, from reflected ultrasound energy using the transducer assembly, an actual focal zone of patient tissue having a temperature increase. Step h) includes correcting for any error between the desired focal zone and the actual focal zone. Step i) includes after step h), medically treating the patient tissue with ultrasound using the transducer assembly.
  • In one example of the seventeenth through nineteenth methods, the end effector is an endoscopic end effector. In another example, the end effector is a laparoscopic end effector. In a further example, the end effector is a catheter end effector (such as, but not limited to, an intravascular catheter end effector). In an additional example, the end effector is a needle end effector. [0133]
  • It is noted that the achieved temperature increase will decrease over time so that the detected temperature increase may not exactly equal the achieved temperature increase. In one implementation of the seventeenth through nineteenth methods, the temperature increase detected in the detecting step is equal substantially to the temperature increase achieved in the activating step. In one application of the seventeenth through nineteenth methods, the detected temperature increase is not greater than about five degrees Celsius. In one variation, the detected temperature increase is not greater than about two degrees Celsius. [0134]
  • It is noted that conventional methods are known to the artisan to convert ultrasound image data into temperature images. In one variation of the seventeenth through nineteenth methods, the correcting step is performed automatically by a feedback control on the same mechanism used to aim the transducer assembly in the aiming step, as can be appreciated by the artisan. As previously noted, mechanisms for aiming an ultrasound medical-treatment transducer assembly include conventional electronic and/or mechanical techniques as are known to those skilled in the art. [0135]
  • Advantages of correcting for any error between the desired and actual focal zones before medical treatment include more precise ultrasound medical treatment of patient tissue. In one example, better targeting maximizes the ablation of a lesion (and any appropriate margin) while minimizing medical treatment of patient tissue outside the lesion (and outside any appropriate margin). [0136]
  • Ultrasound Imaging of Patient Tissue
  • Ultrasound Feedback in Medically-Treated Patients [0137]
  • A twentieth method of the invention is shown in block diagram form in FIG. 27 and is for ultrasound imaging of patient tissue of a patient. The twentieth method includes steps a) through c). Step a) is labeled “Obtain A First Signal From A Location At A First Time” in [0138] block 272 of FIG. 27. Step a) includes obtaining a first signal of a first imaging ultrasound wave which has been reflected back from a location in the patient tissue at a first time. Step b) is labeled “Obtain A Second Signal From The Location At A Later Second Time” in block 274 of FIG. 27. Step b) includes obtaining a second signal of a second imaging ultrasound wave which has been reflected back from the location in the patient tissue at a later second time wherein the patient has received at least some medical treatment by the second time. Step c) is labeled “Create An Image Of The Location Using The Two Signals” in block 276 of FIG. 27. Step c) includes creating an image of the location using the first signal and the second signal. It is understood that the terminology “creating an image” includes, without limitation, creating an image in visual form displayed, for example, on a monitor and creating an image in electronic form which, for example, is used by a computer without being displayed in visual form on a monitor. In one enablement of the twentieth method of the invention, the image of the location is visually displayed at a pixel location on a monitor.
  • In one example of the twentieth method of the invention, step c) includes creating an image of the location using at least the amplitude of the first signal and the amplitude of the second signal. In one variation, step c) calculates the difference in the amplitudes between the first and second signals. In one modification, step c) uses the calculated amplitude difference and uses one of the amplitudes of one of the first and second signals. In one implementation, step c) calculates the sum of the one amplitude and a function of the calculated amplitude difference. In one illustration for a first signal amplitude of 6 and a second signal amplitude of 7, step c) calculates the amplitude difference, adds the difference to the second signal amplitude creating a processed amplitude of 8, and creates the image of the location using the processed amplitude. Other algorithms for using the amplitude of the first and second signals to enhance any amplitude difference in creating the image of the location after medical treatment are left to the artisan. [0139]
  • In another example of the twentieth method of the invention, step c) includes creating an image of the location using at least the phase of the first signal and the phase of the second signal. In one variation, step c) calculates the difference in the phase between the first and second signals. In one modification, step c) uses the calculated phase difference and uses one of the phases of one of the first and second signals. In one implementation, step c) calculates the sum of the one phase and a function of the calculated phase difference. In one illustration of a first signal phase of 6 degrees and a second signal phase of 7 degrees, step c) calculates the phase difference, adds the difference to the second signal phase creating a processed phase of 8 degrees, and creates the image of the location using the processed phase. Other algorithms for using the phase of the first and second signals to enhance any phase difference in creating the image after medical treatment are left to the artisan. [0140]
  • In an additional example of the twentieth method of the invention, step c) includes creating an image of the location using at least the amplitude and the phase of the first signal and the amplitude and phase of the second signal. In one variation step c) combines the discussions in the previous two paragraphs, as is within the ordinary level of skill of the artisan. [0141]
  • In one application of the twentieth method and examples, etc. thereof, the first signal of step a) has a first frequency (e.g., a first center frequency having a sigma) and the second signal of step b) has a second frequency (e.g., a second center frequency having a sigma) which is different from the first frequency (meaning, for example, that the center frequencies are different). In the same or a different application, the medical treatment is ultrasound medical treatment. In the same or a different application, steps a) through c) are repeated for different locations to image the patient tissue, wherein the image of the patient tissue includes medically-treated locations and medically-untreated locations. In one enablement of the twentieth method of the invention, the image of the patient tissue is visually displayed on a monitor. In another enablement, the image remains as an image map in a computer without being displayed on a monitor. In one extension of the twentieth method, additional signals are obtained between steps a) and b) which are also used in creating the image of the location in step c). [0142]
  • Applicants were the first to realize that changes in patient tissue because of medical treatment of patient tissue, such as ultrasound medical treatment, which affect the amplitude and/or phase of ultrasound imaging signals can be used to enhance the ultrasound image differences of medically-treated patient tissue from surrounding untreated tissue. Applicants have theorized that using different frequencies for the two signals can enhance amplitude and/or phase differences for medically treated and untreated tissue and can be used to enhance the ultrasound image differences of medically-treated patient tissue from surrounding untreated tissue. Advantages of the twentieth method and examples, etc. thereof include, in one application, better ultrasound image contrast between treated and untreated patient tissue providing better monitoring during patient treatment. [0143]
  • Other medical treatments applicable to the twentieth method include, without limitation, other thermal ablation techniques such as radio-frequency, laser, and microwave medical treatments and chemical ablation techniques such as ethanol and chemo-therapeutics (including anti-cancer drugs). Other optional steps in the twentieth method include using signal smoothing techniques, as are known to those skilled in the art. [0144]
  • It is understood that any one or more of the previously-described embodiments, expressions of embodiments, examples, methods, etc. can be combined with any one or more of the other previously-described embodiments, expressions of embodiments, examples, methods, etc. For example, and without limitation, any of the end effectors can be used in any of the methods, any of the transducer arrangements can be used in any of the end effectors, and any appropriate methods can be combined such as combining the seventeenth and twentieth methods, etc. [0145]
  • The foregoing description of several expressions of embodiments and methods of the invention has been presented for purposes of illustration. It is not intended to be exhaustive or to limit the invention to the precise forms and procedures disclosed, and obviously many modifications and variations are possible in light of the above teaching. For example, as would be apparent to those skilled in the art, the disclosures herein of the ultrasonic systems and methods have equal application in robotic assisted surgery taking into account the obvious modifications of the invention to be compatible with such a robotic system. It is intended that the scope of the invention be defined by the claims appended hereto. [0146]

Claims (22)

What is claimed is:
1. An ultrasound medical treatment system comprising:
a) a tube having a distal end insertable into a patient and having a lumen;
b) a first end effector having a cutting tool, introducible into the lumen of the inserted tube from outside the patient, and translatable through the lumen of the inserted tube to inside the patient; and
c) a second end effector having an ultrasound medical-treatment transducer assembly, introducible into the lumen of the inserted tube from outside the patient, and translatable through the lumen of the inserted tube to inside the patient.
2. The ultrasound medical treatment system of claim 1, wherein the lumen is sized to allow introduction of only one of the first and second end effectors at a time.
3. The ultrasound medical treatment system of claim 2, wherein the distal end of the tube is interstitially insertable into patient tissue of the patient.
4. The ultrasound medical treatment system of claim 3, wherein the cutting tool is a biopsy cutting tool.
5. An ultrasound medical treatment system comprising:
a) a tube having a distal end insertable into a patient and having a lumen with a distal opening and a proximal opening;
b) a first end effector having a cutting tool, introducible into the proximal opening, and translatable through the lumen to the distal opening; and
c) a second end effector having an ultrasound medical-treatment transducer assembly, introducible into proximal opening, and translatable through the lumen to the distal opening.
6. The ultrasound medical treatment system of claim 5, wherein the lumen is sized to allow introduction of only one of the first and second end effectors at a time.
7. The ultrasound medical treatment system of claim 6, wherein the distal end of the tube is interstitially insertable into patient tissue of the patient.
8. The ultrasound medical treatment system of claim 7, wherein the cutting tool is a biopsy cutting tool.
9. An ultrasound medical treatment system comprising:
a) a tube having a distal end interstitially insertable into breast tissue of a patient and having a lumen with a distal opening and a proximal opening;
b) a first end effector having a biopsy cutting tool, introducible into the proximal opening, and translatable through the lumen to the distal opening; and
c) a second end effector having an ultrasound medical-treatment transducer assembly, introducible into the proximal opening, and translatable through the lumen to the distal opening, wherein the lumen is sized to allow introduction of only one of the first and second end effectors at a time.
10. A method for ultrasound medical treatment of a patient using the ultrasound medical treatment system of claim 9 comprising the steps of:
a) identifying possibly cancerous breast tissue of the patient;
b) interstitially inserting the distal end of the tube into the patient with the distal opening disposed proximate the breast tissue and with the proximal opening disposed outside the patient;
c) introducing the first end effector into the proximal opening and translating the first end effector through the lumen to the distal opening;
d) obtaining a biopsy sample of the breast tissue with the biopsy cutting tool;
e) removing the first end effector from the lumen;
f) introducing the second end effector into the proximal opening and translating the second end effector through the lumen to the distal opening;
g) identifying an area of hemorrhaging in the breast tissue where the biopsy sample was obtained; and
h) medically treating the identified area with ultrasound using the transducer assembly to substantially stop the hemorrhaging.
11. The method of claim 10, also including the steps of testing the biopsy sample for cancer and substantially ablating any remaining cancer in the breast tissue with ultrasound using the transducer assembly.
12. An ultrasound medical treatment system comprising:
a) a tube having a distal end insertable into a patient and having a lumen;
b) a first end effector having a cutting tool, introducible into the lumen of the inserted tube from outside the patient, and translatable through the lumen of the inserted tube to inside the patient; and
c) a second end effector having an ultrasound imaging and medical-treatment transducer assembly, introducible into the lumen of the inserted tube from outside the patient, and translatable through the lumen of the inserted tube to inside the patient.
13. The ultrasound medical treatment system of claim 12, wherein the lumen is sized to allow introduction of only one of the first and second end effectors at a time.
14. The ultrasound medical treatment system of claim 12, wherein the distal end of the tube is interstitially insertable into patient tissue of the patient.
15. The ultrasound medical treatment system of claim 12, wherein the cutting tool is a biopsy cutting tool.
16. An ultrasound medical treatment system comprising:
a) a tube having a distal end insertable into a patient and having a lumen with a distal opening and a proximal opening;
b) a first end effector having a cutting tool, introducible into the proximal opening, and translatable through the lumen to the distal opening; and
c) a second end effector having an ultrasound imaging and medical-treatment transducer assembly, introducible into the proximal opening, and translatable through the lumen to the distal opening.
17. The ultrasound medical treatment system of claim 16, wherein the lumen is sized to allow introduction of only one of the first and second end effectors at a time.
18. The ultrasound medical treatment system of claim 17, wherein the distal end of the tube is interstitially insertable into patient tissue of the patient.
19. The ultrasound medical treatment system of claim 18, wherein the cutting tool is a biopsy cutting tool.
20. An ultrasound medical treatment system comprising:
a) a tube having a distal end interstitially insertable into breast tissue of a patient and having a lumen with a distal opening and a proximal opening;
b) a first end effector having a biopsy cutting tool, introducible into the proximal opening, and translatable through the lumen to the distal opening; and
c) a second end effector having an ultrasound imaging and medical-treatment transducer assembly, introducible into the proxirnal opening, and translatable through the lumen to the distal opening, wherein the lumen is sized to allow introduction of only one of the first and second end effectors at a time.
21. A method for ultrasound medical treatment of a patient using the ultrasound medical treatment system of claim 20 comprising the steps of:
a) identifying possibly cancerous breast tissue of the patient;
b) interstitially inserting the distal end of the tube into the patient with the distal opening disposed proximate the breast tissue and with the proximal opening disposed outside the patient;
c) introducing the first end effector into the proximal opening and translating the first end effector through the lumen to the distal opening;
d) obtaining a biopsy sample of the breast tissue with the biopsy cutting tool;
e) removing the first end effector from the lumen;
f) introducing the second end effector into the proximal opening and translating the second end effector through the lumen to the distal opening;
g) identifying an area of hemorrhaging in the breast tissue where the biopsy sample was obtained from ultrasound imaging using the transducer assembly; and
h) medically treating the identified area with ultrasound using the transducer assembly to substantially stop the hemorrhaging.
22. The method of claim 21, also including the steps of testing the biopsy sample for cancer and substantially ablating any remaining cancer in the breast tissue with ultrasound using the transducer assembly.
US10/153,510 2001-05-29 2002-05-22 Excisional and ultrasound medical treatment system Abandoned US20030014093A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
US10/153,510 US20030014093A1 (en) 2001-05-29 2002-05-22 Excisional and ultrasound medical treatment system
PCT/US2002/016697 WO2002096505A2 (en) 2001-05-29 2002-05-28 Excisional and ultrasound medical treatment system
CA 2449068 CA2449068A1 (en) 2001-05-29 2002-05-28 Excisional and ultrasound medical treatment system
DE60233401T DE60233401D1 (en) 2001-05-29 2002-05-28 MEDICAL EXCEPTIONAL AND ULTRASONIC TREATMENT SYSTEM
EP20020739438 EP1397073B1 (en) 2001-05-29 2002-05-28 Excisional and ultrasound medical treatment system
AT02739438T ATE439807T1 (en) 2001-05-29 2002-05-28 MEDICAL EXCISION AND ULTRASONIC TREATMENT SYSTEM
JP2002593013A JP2004528924A (en) 2001-05-29 2002-05-28 Resection / ultrasound therapy system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29413501P 2001-05-29 2001-05-29
US10/153,510 US20030014093A1 (en) 2001-05-29 2002-05-22 Excisional and ultrasound medical treatment system

Publications (1)

Publication Number Publication Date
US20030014093A1 true US20030014093A1 (en) 2003-01-16

Family

ID=23132036

Family Applications (12)

Application Number Title Priority Date Filing Date
US10/153,581 Abandoned US20030013972A1 (en) 2001-05-29 2002-05-22 Treatment of lung lesions using ultrasound
US10/153,246 Abandoned US20030013960A1 (en) 2001-05-29 2002-05-22 Guiding ultrasound end effector for medical treatment
US10/152,900 Abandoned US20030092988A1 (en) 2001-05-29 2002-05-22 Staging medical treatment using ultrasound
US10/153,241 Abandoned US20030069502A1 (en) 2001-05-29 2002-05-22 Ultrasound feedback in medically-treated patients
US10/152,769 Abandoned US20030032898A1 (en) 2001-05-29 2002-05-22 Method for aiming ultrasound for medical treatment
US10/153,122 Active 2024-09-05 US7473224B2 (en) 2001-05-29 2002-05-22 Deployable ultrasound medical transducers
US10/153,245 Abandoned US20030018266A1 (en) 2001-05-29 2002-05-22 Faceted ultrasound medical transducer assembly
US10/153,247 Abandoned US20030013971A1 (en) 2001-05-29 2002-05-22 Ultrasound-based occlusive procedure for medical treatment
US10/153,510 Abandoned US20030014093A1 (en) 2001-05-29 2002-05-22 Excisional and ultrasound medical treatment system
US10/152,766 Active 2024-03-13 US7806892B2 (en) 2001-05-29 2002-05-22 Tissue-retaining system for ultrasound medical treatment
US12/857,872 Expired - Lifetime US8333721B2 (en) 2001-05-29 2010-08-17 Tissue-retaining system for ultrasound medical treatment
US13/719,172 Expired - Fee Related US9005144B2 (en) 2001-05-29 2012-12-18 Tissue-retaining systems for ultrasound medical treatment

Family Applications Before (8)

Application Number Title Priority Date Filing Date
US10/153,581 Abandoned US20030013972A1 (en) 2001-05-29 2002-05-22 Treatment of lung lesions using ultrasound
US10/153,246 Abandoned US20030013960A1 (en) 2001-05-29 2002-05-22 Guiding ultrasound end effector for medical treatment
US10/152,900 Abandoned US20030092988A1 (en) 2001-05-29 2002-05-22 Staging medical treatment using ultrasound
US10/153,241 Abandoned US20030069502A1 (en) 2001-05-29 2002-05-22 Ultrasound feedback in medically-treated patients
US10/152,769 Abandoned US20030032898A1 (en) 2001-05-29 2002-05-22 Method for aiming ultrasound for medical treatment
US10/153,122 Active 2024-09-05 US7473224B2 (en) 2001-05-29 2002-05-22 Deployable ultrasound medical transducers
US10/153,245 Abandoned US20030018266A1 (en) 2001-05-29 2002-05-22 Faceted ultrasound medical transducer assembly
US10/153,247 Abandoned US20030013971A1 (en) 2001-05-29 2002-05-22 Ultrasound-based occlusive procedure for medical treatment

Family Applications After (3)

Application Number Title Priority Date Filing Date
US10/152,766 Active 2024-03-13 US7806892B2 (en) 2001-05-29 2002-05-22 Tissue-retaining system for ultrasound medical treatment
US12/857,872 Expired - Lifetime US8333721B2 (en) 2001-05-29 2010-08-17 Tissue-retaining system for ultrasound medical treatment
US13/719,172 Expired - Fee Related US9005144B2 (en) 2001-05-29 2012-12-18 Tissue-retaining systems for ultrasound medical treatment

Country Status (9)

Country Link
US (12) US20030013972A1 (en)
EP (8) EP1397070A4 (en)
JP (10) JP2004528925A (en)
AT (3) ATE494041T1 (en)
AU (4) AU2002314816B2 (en)
CA (7) CA2448957A1 (en)
DE (3) DE60238838D1 (en)
ES (1) ES2356808T3 (en)
WO (10) WO2002096505A2 (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030018270A1 (en) * 2001-05-29 2003-01-23 Makin Inder Raj. S. Tissue-retaining system for ultrasound medical treatment
US20040260199A1 (en) * 2003-06-19 2004-12-23 Wilson-Cook Medical, Inc. Cytology collection device
WO2005000097A3 (en) * 2003-06-10 2005-05-19 The Foundry Inc Methods and apparatus for non-invasively treating atrial fibrillation using high intensity focused ultrasound
US20050261611A1 (en) * 2004-05-21 2005-11-24 Makin Inder Raj S Ultrasound medical system and method
US20050277853A1 (en) * 2004-06-14 2005-12-15 Mast T D System and method for medical treatment using ultrasound
US20080108984A1 (en) * 2001-08-29 2008-05-08 Burdette Everette C Ultrasound device for treatment of intervertebral disc tisssue
US7846096B2 (en) 2001-05-29 2010-12-07 Ethicon Endo-Surgery, Inc. Method for monitoring of medical treatment using pulse-echo ultrasound
US8444573B2 (en) 2010-03-30 2013-05-21 Siteselect Medical Technologies, Inc. Tissue excision device
CN105073045A (en) * 2013-03-13 2015-11-18 柯惠Lp公司 Clamp ultrasound probe for lung surgery
US20190015072A1 (en) * 2010-11-18 2019-01-17 Koninklijke Philips N.V. Medical device with forward and sideward ablation monitoring ultrasound transducers
US10183183B2 (en) 2007-04-13 2019-01-22 Acoustic Medsystems, Inc. Acoustic applicators for controlled thermal modification of tissue
US20200384292A1 (en) * 2019-06-07 2020-12-10 The Board Of Trustees Of The Leland Stanford Junior University Pattern Interference Radiation Force (PIRF) neural stimulators
US11896779B2 (en) 2012-08-15 2024-02-13 Acoustic Medsystems, Inc. MRI compatible ablation catheter system incorporating directional high-intensity ultrasound for treatment

Families Citing this family (263)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6050943A (en) 1997-10-14 2000-04-18 Guided Therapy Systems, Inc. Imaging, therapy, and temperature monitoring ultrasonic system
US9198635B2 (en) * 1997-10-31 2015-12-01 University Of Washington Method and apparatus for preparing organs and tissues for laparoscopic surgery
US7364577B2 (en) 2002-02-11 2008-04-29 Sherwood Services Ag Vessel sealing system
US6550482B1 (en) * 2000-04-21 2003-04-22 Vascular Control Systems, Inc. Methods for non-permanent occlusion of a uterine artery
US7223279B2 (en) * 2000-04-21 2007-05-29 Vascular Control Systems, Inc. Methods for minimally-invasive, non-permanent occlusion of a uterine artery
US7914453B2 (en) 2000-12-28 2011-03-29 Ardent Sound, Inc. Visual imaging system for ultrasonic probe
US7354444B2 (en) * 2001-03-28 2008-04-08 Vascular Control Systems, Inc. Occlusion device with deployable paddles for detection and occlusion of blood vessels
JP4227415B2 (en) 2001-03-28 2009-02-18 ヴァスキュラー・コントロール・システムズ・インコーポレーテッド Method and apparatus for detecting and ligating uterine arteries
US20030120286A1 (en) * 2001-03-28 2003-06-26 Vascular Control System Luminal clip applicator with sensor
JP4499992B2 (en) 2001-04-06 2010-07-14 コヴィディエン アクチェンゲゼルシャフト Vascular sealing machine and splitting machine having non-conductive stop member
US6736835B2 (en) * 2002-03-21 2004-05-18 Depuy Acromed, Inc. Early intervention spinal treatment methods and devices for use therein
US7207996B2 (en) * 2002-04-04 2007-04-24 Vascular Control Systems, Inc. Doppler directed suturing and compression device and method
US7617005B2 (en) 2002-04-08 2009-11-10 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US20040082859A1 (en) 2002-07-01 2004-04-29 Alan Schaer Method and apparatus employing ultrasound energy to treat body sphincters
US7258690B2 (en) 2003-03-28 2007-08-21 Relievant Medsystems, Inc. Windowed thermal ablation probe
US8613744B2 (en) 2002-09-30 2013-12-24 Relievant Medsystems, Inc. Systems and methods for navigating an instrument through bone
US8808284B2 (en) 2008-09-26 2014-08-19 Relievant Medsystems, Inc. Systems for navigating an instrument through bone
US6907884B2 (en) 2002-09-30 2005-06-21 Depay Acromed, Inc. Method of straddling an intraosseous nerve
US8361067B2 (en) 2002-09-30 2013-01-29 Relievant Medsystems, Inc. Methods of therapeutically heating a vertebral body to treat back pain
US20040122793A1 (en) * 2002-12-20 2004-06-24 Mese John C. Dynamic generation of disk configuration from XML model
US7404821B2 (en) * 2003-01-30 2008-07-29 Vascular Control Systems, Inc. Treatment for post partum hemorrhage
US7651511B2 (en) * 2003-02-05 2010-01-26 Vascular Control Systems, Inc. Vascular clamp for caesarian section
AU2004226374B2 (en) * 2003-03-27 2009-11-12 Terumo Kabushiki Kaisha Methods and apparatus for treatment of patent foramen ovale
US7293562B2 (en) 2003-03-27 2007-11-13 Cierra, Inc. Energy based devices and methods for treatment of anatomic tissue defects
US7186251B2 (en) * 2003-03-27 2007-03-06 Cierra, Inc. Energy based devices and methods for treatment of patent foramen ovale
US8021362B2 (en) * 2003-03-27 2011-09-20 Terumo Kabushiki Kaisha Methods and apparatus for closing a layered tissue defect
US7972330B2 (en) * 2003-03-27 2011-07-05 Terumo Kabushiki Kaisha Methods and apparatus for closing a layered tissue defect
US7165552B2 (en) * 2003-03-27 2007-01-23 Cierra, Inc. Methods and apparatus for treatment of patent foramen ovale
US6939348B2 (en) * 2003-03-27 2005-09-06 Cierra, Inc. Energy based devices and methods for treatment of patent foramen ovale
US7367976B2 (en) 2003-11-17 2008-05-06 Sherwood Services Ag Bipolar forceps having monopolar extension
US7686817B2 (en) 2003-11-25 2010-03-30 Vascular Control Systems, Inc. Occlusion device for asymmetrical uterine artery anatomy
US8206304B1 (en) * 2003-12-16 2012-06-26 Vascular Technology Incorporated Doppler transceiver and probe for use in minimally invasive procedures
JP4262631B2 (en) * 2004-01-13 2009-05-13 オリンパス株式会社 Ultrasonic treatment device
CA2553885C (en) 2004-01-13 2017-01-03 Robarts Research Institute An ultrasound imaging system and methods of imaging using the same
US20050215899A1 (en) * 2004-01-15 2005-09-29 Trahey Gregg E Methods, systems, and computer program products for acoustic radiation force impulse (ARFI) imaging of ablated tissue
CA2555473A1 (en) 2004-02-17 2005-09-01 Traxtal Technologies Inc. Method and apparatus for registration, verification, and referencing of internal organs
US7247141B2 (en) 2004-03-08 2007-07-24 Ethicon Endo-Surgery, Inc. Intra-cavitary ultrasound medical system and method
US7854733B2 (en) 2004-03-24 2010-12-21 Biosense Webster, Inc. Phased-array for tissue treatment
US20050228286A1 (en) * 2004-04-07 2005-10-13 Messerly Jeffrey D Medical system having a rotatable ultrasound source and a piercing tip
US20050240105A1 (en) * 2004-04-14 2005-10-27 Mast T D Method for reducing electronic artifacts in ultrasound imaging
US20050240123A1 (en) * 2004-04-14 2005-10-27 Mast T D Ultrasound medical treatment system and method
US20050240124A1 (en) * 2004-04-15 2005-10-27 Mast T D Ultrasound medical treatment system and method
US7494467B2 (en) * 2004-04-16 2009-02-24 Ethicon Endo-Surgery, Inc. Medical system having multiple ultrasound transducers or an ultrasound transducer and an RF electrode
JP4578850B2 (en) * 2004-04-19 2010-11-10 オリンパス株式会社 Ultrasonic treatment device
US8235909B2 (en) * 2004-05-12 2012-08-07 Guided Therapy Systems, L.L.C. Method and system for controlled scanning, imaging and/or therapy
US20050256405A1 (en) * 2004-05-17 2005-11-17 Makin Inder Raj S Ultrasound-based procedure for uterine medical treatment
US7883468B2 (en) * 2004-05-18 2011-02-08 Ethicon Endo-Surgery, Inc. Medical system having an ultrasound source and an acoustic coupling medium
US7951095B2 (en) * 2004-05-20 2011-05-31 Ethicon Endo-Surgery, Inc. Ultrasound medical system
US20050261587A1 (en) * 2004-05-20 2005-11-24 Makin Inder R S Ultrasound medical system and method
US20050261588A1 (en) * 2004-05-21 2005-11-24 Makin Inder Raj S Ultrasound medical system
US7695436B2 (en) * 2004-05-21 2010-04-13 Ethicon Endo-Surgery, Inc. Transmit apodization of an ultrasound transducer array
US7367975B2 (en) * 2004-06-21 2008-05-06 Cierra, Inc. Energy based devices and methods for treatment of anatomic tissue defects
US20080177180A1 (en) * 2004-08-17 2008-07-24 Technion Research & Development Ultrasonic Image-Guided Tissue-Damaging Procedure
US9011336B2 (en) 2004-09-16 2015-04-21 Guided Therapy Systems, Llc Method and system for combined energy therapy profile
US7393325B2 (en) 2004-09-16 2008-07-01 Guided Therapy Systems, L.L.C. Method and system for ultrasound treatment with a multi-directional transducer
US7824348B2 (en) 2004-09-16 2010-11-02 Guided Therapy Systems, L.L.C. System and method for variable depth ultrasound treatment
US8444562B2 (en) 2004-10-06 2013-05-21 Guided Therapy Systems, Llc System and method for treating muscle, tendon, ligament and cartilage tissue
US8535228B2 (en) 2004-10-06 2013-09-17 Guided Therapy Systems, Llc Method and system for noninvasive face lifts and deep tissue tightening
US10864385B2 (en) 2004-09-24 2020-12-15 Guided Therapy Systems, Llc Rejuvenating skin by heating tissue for cosmetic treatment of the face and body
US20060111744A1 (en) 2004-10-13 2006-05-25 Guided Therapy Systems, L.L.C. Method and system for treatment of sweat glands
US9827449B2 (en) 2004-10-06 2017-11-28 Guided Therapy Systems, L.L.C. Systems for treating skin laxity
US11235179B2 (en) 2004-10-06 2022-02-01 Guided Therapy Systems, Llc Energy based skin gland treatment
US8690778B2 (en) 2004-10-06 2014-04-08 Guided Therapy Systems, Llc Energy-based tissue tightening
JP2008522642A (en) 2004-10-06 2008-07-03 ガイデッド セラピー システムズ, エル.エル.シー. Method and system for beauty enhancement
US9694212B2 (en) 2004-10-06 2017-07-04 Guided Therapy Systems, Llc Method and system for ultrasound treatment of skin
DE202005022028U1 (en) 2004-10-06 2012-07-09 Guided Therapy Systems, Llc Ultrasonic tissue treatment system
US7758524B2 (en) 2004-10-06 2010-07-20 Guided Therapy Systems, L.L.C. Method and system for ultra-high frequency ultrasound treatment
US8663112B2 (en) 2004-10-06 2014-03-04 Guided Therapy Systems, Llc Methods and systems for fat reduction and/or cellulite treatment
US11883688B2 (en) 2004-10-06 2024-01-30 Guided Therapy Systems, Llc Energy based fat reduction
US8133180B2 (en) 2004-10-06 2012-03-13 Guided Therapy Systems, L.L.C. Method and system for treating cellulite
US11724133B2 (en) 2004-10-07 2023-08-15 Guided Therapy Systems, Llc Ultrasound probe for treatment of skin
US11207548B2 (en) 2004-10-07 2021-12-28 Guided Therapy Systems, L.L.C. Ultrasound probe for treating skin laxity
US20060089626A1 (en) * 2004-10-22 2006-04-27 Vlegele James W Surgical device guide for use with an imaging system
US7452357B2 (en) * 2004-10-22 2008-11-18 Ethicon Endo-Surgery, Inc. System and method for planning treatment of tissue
US7833221B2 (en) * 2004-10-22 2010-11-16 Ethicon Endo-Surgery, Inc. System and method for treatment of tissue using the tissue as a fiducial
CA2586560A1 (en) * 2004-11-05 2006-06-01 The Government Of The United States Of America, As Represented By The Se Cretary, Department Of Health And Human Services Access system
US7751868B2 (en) * 2004-11-12 2010-07-06 Philips Electronics Ltd Integrated skin-mounted multifunction device for use in image-guided surgery
US20060184070A1 (en) * 2004-11-12 2006-08-17 Hansmann Douglas R External ultrasonic therapy
US7805269B2 (en) * 2004-11-12 2010-09-28 Philips Electronics Ltd Device and method for ensuring the accuracy of a tracking device in a volume
KR100714682B1 (en) * 2004-12-02 2007-05-04 삼성전자주식회사 File system path processing device and method thereof
US20060173387A1 (en) * 2004-12-10 2006-08-03 Douglas Hansmann Externally enhanced ultrasonic therapy
WO2006078678A2 (en) * 2005-01-18 2006-07-27 Traxtal Inc. Method and apparatus for guiding an instrument to a target in the lung
EP1838215B1 (en) * 2005-01-18 2012-08-01 Philips Electronics LTD Electromagnetically tracked k-wire device
DE602006008740D1 (en) * 2005-01-20 2009-10-08 Wilson Cook Medical Inc BIOPSY FORCEPS
US7771418B2 (en) * 2005-03-09 2010-08-10 Sunnybrook Health Sciences Centre Treatment of diseased tissue using controlled ultrasonic heating
US8801701B2 (en) * 2005-03-09 2014-08-12 Sunnybrook Health Sciences Centre Method and apparatus for obtaining quantitative temperature measurements in prostate and other tissue undergoing thermal therapy treatment
JP2008534045A (en) * 2005-03-22 2008-08-28 アトロポス・リミテッド Surgical instruments
WO2006110830A2 (en) * 2005-04-11 2006-10-19 Cierra, Inc. Methods and apparatus to achieve a closure of a layered tissue defect
US20060243280A1 (en) * 2005-04-27 2006-11-02 Caro Richard G Method of determining lung condition indicators
US8241223B2 (en) 2005-04-29 2012-08-14 Isonea Limited Cough detector
US20070055175A1 (en) * 2005-05-25 2007-03-08 Pulmosonix Pty Ltd Devices and methods for tissue analysis
US8632461B2 (en) * 2005-06-21 2014-01-21 Koninklijke Philips N.V. System, method and apparatus for navigated therapy and diagnosis
EP1937153B1 (en) * 2005-06-21 2010-12-22 Traxtal Inc. Device and method for a trackable ultrasound
US7625343B2 (en) * 2005-07-01 2009-12-01 Scimed Life Systems, Inc. Concave phased array imaging catheter
US20070016184A1 (en) * 2005-07-14 2007-01-18 Ethicon Endo-Surgery, Inc. Medical-treatment electrode assembly and method for medical treatment
US7837619B2 (en) * 2005-08-19 2010-11-23 Boston Scientific Scimed, Inc. Transeptal apparatus, system, and method
US7824397B2 (en) 2005-08-19 2010-11-02 Boston Scientific Scimed, Inc. Occlusion apparatus
US7998095B2 (en) * 2005-08-19 2011-08-16 Boston Scientific Scimed, Inc. Occlusion device
US8062309B2 (en) * 2005-08-19 2011-11-22 Boston Scientific Scimed, Inc. Defect occlusion apparatus, system, and method
US9661991B2 (en) * 2005-08-24 2017-05-30 Koninklijke Philips N.V. System, method and devices for navigated flexible endoscopy
US20070049973A1 (en) * 2005-08-29 2007-03-01 Vascular Control Systems, Inc. Method and device for treating adenomyosis and endometriosis
US9486274B2 (en) 2005-09-07 2016-11-08 Ulthera, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US8518069B2 (en) 2005-09-07 2013-08-27 Cabochon Aesthetics, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US9011473B2 (en) 2005-09-07 2015-04-21 Ulthera, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US10548659B2 (en) * 2006-01-17 2020-02-04 Ulthera, Inc. High pressure pre-burst for improved fluid delivery
US9358033B2 (en) 2005-09-07 2016-06-07 Ulthera, Inc. Fluid-jet dissection system and method for reducing the appearance of cellulite
US20070083121A1 (en) * 2005-09-26 2007-04-12 Hastings Harold M Transesophageal ultrasound probe with reduced width
DE102005049268A1 (en) * 2005-10-14 2007-04-19 Siemens Ag Medical technical system with patient bed for conducting clinical processes has reading devices designed and arranged so evaluation unit can determine position of patient on bed using reading device signals
US9248317B2 (en) 2005-12-02 2016-02-02 Ulthera, Inc. Devices and methods for selectively lysing cells
US7885793B2 (en) 2007-05-22 2011-02-08 International Business Machines Corporation Method and system for developing a conceptual model to facilitate generating a business-aligned information technology solution
US20070239011A1 (en) * 2006-01-13 2007-10-11 Mirabilis Medica, Inc. Apparatus for delivering high intensity focused ultrasound energy to a treatment site internal to a patient's body
CN100463660C (en) * 2006-01-18 2009-02-25 重庆海扶(Hifu)技术有限公司 Ultrasonic therapeutic pincers
US20070197895A1 (en) 2006-02-17 2007-08-23 Sdgi Holdings, Inc. Surgical instrument to assess tissue characteristics
US9107798B2 (en) 2006-03-09 2015-08-18 Slender Medical Ltd. Method and system for lipolysis and body contouring
US7828734B2 (en) 2006-03-09 2010-11-09 Slender Medical Ltd. Device for ultrasound monitored tissue treatment
US20070270661A1 (en) * 2006-03-28 2007-11-22 Marc Philippon Method and apparatus for monitoring blood flow to the hip joint
CA2649119A1 (en) 2006-04-13 2007-12-13 Mirabilis Medica, Inc. Methods and apparatus for the treatment of menometrorrhagia, endometrial pathology, and cervical neoplasia using high intensity focused ultrasound energy
DE102006029122A1 (en) * 2006-06-22 2007-12-27 Amedo Gmbh System for determining the position of a medical instrument
JP5336369B2 (en) * 2006-08-11 2013-11-06 コーニンクレッカ フィリップス エヌ ヴェ Ultrasound system for cerebral blood flow imaging and microbubble improvement thrombus resolution
EP2465439A1 (en) * 2006-08-14 2012-06-20 Volcano Corporation Imaging device, imaging system, and methods of imaging
US9566454B2 (en) 2006-09-18 2017-02-14 Guided Therapy Systems, Llc Method and sysem for non-ablative acne treatment and prevention
EP2088944B1 (en) 2006-10-30 2017-07-12 Dgimed Ortho, Inc. Surgical cutting devices
US20080140070A1 (en) * 2006-12-07 2008-06-12 Cierra, Inc. Multi-electrode apparatus for tissue welding and ablation
US20080140112A1 (en) * 2006-12-07 2008-06-12 Cierra, Inc. Method for orienting a multi-electrode apparatus
US20080146937A1 (en) * 2006-12-14 2008-06-19 General Electric Company Mechanically expanding transducer assembly
JP2008245891A (en) * 2007-03-30 2008-10-16 Ge Medical Systems Global Technology Co Llc Ultrasonic contrast radiography and ultrasonic diagnostic equipment
US20150174388A1 (en) 2007-05-07 2015-06-25 Guided Therapy Systems, Llc Methods and Systems for Ultrasound Assisted Delivery of a Medicant to Tissue
JP2010526589A (en) 2007-05-07 2010-08-05 ガイデッド セラピー システムズ, エル.エル.シー. Method and system for modulating a mediant using acoustic energy
JP5038022B2 (en) * 2007-05-29 2012-10-03 バイオマップ有限会社 Ultrasonic therapy device and program
US8285362B2 (en) 2007-06-28 2012-10-09 W. L. Gore & Associates, Inc. Catheter with deflectable imaging device
US8864675B2 (en) * 2007-06-28 2014-10-21 W. L. Gore & Associates, Inc. Catheter
US8852112B2 (en) 2007-06-28 2014-10-07 W. L. Gore & Associates, Inc. Catheter with deflectable imaging device and bendable electrical conductor
US8052604B2 (en) * 2007-07-31 2011-11-08 Mirabilis Medica Inc. Methods and apparatus for engagement and coupling of an intracavitory imaging and high intensity focused ultrasound probe
US9125552B2 (en) * 2007-07-31 2015-09-08 Ethicon Endo-Surgery, Inc. Optical scanning module and means for attaching the module to medical instruments for introducing the module into the anatomy
US8439940B2 (en) 2010-12-22 2013-05-14 Cabochon Aesthetics, Inc. Dissection handpiece with aspiration means for reducing the appearance of cellulite
WO2009048969A1 (en) * 2007-10-09 2009-04-16 Cabochon Aesthetics, Inc. Ultrasound apparatus with treatment lens
WO2009050719A2 (en) * 2007-10-15 2009-04-23 Slender Medical, Ltd. Implosion techniques for ultrasound
US8187270B2 (en) * 2007-11-07 2012-05-29 Mirabilis Medica Inc. Hemostatic spark erosion tissue tunnel generator with integral treatment providing variable volumetric necrotization of tissue
US8439907B2 (en) 2007-11-07 2013-05-14 Mirabilis Medica Inc. Hemostatic tissue tunnel generator for inserting treatment apparatus into tissue of a patient
KR102147455B1 (en) 2008-06-06 2020-08-24 얼테라, 인크 Ultrasound treatment system
US8216161B2 (en) * 2008-08-06 2012-07-10 Mirabilis Medica Inc. Optimization and feedback control of HIFU power deposition through the frequency analysis of backscattered HIFU signals
US9248318B2 (en) 2008-08-06 2016-02-02 Mirabilis Medica Inc. Optimization and feedback control of HIFU power deposition through the analysis of detected signal characteristics
US20110178541A1 (en) * 2008-09-12 2011-07-21 Slender Medical, Ltd. Virtual ultrasonic scissors
CA2957010C (en) 2008-09-26 2017-07-04 Relievant Medsystems, Inc. Systems and methods for navigating an instrument through bone
US10028753B2 (en) 2008-09-26 2018-07-24 Relievant Medsystems, Inc. Spine treatment kits
US8142473B2 (en) 2008-10-03 2012-03-27 Tyco Healthcare Group Lp Method of transferring rotational motion in an articulating surgical instrument
US9050449B2 (en) 2008-10-03 2015-06-09 Mirabilis Medica, Inc. System for treating a volume of tissue with high intensity focused ultrasound
CA2739425A1 (en) 2008-10-03 2010-04-08 Mirabilis Medica, Inc. Method and apparatus for treating tissues with hifu
US20100106015A1 (en) * 2008-10-23 2010-04-29 Norris Perry R Medical device alignment
US8162852B2 (en) * 2008-10-23 2012-04-24 Devicor Medical Products, Inc. Methods for medical device alignment
US8161838B2 (en) 2008-12-22 2012-04-24 Intuitive Surgical Operations, Inc. Method and apparatus for reducing at least one friction force opposing an axial force exerted through an actuator element
CN102301418B (en) * 2009-01-30 2013-06-05 皇家飞利浦电子股份有限公司 An acoustic device for ultrasonic imaging
US8246618B2 (en) 2009-07-08 2012-08-21 Tyco Healthcare Group Lp Electrosurgical jaws with offset knife
US11096708B2 (en) 2009-08-07 2021-08-24 Ulthera, Inc. Devices and methods for performing subcutaneous surgery
US9358064B2 (en) 2009-08-07 2016-06-07 Ulthera, Inc. Handpiece and methods for performing subcutaneous surgery
US8388647B2 (en) * 2009-10-28 2013-03-05 Covidien Lp Apparatus for tissue sealing
KR101673574B1 (en) 2009-10-30 2016-11-07 레코 메디컬, 인코포레이티드 Method and apparatus for treatment of hypertension through percutaneous ultrasound renal denervation
US8715186B2 (en) 2009-11-24 2014-05-06 Guided Therapy Systems, Llc Methods and systems for generating thermal bubbles for improved ultrasound imaging and therapy
TW201129344A (en) * 2010-02-23 2011-09-01 Ying-Jie Su Disease search device
JP2013517030A (en) * 2010-03-05 2013-05-16 ベー.ブラウン メルズンゲン アーゲー System and method for monitoring at least one blood parameter
US20110218550A1 (en) * 2010-03-08 2011-09-08 Tyco Healthcare Group Lp System and method for determining and adjusting positioning and orientation of a surgical device
US9566455B2 (en) * 2010-03-09 2017-02-14 Profound Medical Inc. Fluid circuits for temperature control in a thermal therapy system
CA2800238C (en) 2010-03-09 2018-07-10 Profound Medical Inc. Ultrasonic therapy applicator
US9707413B2 (en) 2010-03-09 2017-07-18 Profound Medical Inc. Controllable rotating ultrasound therapy applicator
US11027154B2 (en) 2010-03-09 2021-06-08 Profound Medical Inc. Ultrasonic therapy applicator and method of determining position of ultrasonic transducers
WO2011115664A2 (en) * 2010-03-14 2011-09-22 Profound Medical Inc. Mri-compatible motor and positioning system
US8977013B2 (en) * 2010-07-12 2015-03-10 The Institute For Diagnostic Imaging Research, University Of Windsor Biometric sensor and method for generating a three-dimensional representation of a portion of a finger
EP2600937B8 (en) 2010-08-02 2024-03-06 Guided Therapy Systems, L.L.C. Systems for treating acute and/or chronic injuries in soft tissue
US9504446B2 (en) 2010-08-02 2016-11-29 Guided Therapy Systems, Llc Systems and methods for coupling an ultrasound source to tissue
US9498278B2 (en) 2010-09-08 2016-11-22 Covidien Lp Asymmetrical electrodes for bipolar vessel sealing
US8696581B2 (en) 2010-10-18 2014-04-15 CardioSonic Ltd. Ultrasound transducer and uses thereof
US8857438B2 (en) 2010-11-08 2014-10-14 Ulthera, Inc. Devices and methods for acoustic shielding
JP2012105815A (en) * 2010-11-17 2012-06-07 Olympus Corp Ultrasonic irradiation device
US9113940B2 (en) 2011-01-14 2015-08-25 Covidien Lp Trigger lockout and kickback mechanism for surgical instruments
WO2012112165A1 (en) * 2011-02-18 2012-08-23 Recor Medical, Inc. Apparatus for effecting renal denervation using ultrasound
US20120296240A1 (en) * 2011-05-20 2012-11-22 Slender Medical Ltd. Ultrasound eye bag treatment
US8858471B2 (en) 2011-07-10 2014-10-14 Guided Therapy Systems, Llc Methods and systems for ultrasound treatment
KR20190080967A (en) 2011-07-11 2019-07-08 가이디드 테라피 시스템스, 엘.엘.씨. Systems and methods for coupling an ultrasound source to tissue
EP3366250A1 (en) * 2011-11-08 2018-08-29 Boston Scientific Scimed, Inc. Ostial renal nerve ablation
WO2013101772A1 (en) 2011-12-30 2013-07-04 Relievant Medsystems, Inc. Systems and methods for treating back pain
USD680220S1 (en) 2012-01-12 2013-04-16 Coviden IP Slider handle for laparoscopic device
CN103841910B (en) * 2012-01-19 2017-02-15 奥林巴斯株式会社 Medical system
US11083475B2 (en) 2012-02-22 2021-08-10 Carter J. Kovarik Medical device to remove an obstruction from a body lumen, vessel or organ
US9592066B2 (en) 2012-02-22 2017-03-14 Carter J. Kovarik Selectively bendable remote gripping tool
US10226266B2 (en) 2012-02-22 2019-03-12 Carter J. Kovarik Selectively bendable remote gripping tool
USD780547S1 (en) 2013-08-08 2017-03-07 Carter J. Kovarik Pick up device with flexible shaft portion
US9832980B2 (en) 2012-02-22 2017-12-05 Carter J. Kovarik Selectively bendable remote gripping tool
US9901245B2 (en) 2012-02-22 2018-02-27 Carter J. Kovarik Selectively bendable remote gripping tool
US9263663B2 (en) 2012-04-13 2016-02-16 Ardent Sound, Inc. Method of making thick film transducer arrays
US10357304B2 (en) 2012-04-18 2019-07-23 CardioSonic Ltd. Tissue treatment
JP6008580B2 (en) * 2012-05-25 2016-10-19 富士フイルム株式会社 Ultrasonic diagnostic apparatus, control method of ultrasonic diagnostic apparatus, and ultrasonic diagnostic program
JP6008581B2 (en) * 2012-05-25 2016-10-19 富士フイルム株式会社 Ultrasonic diagnostic apparatus, control method of ultrasonic diagnostic apparatus, and ultrasonic diagnostic program
US11357447B2 (en) 2012-05-31 2022-06-14 Sonivie Ltd. Method and/or apparatus for measuring renal denervation effectiveness
US9155520B2 (en) * 2012-06-15 2015-10-13 Caitlin Marie Schneider Ultrasound probe for laparoscopy
CA2879996A1 (en) * 2012-07-23 2014-01-30 Lazure Scientific, Inc. Systems, methods and devices for precision high-intensity focused ultrasound
US10588691B2 (en) 2012-09-12 2020-03-17 Relievant Medsystems, Inc. Radiofrequency ablation of tissue within a vertebral body
US9510802B2 (en) 2012-09-21 2016-12-06 Guided Therapy Systems, Llc Reflective ultrasound technology for dermatological treatments
US10537375B2 (en) 2015-04-24 2020-01-21 Neurotronic, Inc. Chemical ablation and method of treatment for various diseases
JP6389185B2 (en) 2012-11-02 2018-09-12 ニューロトロニック・インコーポレイテッドNeurotronic, Inc. Formulation for chemical ablation and method for treating various diseases
CA2889478C (en) 2012-11-05 2020-11-24 Relievant Medsystems, Inc. Systems and methods for creating curved paths through bone and modulating nerves within the bone
US20140163371A1 (en) * 2012-12-12 2014-06-12 Olympus Medical Systems Corp. Tumor tissue reductive procedure under ultrasound observation
EP2939630B1 (en) * 2012-12-26 2018-02-14 Tohoku University Shock wave focusing device, shock wave generation apparatus, and shock wave ablation system
KR20140095164A (en) * 2013-01-23 2014-08-01 삼성전자주식회사 Untrasonic probe and medical system using the same
US10265119B2 (en) 2013-02-15 2019-04-23 Covidien Lp Electrosurgical forceps
CN204637350U (en) 2013-03-08 2015-09-16 奥赛拉公司 Aesthstic imaging and processing system, multifocal processing system and perform the system of aesthetic procedure
WO2014159276A1 (en) 2013-03-14 2014-10-02 Recor Medical, Inc. Ultrasound-based neuromodulation system
JP6337080B2 (en) 2013-03-14 2018-06-06 リコール メディカル インコーポレイテッドReCor Medical, Inc. Method for plating or coating an ultrasonic transducer
EP4233991A1 (en) 2013-03-15 2023-08-30 Medtronic Ardian Luxembourg S.à.r.l. Controlled neuromodulation systems
WO2014146022A2 (en) 2013-03-15 2014-09-18 Guided Therapy Systems Llc Ultrasound treatment device and methods of use
US20140330124A1 (en) * 2013-05-03 2014-11-06 SonaCare Medical, LLC Flexible endoscopic probe system and method of using same
WO2014188430A2 (en) * 2013-05-23 2014-11-27 CardioSonic Ltd. Devices and methods for renal denervation and assessment thereof
DE102013011964A1 (en) 2013-07-15 2015-01-15 SRH Wald-Klinikum Gera gGmbH Arrangement and method for in vitro and in vivo treatment of lung tumors
US9724151B2 (en) 2013-08-08 2017-08-08 Relievant Medsystems, Inc. Modulating nerves within bone using bone fasteners
US9907600B2 (en) * 2013-11-15 2018-03-06 Ethicon Llc Ultrasonic anastomosis instrument with piezoelectric sealing head
JP6740131B2 (en) 2014-02-21 2020-08-12 スリーディインテグレイテッド アーペーエス3Dintegrated Aps Set with surgical instrument, surgical system, and training method
BR112016023889B1 (en) 2014-04-18 2023-02-07 Ulthera, Inc ULTRASOUND TRANSDUCTION SYSTEM FOR LINEAR FOCUSING ULTRASOUND
US9603668B2 (en) 2014-07-02 2017-03-28 Covidien Lp Dynamic 3D lung map view for tool navigation inside the lung
US9633431B2 (en) 2014-07-02 2017-04-25 Covidien Lp Fluoroscopic pose estimation
US10286191B2 (en) 2014-10-30 2019-05-14 Neurotronic, Inc. Chemical ablation and method of treatment for various diseases
US9986983B2 (en) 2014-10-31 2018-06-05 Covidien Lp Computed tomography enhanced fluoroscopic system, device, and method of utilizing the same
KR101684781B1 (en) * 2015-05-11 2016-12-08 고려대학교 산학협력단 X-ray imaging apparatus for minimally invasive surgery
US11020144B2 (en) 2015-07-21 2021-06-01 3Dintegrated Aps Minimally invasive surgery system
JP6776327B2 (en) 2015-07-21 2020-10-28 スリーディインテグレイテッド アーペーエス3Dintegrated Aps Cannula Assembly Kit, Needle Assembly Kit, Sleeve Assembly, Minimally Invasive Surgical System and Methods
US10716525B2 (en) 2015-08-06 2020-07-21 Covidien Lp System and method for navigating to target and performing procedure on target utilizing fluoroscopic-based local three dimensional volume reconstruction
US10702226B2 (en) 2015-08-06 2020-07-07 Covidien Lp System and method for local three dimensional volume reconstruction using a standard fluoroscope
US10674982B2 (en) 2015-08-06 2020-06-09 Covidien Lp System and method for local three dimensional volume reconstruction using a standard fluoroscope
DK178899B1 (en) 2015-10-09 2017-05-08 3Dintegrated Aps A depiction system
CA3005901A1 (en) * 2015-11-18 2017-05-26 Scott & White Healthcare Apparatuses for detecting and/or destroying abnormal tissue, such as cancer tissue, and related methods
DE112016005463T5 (en) 2015-11-30 2018-08-09 Sony Corporation Hand-held instrument for endoscopic surgery
PT3405294T (en) 2016-01-18 2023-03-03 Ulthera Inc Compact ultrasound device having annular ultrasound array peripherally electrically connected to flexible printed circuit board and method of assembly thereof
US10772655B2 (en) * 2016-02-23 2020-09-15 Koninklijke Philips N.V. Ultrasound ablation device
US10786224B2 (en) 2016-04-21 2020-09-29 Covidien Lp Biopsy devices and methods of use thereof
KR20230149878A (en) 2016-08-16 2023-10-27 얼테라, 인크 Systems and methods for cosmetic ultrasound treatment of skin
US11529190B2 (en) 2017-01-30 2022-12-20 Covidien Lp Enhanced ablation and visualization techniques for percutaneous surgical procedures
US11793579B2 (en) 2017-02-22 2023-10-24 Covidien Lp Integration of multiple data sources for localization and navigation
WO2018173053A1 (en) 2017-03-20 2018-09-27 Sonievie Ltd. Pulmonary hypertension treatment method and/or system
US10699448B2 (en) 2017-06-29 2020-06-30 Covidien Lp System and method for identifying, marking and navigating to a target using real time two dimensional fluoroscopic data
US10925628B2 (en) 2017-09-18 2021-02-23 Novuson Surgical, Inc. Tissue engagement apparatus for theapeutic ultrasound apparatus and method
EP3694412A4 (en) 2017-10-10 2021-08-18 Covidien LP System and method for identifying and marking a target in a fluoroscopic three-dimensional reconstruction
US10930064B2 (en) 2018-02-08 2021-02-23 Covidien Lp Imaging reconstruction system and method
US10905498B2 (en) 2018-02-08 2021-02-02 Covidien Lp System and method for catheter detection in fluoroscopic images and updating displayed position of catheter
US11364004B2 (en) 2018-02-08 2022-06-21 Covidien Lp System and method for pose estimation of an imaging device and for determining the location of a medical device with respect to a target
US11331161B2 (en) 2018-03-23 2022-05-17 Covidien Lp Surgical assemblies facilitating tissue marking and methods of use thereof
US11071591B2 (en) 2018-07-26 2021-07-27 Covidien Lp Modeling a collapsed lung using CT data
US11705238B2 (en) 2018-07-26 2023-07-18 Covidien Lp Systems and methods for providing assistance during surgery
US11877806B2 (en) 2018-12-06 2024-01-23 Covidien Lp Deformable registration of computer-generated airway models to airway trees
US11045075B2 (en) 2018-12-10 2021-06-29 Covidien Lp System and method for generating a three-dimensional model of a surgical site
US11801113B2 (en) 2018-12-13 2023-10-31 Covidien Lp Thoracic imaging, distance measuring, and notification system and method
US11617493B2 (en) 2018-12-13 2023-04-04 Covidien Lp Thoracic imaging, distance measuring, surgical awareness, and notification system and method
US11357593B2 (en) 2019-01-10 2022-06-14 Covidien Lp Endoscopic imaging with augmented parallax
US11625825B2 (en) 2019-01-30 2023-04-11 Covidien Lp Method for displaying tumor location within endoscopic images
US11564751B2 (en) 2019-02-01 2023-01-31 Covidien Lp Systems and methods for visualizing navigation of medical devices relative to targets
US11744643B2 (en) 2019-02-04 2023-09-05 Covidien Lp Systems and methods facilitating pre-operative prediction of post-operative tissue function
US11819285B2 (en) 2019-04-05 2023-11-21 Covidien Lp Magnetic interference detection systems and methods
US11517294B2 (en) 2019-05-07 2022-12-06 Covidien Lp Biopsy devices and methods of use thereof
US11269173B2 (en) 2019-08-19 2022-03-08 Covidien Lp Systems and methods for displaying medical video images and/or medical 3D models
CN110465008B (en) * 2019-08-28 2021-02-12 黄晶 Focused ultrasound treatment system
US11864935B2 (en) 2019-09-09 2024-01-09 Covidien Lp Systems and methods for pose estimation of a fluoroscopic imaging device and for three-dimensional imaging of body structures
EP4027912A4 (en) 2019-09-12 2023-08-16 Relievant Medsystems, Inc. Systems and methods for tissue modulation
US11627924B2 (en) 2019-09-24 2023-04-18 Covidien Lp Systems and methods for image-guided navigation of percutaneously-inserted devices
US11380060B2 (en) 2020-01-24 2022-07-05 Covidien Lp System and method for linking a segmentation graph to volumetric data
US11847730B2 (en) 2020-01-24 2023-12-19 Covidien Lp Orientation detection in fluoroscopic images
WO2023043693A1 (en) * 2021-09-20 2023-03-23 The Penn State Research Foundation Free motion laparoscopic surgical system

Citations (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4315514A (en) * 1980-05-08 1982-02-16 William Drewes Method and apparatus for selective cell destruction
US4323077A (en) * 1980-03-12 1982-04-06 General Electric Company Acoustic intensity monitor
US4646756A (en) * 1982-10-26 1987-03-03 The University Of Aberdeen Ultra sound hyperthermia device
US4818954A (en) * 1986-02-15 1989-04-04 Karl Storz Endoscopy-America, Inc. High-frequency generator with automatic power-control for high-frequency surgery
US4932414A (en) * 1987-11-02 1990-06-12 Cornell Research Foundation, Inc. System of therapeutic ultrasound and real-time ultrasonic scanning
US4984575A (en) * 1987-04-16 1991-01-15 Olympus Optical Co., Ltd. Therapeutical apparatus of extracorporeal type
US4986275A (en) * 1987-08-05 1991-01-22 Kabushiki Kaisha Toshiba Ultrasonic therapy apparatus
US5005580A (en) * 1988-04-22 1991-04-09 Kabushiki Kaisha Toshiba Destroying wave treatment apparatus
US5015929A (en) * 1987-09-07 1991-05-14 Technomed International, S.A. Piezoelectric device with reduced negative waves, and use of said device for extracorporeal lithotrity or for destroying particular tissues
USRE33590E (en) * 1983-12-14 1991-05-21 Edap International, S.A. Method for examining, localizing and treating with ultrasound
US5078144A (en) * 1988-08-19 1992-01-07 Olympus Optical Co. Ltd. System for applying ultrasonic waves and a treatment instrument to a body part
US5080101A (en) * 1983-12-14 1992-01-14 Edap International, S.A. Method for examining and aiming treatment with untrasound
US5095907A (en) * 1989-06-21 1992-03-17 Kabushiki Kaisha Toshiba Acoustic wave therapy apparatus
US5095906A (en) * 1987-09-30 1992-03-17 Kabushiki Kaisha Toshiba Image processing system
US5203333A (en) * 1989-05-15 1993-04-20 Kabushiki Kaisha Toshiba Acoustic wave therapy apparatus
US5209221A (en) * 1988-03-01 1993-05-11 Richard Wolf Gmbh Ultrasonic treatment of pathological tissue
US5295484A (en) * 1992-05-19 1994-03-22 Arizona Board Of Regents For And On Behalf Of The University Of Arizona Apparatus and method for intra-cardiac ablation of arrhythmias
US5304115A (en) * 1991-01-11 1994-04-19 Baxter International Inc. Ultrasonic angioplasty device incorporating improved transmission member and ablation probe
US5311869A (en) * 1990-03-24 1994-05-17 Kabushiki Kaisha Toshiba Method and apparatus for ultrasonic wave treatment in which medical progress may be evaluated
US5391140A (en) * 1993-01-29 1995-02-21 Siemens Aktiengesellschaft Therapy apparatus for locating and treating a zone in the body of a life form with acoustic waves
US5391197A (en) * 1992-11-13 1995-02-21 Dornier Medical Systems, Inc. Ultrasound thermotherapy probe
US5398690A (en) * 1994-08-03 1995-03-21 Batten; Bobby G. Slaved biopsy device, analysis apparatus, and process
US5402792A (en) * 1993-03-30 1995-04-04 Shimadzu Corporation Ultrasonic medical apparatus
US5409002A (en) * 1989-07-12 1995-04-25 Focus Surgery Incorporated Treatment system with localization
US5421338A (en) * 1988-03-21 1995-06-06 Boston Scientific Corporation Acoustic imaging catheter and the like
US5485839A (en) * 1992-02-28 1996-01-23 Kabushiki Kaisha Toshiba Method and apparatus for ultrasonic wave medical treatment using computed tomography
US5492126A (en) * 1994-05-02 1996-02-20 Focal Surgery Probe for medical imaging and therapy using ultrasound
US5514085A (en) * 1990-07-24 1996-05-07 Yoon; Inbae Multifunctional devices for use in endoscopic surgical procedures and methods therefor
US5520188A (en) * 1994-11-02 1996-05-28 Focus Surgery Inc. Annular array transducer
US5522869A (en) * 1994-05-17 1996-06-04 Burdette; Everette C. Ultrasound device for use in a thermotherapy apparatus
US5524620A (en) * 1991-11-12 1996-06-11 November Technologies Ltd. Ablation of blood thrombi by means of acoustic energy
US5526815A (en) * 1993-01-29 1996-06-18 Siemens Aktiengesellschat Therapy apparatus for locating and treating a zone located in the body of a life form with acoustic waves
US5526822A (en) * 1994-03-24 1996-06-18 Biopsys Medical, Inc. Method and apparatus for automated biopsy and collection of soft tissue
US5590657A (en) * 1995-11-06 1997-01-07 The Regents Of The University Of Michigan Phased array ultrasound system and method for cardiac ablation
US5596991A (en) * 1994-04-07 1997-01-28 Fuji Photo Optical Co., Ltd. Catheter type ultrasound probe
US5601526A (en) * 1991-12-20 1997-02-11 Technomed Medical Systems Ultrasound therapy apparatus delivering ultrasound waves having thermal and cavitation effects
US5603326A (en) * 1993-03-22 1997-02-18 Siemens Aktiengesellschaft Method and apparatus for displaying an image obtained by echo signals
US5606975A (en) * 1994-09-19 1997-03-04 The Board Of Trustees Of The Leland Stanford Junior University Forward viewing ultrasonic imaging catheter
US5620479A (en) * 1992-11-13 1997-04-15 The Regents Of The University Of California Method and apparatus for thermal therapy of tumors
US5624382A (en) * 1992-03-10 1997-04-29 Siemens Aktiengesellschaft Method and apparatus for ultrasound tissue therapy
US5626607A (en) * 1995-04-03 1997-05-06 Heartport, Inc. Clamp assembly and method of use
US5628743A (en) * 1994-12-21 1997-05-13 Valleylab Inc. Dual mode ultrasonic surgical apparatus
US5720287A (en) * 1993-07-26 1998-02-24 Technomed Medical Systems Therapy and imaging probe and therapeutic treatment apparatus utilizing it
US5722411A (en) * 1993-03-12 1998-03-03 Kabushiki Kaisha Toshiba Ultrasound medical treatment apparatus with reduction of noise due to treatment ultrasound irradiation at ultrasound imaging device
US5728062A (en) * 1995-11-30 1998-03-17 Pharmasonics, Inc. Apparatus and methods for vibratory intraluminal therapy employing magnetostrictive transducers
US5733315A (en) * 1992-11-13 1998-03-31 Burdette; Everette C. Method of manufacture of a transurethral ultrasound applicator for prostate gland thermal therapy
US5735280A (en) * 1995-05-02 1998-04-07 Heart Rhythm Technologies, Inc. Ultrasound energy delivery system and method
US5735796A (en) * 1995-11-23 1998-04-07 Siemens Aktiengesellschaft Therapy apparatus with a source of acoustic waves
US5738635A (en) * 1993-01-22 1998-04-14 Technomed Medical Systems Adjustable focusing therapeutic apparatus with no secondary focusing
US5743862A (en) * 1994-09-19 1998-04-28 Kabushiki Kaisha Toshiba Ultrasonic medical treatment apparatus
US5743863A (en) * 1993-01-22 1998-04-28 Technomed Medical Systems And Institut National High-intensity ultrasound therapy method and apparatus with controlled cavitation effect and reduced side lobes
US5746224A (en) * 1994-06-24 1998-05-05 Somnus Medical Technologies, Inc. Method for ablating turbinates
US5762066A (en) * 1992-02-21 1998-06-09 Ths International, Inc. Multifaceted ultrasound transducer probe system and methods for its use
US5769086A (en) * 1995-12-06 1998-06-23 Biopsys Medical, Inc. Control system and method for automated biopsy device
US5769790A (en) * 1996-10-25 1998-06-23 General Electric Company Focused ultrasound surgery system guided by ultrasound imaging
US5860974A (en) * 1993-07-01 1999-01-19 Boston Scientific Corporation Heart ablation catheter with expandable electrode and method of coupling energy to an electrode on a catheter shaft
US5873828A (en) * 1994-02-18 1999-02-23 Olympus Optical Co., Ltd. Ultrasonic diagnosis and treatment system
US5873845A (en) * 1997-03-17 1999-02-23 General Electric Company Ultrasound transducer with focused ultrasound refraction plate
US5873902A (en) * 1995-03-31 1999-02-23 Focus Surgery, Inc. Ultrasound intensity determining method and apparatus
US5882302A (en) * 1992-02-21 1999-03-16 Ths International, Inc. Methods and devices for providing acoustic hemostasis
US5893835A (en) * 1997-10-10 1999-04-13 Ethicon Endo-Surgery, Inc. Ultrasonic clamp coagulator apparatus having dual rotational positioning
US5895356A (en) * 1995-11-15 1999-04-20 American Medical Systems, Inc. Apparatus and method for transurethral focussed ultrasound therapy
US5897495A (en) * 1993-03-10 1999-04-27 Kabushiki Kaisha Toshiba Ultrasonic wave medical treatment apparatus suitable for use under guidance of magnetic resonance imaging
US6010531A (en) * 1993-02-22 2000-01-04 Heartport, Inc. Less-invasive devices and methods for cardiac valve surgery
US6013031A (en) * 1998-03-09 2000-01-11 Mendlein; John D. Methods and devices for improving ultrasonic measurements using anatomic landmarks and soft tissue correction
US6024718A (en) * 1996-09-04 2000-02-15 The Regents Of The University Of California Intraluminal directed ultrasound delivery device
US6024740A (en) * 1997-07-08 2000-02-15 The Regents Of The University Of California Circumferential ablation device assembly
US6030344A (en) * 1996-12-04 2000-02-29 Acuson Corporation Methods and apparatus for ultrasound image quantification
US6039689A (en) * 1998-03-11 2000-03-21 Riverside Research Institute Stripe electrode transducer for use with therapeutic ultrasonic radiation treatment
US6042556A (en) * 1998-09-04 2000-03-28 University Of Washington Method for determining phase advancement of transducer elements in high intensity focused ultrasound
US6050943A (en) * 1997-10-14 2000-04-18 Guided Therapy Systems, Inc. Imaging, therapy, and temperature monitoring ultrasonic system
US6053868A (en) * 1997-04-24 2000-04-25 Sulzer Osypka Gmbh Apparatus for a cardiological therapy
US6059731A (en) * 1998-08-19 2000-05-09 Mayo Foundation For Medical Education And Research Simultaneous side-and-end viewing underfluid catheter
US6063050A (en) * 1996-10-04 2000-05-16 United States Surgical Corp. Ultrasonic dissection and coagulation system
US6066123A (en) * 1998-04-09 2000-05-23 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of bioavailability by use of focused energy delivery to a target tissue
US6071239A (en) * 1997-10-27 2000-06-06 Cribbs; Robert W. Method and apparatus for lipolytic therapy using ultrasound energy
US6071238A (en) * 1996-06-28 2000-06-06 Technomed Medical Systems Therapy probe
US6071279A (en) * 1996-12-19 2000-06-06 Ep Technologies, Inc. Branched structures for supporting multiple electrode elements
US6193709B1 (en) * 1998-05-13 2001-02-27 Olympus Optical Co., Ltd. Ultrasonic treatment apparatus
US6193664B1 (en) * 1996-12-04 2001-02-27 Acuson Corporation Method and apparatus for ultrasound image quantification
US6206843B1 (en) * 1999-01-28 2001-03-27 Ultra Cure Ltd. Ultrasound system and methods utilizing same
US6210330B1 (en) * 1999-08-04 2001-04-03 Rontech Medical Ltd. Apparatus, system and method for real-time endovaginal sonography guidance of intra-uterine, cervical and tubal procedures
US6221014B1 (en) * 1996-11-22 2001-04-24 Richard Wolf Gmbh Device for tracking the focus position for a therapy apparatus
US6246898B1 (en) * 1995-03-28 2001-06-12 Sonometrics Corporation Method for carrying out a medical procedure using a three-dimensional tracking and imaging system
US6340352B1 (en) * 1995-04-06 2002-01-22 Olympus Optical Co., Ltd. Ultrasound treatment system
US6340348B1 (en) * 1999-07-02 2002-01-22 Acuson Corporation Contrast agent imaging with destruction pulses in diagnostic medical ultrasound
US6352532B1 (en) * 1999-12-14 2002-03-05 Ethicon Endo-Surgery, Inc. Active load control of ultrasonic surgical instruments
US6371903B1 (en) * 2000-06-22 2002-04-16 Technomed Medical Systems, S.A. Therapy probe
US6533726B1 (en) * 1999-08-09 2003-03-18 Riverside Research Institute System and method for ultrasonic harmonic imaging for therapy guidance and monitoring
US6540700B1 (en) * 1998-10-26 2003-04-01 Kabushiki Kaisha Toshiba Ultrasound treatment apparatus
US6562033B2 (en) * 2001-04-09 2003-05-13 Baylis Medical Co. Intradiscal lesioning apparatus
US6575969B1 (en) * 1995-05-04 2003-06-10 Sherwood Services Ag Cool-tip radiofrequency thermosurgery electrode system for tumor ablation
US20030120306A1 (en) * 2000-04-21 2003-06-26 Vascular Control System Method and apparatus for the detection and occlusion of blood vessels
US20040041880A1 (en) * 2002-08-30 2004-03-04 Canon Kabushiki Kaisha Recording apparatus
US6702745B1 (en) * 1999-01-21 2004-03-09 David Smythe 3D/4D ultrasound imaging system
US6726677B1 (en) * 1995-10-13 2004-04-27 Transvascular, Inc. Stabilized tissue penetrating catheters

Family Cites Families (326)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US538017A (en) * 1895-04-23 Mail-marking machine
US3168659A (en) 1960-01-11 1965-02-02 Gen Motors Corp Variable focus transducer
US3779234A (en) 1971-06-30 1973-12-18 Intersc Res Inst Ultrasonic catheter with rotating transducers
US3902501A (en) 1973-06-21 1975-09-02 Medtronic Inc Endocardial electrode
US3927557A (en) 1974-05-30 1975-12-23 Gen Electric Acoustic imaging apparatus with liquid-filled acoustic corrector lens
US4185502A (en) * 1977-10-11 1980-01-29 Ralph Frank Transducer coupling apparatus
US4396019A (en) 1978-03-06 1983-08-02 Perry Jr John D Vaginal myograph method and apparatus
US4211948A (en) 1978-11-08 1980-07-08 General Electric Company Front surface matched piezoelectric ultrasonic transducer array with wide field of view
US4798215A (en) 1984-03-15 1989-01-17 Bsd Medical Corporation Hyperthermia apparatus
US4484569A (en) 1981-03-13 1984-11-27 Riverside Research Institute Ultrasonic diagnostic and therapeutic transducer assembly and method for using
US5150711A (en) 1983-12-14 1992-09-29 Edap International, S.A. Ultra-high-speed extracorporeal ultrasound hyperthermia treatment device
US5150712A (en) 1983-12-14 1992-09-29 Edap International, S.A. Apparatus for examining and localizing tumors using ultra sounds, comprising a device for localized hyperthermia treatment
US5158070A (en) 1983-12-14 1992-10-27 Edap International, S.A. Method for the localized destruction of soft structures using negative pressure elastic waves
US5143074A (en) 1983-12-14 1992-09-01 Edap International Ultrasonic treatment device using a focussing and oscillating piezoelectric element
US4884080A (en) 1985-01-31 1989-11-28 Kabushiki Kaisha Toshiba Color image printing apparatus
JPS61209643A (en) 1985-03-15 1986-09-17 株式会社東芝 Ultrasonic diagnostic and medical treatment apparatus
JPH0653120B2 (en) 1985-05-10 1994-07-20 オリンパス光学工業株式会社 Ultrasonic diagnostic equipment
US5000185A (en) * 1986-02-28 1991-03-19 Cardiovascular Imaging Systems, Inc. Method for intravascular two-dimensional ultrasonography and recanalization
JPS6346147A (en) 1986-04-24 1988-02-27 株式会社東芝 Ultrasonic remedy apparatus
EP0272347B1 (en) 1986-12-24 1989-06-07 Hewlett-Packard GmbH Method of and apparatus for adjusting the intensity profile of an ultrasound beam
JPS63164944A (en) * 1986-12-26 1988-07-08 株式会社東芝 Ultrasonic remedy apparatus
US4765331A (en) 1987-02-10 1988-08-23 Circon Corporation Electrosurgical device with treatment arc of less than 360 degrees
US4844080A (en) 1987-02-19 1989-07-04 Michael Frass Ultrasound contact medium dispenser
US4790329A (en) 1987-06-12 1988-12-13 Trustees Of Beth Israel Hospital Adjustable biopsy localization device
EP0310380B2 (en) 1987-09-30 1997-04-02 Kabushiki Kaisha Toshiba Ultrasonic medical treatment apparatus
US4955366A (en) 1987-11-27 1990-09-11 Olympus Optical Co., Ltd. Ultrasonic therapeutical apparatus
US4899757A (en) * 1988-02-22 1990-02-13 Intertherapy, Inc. Ultrasound imaging probe with zero dead space
US5036855A (en) 1988-03-02 1991-08-06 Laboratory Equipment, Corp. Localization and therapy system for treatment of spatially oriented focal disease
US4951653A (en) 1988-03-02 1990-08-28 Laboratory Equipment, Corp. Ultrasound brain lesioning system
US4858613A (en) 1988-03-02 1989-08-22 Laboratory Equipment, Corp. Localization and therapy system for treatment of spatially oriented focal disease
US5054470A (en) 1988-03-02 1991-10-08 Laboratory Equipment, Corp. Ultrasonic treatment transducer with pressurized acoustic coupling
US4955365A (en) 1988-03-02 1990-09-11 Laboratory Equipment, Corp. Localization and therapy system for treatment of spatially oriented focal disease
US5588432A (en) 1988-03-21 1996-12-31 Boston Scientific Corporation Catheters for imaging, sensing electrical potentials, and ablating tissue
US6027449A (en) 1988-05-11 2000-02-22 Lunar Corporation Ultrasonometer employing distensible membranes
JPH01288242A (en) 1988-05-17 1989-11-20 Nippon Oil Co Ltd Ultrasonic probe for diagnosis in body cavity
US5242437A (en) 1988-06-10 1993-09-07 Trimedyne Laser Systems, Inc. Medical device applying localized high intensity light and heat, particularly for destruction of the endometrium
US4938216A (en) * 1988-06-21 1990-07-03 Massachusetts Institute Of Technology Mechanically scanned line-focus ultrasound hyperthermia system
US4960109A (en) 1988-06-21 1990-10-02 Massachusetts Institute Of Technology Multi-purpose temperature sensing probe for hyperthermia therapy
US5158071A (en) 1988-07-01 1992-10-27 Hitachi, Ltd. Ultrasonic apparatus for therapeutical use
EP0355175A1 (en) * 1988-08-17 1990-02-28 Siemens Aktiengesellschaft Apparatus for the contactless disintegration of concrements in the body of a living being
US5435311A (en) * 1989-06-27 1995-07-25 Hitachi, Ltd. Ultrasound therapeutic system
EP0419729A1 (en) 1989-09-29 1991-04-03 Siemens Aktiengesellschaft Position finding of a catheter by means of non-ionising fields
US6088613A (en) 1989-12-22 2000-07-11 Imarx Pharmaceutical Corp. Method of magnetic resonance focused surgical and therapeutic ultrasound
US5149319A (en) 1990-09-11 1992-09-22 Unger Evan C Methods for providing localized therapeutic heat to biological tissues and fluids
US20020150539A1 (en) 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
US5148809A (en) 1990-02-28 1992-09-22 Asgard Medical Systems, Inc. Method and apparatus for detecting blood vessels and displaying an enhanced video image from an ultrasound scan
JPH03251240A (en) 1990-02-28 1991-11-08 Toshiba Corp Ultrasonic medical treatment device
US5117832A (en) 1990-09-21 1992-06-02 Diasonics, Inc. Curved rectangular/elliptical transducer
DE4037160A1 (en) 1990-11-22 1992-05-27 Dornier Medizintechnik ACOUSTIC FOCUSING DEVICE
US5269291A (en) 1990-12-10 1993-12-14 Coraje, Inc. Miniature ultrasonic transducer for plaque ablation
US5316000A (en) 1991-03-05 1994-05-31 Technomed International (Societe Anonyme) Use of at least one composite piezoelectric transducer in the manufacture of an ultrasonic therapy apparatus for applying therapy, in a body zone, in particular to concretions, to tissue, or to bones, of a living being and method of ultrasonic therapy
JPH04307044A (en) 1991-04-02 1992-10-29 Olympus Optical Co Ltd Forceps apparatus
US5219335A (en) 1991-05-23 1993-06-15 Scimed Life Systems, Inc. Intravascular device such as introducer sheath or balloon catheter or the like and methods for use thereof
DE4136004C1 (en) 1991-10-31 1993-01-28 Siemens Ag, 8000 Muenchen, De
US5325860A (en) 1991-11-08 1994-07-05 Mayo Foundation For Medical Education And Research Ultrasonic and interventional catheter and method
US5238007A (en) 1991-12-12 1993-08-24 Vitatron Medical B.V. Pacing lead with improved anchor mechanism
FR2685872A1 (en) 1992-01-07 1993-07-09 Edap Int APPARATUS OF EXTRACORPOREAL ULTRASONIC HYPERTHERMIA WITH VERY HIGH POWER AND ITS OPERATING METHOD.
US6183469B1 (en) * 1997-08-27 2001-02-06 Arthrocare Corporation Electrosurgical systems and methods for the removal of pacemaker leads
JP3369504B2 (en) 1992-02-28 2003-01-20 株式会社東芝 Ultrasound therapy equipment
WO1993019705A1 (en) 1992-03-31 1993-10-14 Massachusetts Institute Of Technology Apparatus and method for acoustic heat generation and hyperthermia
DE4213586C2 (en) 1992-04-24 1995-01-19 Siemens Ag Therapy device for treatment with focused acoustic waves
US5443470A (en) 1992-05-01 1995-08-22 Vesta Medical, Inc. Method and apparatus for endometrial ablation
WO1994002077A2 (en) 1992-07-15 1994-02-03 Angelase, Inc. Ablation catheter system
DE4229630C2 (en) 1992-09-04 1994-06-16 Siemens Ag Acoustic lens
DE4229817C2 (en) 1992-09-07 1996-09-12 Siemens Ag Method for the non-destructive and / or non-invasive measurement of a temperature change in the interior of a living object in particular
DE4238645C1 (en) 1992-11-16 1994-05-05 Siemens Ag Therapeutic ultrasonic applicator for urogenital area - has ultrasonic waves focussed onto working zone defined by envelope curve with two perpendicular main axes
JPH06181923A (en) 1992-12-21 1994-07-05 Fujitsu Ltd Ultrasonic diagnostic device
US5348017A (en) 1993-01-19 1994-09-20 Cardiovascular Imaging Systems, Inc. Drive shaft for an intravascular catheter system
DE4309597A1 (en) * 1993-03-22 1994-09-29 Kari Dr Richter Process for imaging a part of the human body
JP3578217B2 (en) 1993-04-15 2004-10-20 シーメンス アクチエンゲゼルシヤフト Treatment device for treating heart disease and blood vessels near the heart
US5462522A (en) 1993-04-19 1995-10-31 Olympus Optical Co., Ltd. Ultrasonic therapeutic apparatus
US5465724A (en) 1993-05-28 1995-11-14 Acuson Corporation Compact rotationally steerable ultrasound transducer
DE69432148T2 (en) 1993-07-01 2003-10-16 Boston Scient Ltd CATHETER FOR IMAGE DISPLAY, DISPLAY OF ELECTRICAL SIGNALS AND ABLATION
US5630837A (en) 1993-07-01 1997-05-20 Boston Scientific Corporation Acoustic ablation
US5840031A (en) 1993-07-01 1998-11-24 Boston Scientific Corporation Catheters for imaging, sensing electrical potentials and ablating tissue
US5571088A (en) 1993-07-01 1996-11-05 Boston Scientific Corporation Ablation catheters
US5413550A (en) 1993-07-21 1995-05-09 Pti, Inc. Ultrasound therapy system with automatic dose control
US5398691A (en) 1993-09-03 1995-03-21 University Of Washington Method and apparatus for three-dimensional translumenal ultrasonic imaging
US5458597A (en) 1993-11-08 1995-10-17 Zomed International Device for treating cancer and non-malignant tumors and methods
US5474075A (en) * 1993-11-24 1995-12-12 Thomas Jefferson University Brush-tipped catheter for ultrasound imaging
US5462521A (en) 1993-12-21 1995-10-31 Angeion Corporation Fluid cooled and perfused tip for a catheter
US5471988A (en) 1993-12-24 1995-12-05 Olympus Optical Co., Ltd. Ultrasonic diagnosis and therapy system in which focusing point of therapeutic ultrasonic wave is locked at predetermined position within observation ultrasonic scanning range
JPH07184907A (en) 1993-12-28 1995-07-25 Toshiba Corp Ultrasonic treating device
DE4443947B4 (en) 1994-01-14 2005-09-22 Siemens Ag endoscope
FR2715313B1 (en) 1994-01-27 1996-05-31 Edap Int Method for controlling a hyperthermia treatment device using ultrasound.
GB2287375B (en) 1994-03-11 1998-04-15 Intravascular Res Ltd Ultrasonic transducer array and method of manufacturing the same
DE59409469D1 (en) 1994-03-23 2000-09-07 Erbe Elektromedizin Multifunctional instrument for ultrasound surgery
US5649547A (en) 1994-03-24 1997-07-22 Biopsys Medical, Inc. Methods and devices for automated biopsy and collection of soft tissue
AU2373695A (en) 1994-05-03 1995-11-29 Board Of Regents, The University Of Texas System Apparatus and method for noninvasive doppler ultrasound-guided real-time control of tissue damage in thermal therapy
US5807308A (en) 1996-02-23 1998-09-15 Somnus Medical Technologies, Inc. Method and apparatus for treatment of air way obstructions
US5817049A (en) 1994-05-09 1998-10-06 Somnus Medical Technologies, Inc. Method for treatment of airway obstructions
DE4421795C1 (en) 1994-06-22 1996-01-04 Siemens Ag Implanted therapeutic acoustic wave source
US5672172A (en) 1994-06-23 1997-09-30 Vros Corporation Surgical instrument with ultrasound pulse generator
US5575788A (en) * 1994-06-24 1996-11-19 Stuart D. Edwards Thin layer ablation apparatus
US5505730A (en) * 1994-06-24 1996-04-09 Stuart D. Edwards Thin layer ablation apparatus
US5545195A (en) 1994-08-01 1996-08-13 Boston Scientific Corporation Interstitial heating of tissue
JP3257908B2 (en) 1994-09-08 2002-02-18 オリジン電気株式会社 DC high voltage generator
JPH0884740A (en) 1994-09-16 1996-04-02 Toshiba Corp Treatment apparatus
US5694936A (en) 1994-09-17 1997-12-09 Kabushiki Kaisha Toshiba Ultrasonic apparatus for thermotherapy with variable frequency for suppressing cavitation
US5526816A (en) 1994-09-22 1996-06-18 Bracco Research S.A. Ultrasonic spectral contrast imaging
JP2848586B2 (en) * 1994-10-03 1999-01-20 オリンパス光学工業株式会社 Ultrasound diagnostic equipment
US5785705A (en) 1994-10-11 1998-07-28 Oratec Interventions, Inc. RF method for controlled depth ablation of soft tissue
US5514130A (en) 1994-10-11 1996-05-07 Dorsal Med International RF apparatus for controlled depth ablation of soft tissue
US5810742A (en) 1994-10-24 1998-09-22 Transcan Research & Development Co., Ltd. Tissue characterization based on impedance images and on impedance measurements
US5547459A (en) 1994-10-25 1996-08-20 Orthologic Corporation Ultrasonic bone-therapy apparatus and method
US5575789A (en) 1994-10-27 1996-11-19 Valleylab Inc. Energizable surgical tool safety device and method
DE4446429C1 (en) 1994-12-23 1996-08-22 Siemens Ag Device for treating an object with focused ultrasound waves
US6936024B1 (en) 1995-01-23 2005-08-30 Russell A. Houser Percutaneous transmyocardial revascularization (PTMR) system
DE19507478C1 (en) 1995-03-03 1996-05-15 Siemens Ag Therapy device for treatment with focused ultrasound
US6176842B1 (en) * 1995-03-08 2001-01-23 Ekos Corporation Ultrasound assembly for use with light activated drugs
DE69634714T2 (en) 1995-03-31 2006-01-19 Kabushiki Kaisha Toshiba, Kawasaki Therapeutic ultrasound device
DE19515748A1 (en) 1995-04-28 1996-10-31 Siemens Ag Device for treatment with acoustic waves
US5558092A (en) 1995-06-06 1996-09-24 Imarx Pharmaceutical Corp. Methods and apparatus for performing diagnostic and therapeutic ultrasound simultaneously
US5709224A (en) * 1995-06-07 1998-01-20 Radiotherapeutics Corporation Method and device for permanent vessel occlusion
DE19520749C1 (en) 1995-06-07 1996-08-08 Siemens Ag Ultrasonic therapeutic appts. with X-ray transparent source of waves
US6231834B1 (en) 1995-06-07 2001-05-15 Imarx Pharmaceutical Corp. Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
DE19520748C2 (en) 1995-06-07 1999-09-02 Siemens Ag Therapy device with a radiation source
US5782764A (en) 1995-11-07 1998-07-21 Iti Medical Technologies, Inc. Fiber composite invasive medical instruments and methods for use in interventional imaging procedures
US5979453A (en) 1995-11-09 1999-11-09 Femrx, Inc. Needle myolysis system for uterine fibriods
US6135971A (en) 1995-11-09 2000-10-24 Brigham And Women's Hospital Apparatus for deposition of ultrasound energy in body tissue
US5857760A (en) * 1995-11-29 1999-01-12 Lumatech Corporation Illuminated balloon apparatus and method
WO1997022015A1 (en) 1995-12-14 1997-06-19 Philips Electronics N.V. Method and device for heating by means of ultrasound guided by magnetic resonance imaging
JPH09192139A (en) 1996-01-17 1997-07-29 Olympus Optical Co Ltd Ultrasonic wave probe
US6332089B1 (en) * 1996-02-15 2001-12-18 Biosense, Inc. Medical procedures and apparatus using intrabody probes
US5820580A (en) * 1996-02-23 1998-10-13 Somnus Medical Technologies, Inc. Method for ablating interior sections of the tongue
US5800379A (en) 1996-02-23 1998-09-01 Sommus Medical Technologies, Inc. Method for ablating interior sections of the tongue
US6033397A (en) 1996-03-05 2000-03-07 Vnus Medical Technologies, Inc. Method and apparatus for treating esophageal varices
US5676692A (en) * 1996-03-28 1997-10-14 Indianapolis Center For Advanced Research, Inc. Focussed ultrasound tissue treatment method
US5779643A (en) * 1996-11-26 1998-07-14 Hewlett-Packard Company Imaging guidewire with back and forth sweeping ultrasonic source
US5699805A (en) 1996-06-20 1997-12-23 Mayo Foundation For Medical Education And Research Longitudinal multiplane ultrasound transducer underfluid catheter system
SE9602574D0 (en) 1996-06-28 1996-06-28 Siemens Elema Ab Method and arrangement for locating a measurement and / or treatment catheter in a vessel or organ of a patient
DE19626408A1 (en) 1996-07-01 1998-01-08 Berchtold Gmbh & Co Geb Trocar for laparoscopic operations
DE69710725T2 (en) 1996-07-02 2002-11-21 B K Medical As Gentofte DEVICE FOR DETERMINING MOVEMENTS AND SPEEDS OF MOVING OBJECTS
US5836896A (en) 1996-08-19 1998-11-17 Angiosonics Method of inhibiting restenosis by applying ultrasonic energy
US5984882A (en) 1996-08-19 1999-11-16 Angiosonics Inc. Methods for prevention and treatment of cancer and other proliferative diseases with ultrasonic energy
DE19635593C1 (en) 1996-09-02 1998-04-23 Siemens Ag Ultrasound transducer for diagnostic and therapeutic use
US6719755B2 (en) 1996-10-22 2004-04-13 Epicor Medical, Inc. Methods and devices for ablation
US7052493B2 (en) 1996-10-22 2006-05-30 Epicor Medical, Inc. Methods and devices for ablation
US5827204A (en) * 1996-11-26 1998-10-27 Grandia; Willem Medical noninvasive operations using focused modulated high power ultrasound
US5931848A (en) 1996-12-02 1999-08-03 Angiotrax, Inc. Methods for transluminally performing surgery
US5820564A (en) 1996-12-16 1998-10-13 Albatross Technologies, Inc. Method and apparatus for surface ultrasound imaging
US5759154A (en) 1996-12-23 1998-06-02 C. R. Bard, Inc. Print mask technique for echogenic enhancement of a medical device
JP3850094B2 (en) 1997-02-12 2006-11-29 オリンパス株式会社 Ultrasound diagnostic treatment system and treatment adapter
US5788636A (en) 1997-02-25 1998-08-04 Acuson Corporation Method and system for forming an ultrasound image of a tissue while simultaneously ablating the tissue
US5897356A (en) * 1997-02-27 1999-04-27 Micron Technology, Inc. Methods of forming field oxide and active area regions on a semiconductive substrate
US6045508A (en) * 1997-02-27 2000-04-04 Acuson Corporation Ultrasonic probe, system and method for two-dimensional imaging or three-dimensional reconstruction
US5976105A (en) * 1997-03-05 1999-11-02 Marcove; Ralph C. Intra annular ultrasound disc apparatus and method
SE518490C2 (en) * 1997-04-18 2002-10-15 Ultrazonix Dnt Ab Device for non-invasive treatment of biological tissue
WO1998048711A1 (en) 1997-05-01 1998-11-05 Ekos Corporation Ultrasound catheter
US5906580A (en) 1997-05-05 1999-05-25 Creare Inc. Ultrasound system and method of administering ultrasound including a plurality of multi-layer transducer elements
US5792140A (en) 1997-05-15 1998-08-11 Irvine Biomedical, Inc. Catheter having cooled multiple-needle electrode
US6217576B1 (en) * 1997-05-19 2001-04-17 Irvine Biomedical Inc. Catheter probe for treating focal atrial fibrillation in pulmonary veins
US5876399A (en) 1997-05-28 1999-03-02 Irvine Biomedical, Inc. Catheter system and methods thereof
US5931805A (en) 1997-06-02 1999-08-03 Pharmasonics, Inc. Catheters comprising bending transducers and methods for their use
US5987523A (en) 1997-06-04 1999-11-16 International Business Machines Corporation Applet redirection for controlled access to non-orginating hosts
US6086583A (en) 1997-06-05 2000-07-11 Asahi Kogaku Kogyo Kabushiki Kaisha Electric cautery for endoscope
FR2764516B1 (en) * 1997-06-11 1999-09-03 Inst Nat Sante Rech Med ULTRASONIC INTRATISSULAIRE APPLICATOR FOR HYPERTHERMIA
WO1998058588A1 (en) * 1997-06-23 1998-12-30 Focus Surgery, Inc. Methods and devices for providing acoustic hemostasis
US5957849A (en) * 1997-06-30 1999-09-28 The Regents Of The University Of California Endoluminal ultrasound-guided resectoscope
US5842994A (en) 1997-07-02 1998-12-01 Boston Scientific Technology, Inc. Multifunction intraluminal ultrasound catheter having a removable core with maximized transducer aperture
US6117101A (en) 1997-07-08 2000-09-12 The Regents Of The University Of California Circumferential ablation device assembly
US6547788B1 (en) 1997-07-08 2003-04-15 Atrionx, Inc. Medical device with sensor cooperating with expandable member
US5769760A (en) * 1997-07-22 1998-06-23 Lin; Michael Stationary exercise device
US6159207A (en) 1997-07-31 2000-12-12 Yoon; Inbae Protected ablation method and apparatus
WO1999008614A1 (en) * 1997-08-13 1999-02-25 Surx, Inc. Noninvasive devices, methods, and systems for shrinking of tissues
EP1014859A4 (en) * 1997-08-19 2007-05-02 Philipp Lang Measurement of capillary related interstitial fluid using ultrasound methods and devices
US6128958A (en) 1997-09-11 2000-10-10 The Regents Of The University Of Michigan Phased array system architecture
US6113558A (en) 1997-09-29 2000-09-05 Angiosonics Inc. Pulsed mode lysis method
US6049159A (en) 1997-10-06 2000-04-11 Albatros Technologies, Inc. Wideband acoustic transducer
US6500121B1 (en) 1997-10-14 2002-12-31 Guided Therapy Systems, Inc. Imaging, therapy, and temperature monitoring ultrasonic system
US6623430B1 (en) 1997-10-14 2003-09-23 Guided Therapy Systems, Inc. Method and apparatus for safety delivering medicants to a region of tissue using imaging, therapy and temperature monitoring ultrasonic system
US9198635B2 (en) * 1997-10-31 2015-12-01 University Of Washington Method and apparatus for preparing organs and tissues for laparoscopic surgery
US6007499A (en) * 1997-10-31 1999-12-28 University Of Washington Method and apparatus for medical procedures using high-intensity focused ultrasound
US6156029A (en) * 1997-11-25 2000-12-05 Eclipse Surgical Technologies, Inc. Selective treatment of endocardial/myocardial boundary
US6093150A (en) * 1997-12-31 2000-07-25 Acuson Corporation Ultrasound otoscope
WO1999033500A2 (en) 1997-12-31 1999-07-08 Pharmasonics, Inc. Methods, systems, and kits for intravascular nucleic acid delivery
US6575956B1 (en) 1997-12-31 2003-06-10 Pharmasonics, Inc. Methods and apparatus for uniform transcutaneous therapeutic ultrasound
US6562844B2 (en) 1998-01-23 2003-05-13 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
US6012458A (en) 1998-03-20 2000-01-11 Mo; Larry Y. L. Method and apparatus for tracking scan plane motion in free-hand three-dimensional ultrasound scanning using adaptive speckle correlation
US6074352A (en) * 1998-03-26 2000-06-13 Brigham And Women's Hospital Method for the treatment of joint diseases characterized by unwanted pannus
US6432057B1 (en) 1998-03-31 2002-08-13 Lunar Corporation Stabilizing acoustic coupler for limb densitometry
JPH11276422A (en) 1998-03-31 1999-10-12 Fuji Photo Optical Co Ltd Ultrasonic endoscope
US5897523A (en) 1998-04-13 1999-04-27 Ethicon Endo-Surgery, Inc. Articulating ultrasonic surgical instrument
US6066096A (en) 1998-05-08 2000-05-23 Duke University Imaging probes and catheters for volumetric intraluminal ultrasound imaging and related systems
US6740082B2 (en) 1998-12-29 2004-05-25 John H. Shadduck Surgical instruments for treating gastro-esophageal reflux
US5997534A (en) 1998-06-08 1999-12-07 Tu; Hosheng Medical ablation device and methods thereof
US6036646A (en) 1998-07-10 2000-03-14 Guided Therapy Systems, Inc. Method and apparatus for three dimensional ultrasound imaging
US6346105B1 (en) * 1998-07-27 2002-02-12 Quantum Cor Incorporated Device for treating tissue and methods thereof
US6112123A (en) 1998-07-28 2000-08-29 Endonetics, Inc. Device and method for ablation of tissue
US6440147B1 (en) 1998-09-03 2002-08-27 Rubicor Medical, Inc. Excisional biopsy devices and methods
US6022362A (en) 1998-09-03 2000-02-08 Rubicor Medical, Inc. Excisional biopsy devices and methods
US6626852B2 (en) 1998-09-08 2003-09-30 Scimed Life Systems, Inc. System for intraluminal imaging
US6093194A (en) * 1998-09-14 2000-07-25 Endocare, Inc. Insertion device for stents and methods for use
US7722539B2 (en) 1998-09-18 2010-05-25 University Of Washington Treatment of unwanted tissue by the selective destruction of vasculature providing nutrients to the tissue
US6425867B1 (en) * 1998-09-18 2002-07-30 University Of Washington Noise-free real time ultrasonic imaging of a treatment site undergoing high intensity focused ultrasound therapy
JP3330092B2 (en) 1998-09-30 2002-09-30 松下電器産業株式会社 Ultrasound diagnostic equipment
AU1442500A (en) 1998-10-05 2000-04-26 Scimed Life Systems, Inc. Large area thermal ablation
JP4095729B2 (en) 1998-10-26 2008-06-04 株式会社日立製作所 Therapeutic ultrasound system
JP4091179B2 (en) 1998-10-26 2008-05-28 株式会社東芝 Ultrasonic therapy device
US6135963A (en) 1998-12-07 2000-10-24 General Electric Company Imaging system with transmit apodization using pulse width variation
US6254601B1 (en) 1998-12-08 2001-07-03 Hysterx, Inc. Methods for occlusion of the uterine arteries
US6296619B1 (en) 1998-12-30 2001-10-02 Pharmasonics, Inc. Therapeutic ultrasonic catheter for delivering a uniform energy dose
US6138513A (en) 1999-01-09 2000-10-31 Barabash; Leonid S. Method and apparatus for fast acquisition of ultrasound images
CA2368707C (en) 1999-02-02 2006-06-06 Transurgical, Inc. Intrabody hifu applicator
JP2000237205A (en) 1999-02-17 2000-09-05 Toshiba Corp Ultrasonic therapeutic apparatus
GB2347043A (en) 1999-02-19 2000-08-23 Imp College Innovations Ltd Ultrasound transducer arrays
US6508774B1 (en) * 1999-03-09 2003-01-21 Transurgical, Inc. Hifu applications with feedback control
US6488626B1 (en) 1999-04-07 2002-12-03 Riverside Research Institute Ultrasonic sensing by induced tissue motion
US6482178B1 (en) 1999-05-21 2002-11-19 Cook Urological Incorporated Localization device with anchoring barbs
AU770327B2 (en) 1999-05-21 2004-02-19 Exogen, Inc. Apparatus and method for ultrasonically and electromagnetically treating tissue
US6682483B1 (en) * 1999-05-28 2004-01-27 Vuesonix Sensors, Inc. Device and method for mapping and tracking blood flow and determining parameters of blood flow
JP2000336604A (en) 1999-05-31 2000-12-05 Nippon Hodo Co Ltd Vehicle test course road surface
US20010007940A1 (en) 1999-06-21 2001-07-12 Hosheng Tu Medical device having ultrasound imaging and therapeutic means
US20020068934A1 (en) 1999-06-23 2002-06-06 Edwards Stuart D. Thin layer ablation apparatus
US6626899B2 (en) 1999-06-25 2003-09-30 Nidus Medical, Llc Apparatus and methods for treating tissue
DE19930266A1 (en) * 1999-06-25 2000-12-28 Biotronik Mess & Therapieg catheter
CA2377583A1 (en) 1999-07-19 2001-01-25 Epicor, Inc. Apparatus and method for ablating tissue
US6371973B1 (en) * 1999-08-04 2002-04-16 Ron-Tech Medical Ltd. Forceps useful for intrabody guiding and/or positioning of a medical instrument
JP2001104358A (en) 1999-10-08 2001-04-17 Toshiba Corp Ultrasonic therapy apparatus
US6315723B1 (en) 1999-10-08 2001-11-13 Atl Ultrasound Ultrasonic diagnostic imaging system with synthesized transmit focus
US6440071B1 (en) 1999-10-18 2002-08-27 Guided Therapy Systems, Inc. Peripheral ultrasound imaging system
WO2001034018A2 (en) * 1999-10-25 2001-05-17 Therus Corporation Use of focused ultrasound for vascular sealing
JP2001149372A (en) 1999-11-26 2001-06-05 Matsushita Electric Ind Co Ltd Ultrasonic probe
US6626855B1 (en) 1999-11-26 2003-09-30 Therus Corpoation Controlled high efficiency lesion formation using high intensity ultrasound
AU7613600A (en) * 1999-12-15 2001-06-25 Super Dimension Ltd. Device and method for applying energy to a target
US6719694B2 (en) * 1999-12-23 2004-04-13 Therus Corporation Ultrasound transducers for imaging and therapy
US6361531B1 (en) * 2000-01-21 2002-03-26 Medtronic Xomed, Inc. Focused ultrasound ablation devices having malleable handle shafts and methods of using the same
JP2001212144A (en) * 2000-01-31 2001-08-07 Toshiba Corp Ultrasonic diagnostic apparatus and ultrasonic imaging method
US6428477B1 (en) 2000-03-10 2002-08-06 Koninklijke Philips Electronics, N.V. Delivery of theraputic ultrasound by two dimensional ultrasound array
IL139788A (en) 2000-11-20 2006-10-05 Minelu Zonnenschein Stapler for endoscopes
US6770070B1 (en) 2000-03-17 2004-08-03 Rita Medical Systems, Inc. Lung treatment apparatus and method
US6613004B1 (en) 2000-04-21 2003-09-02 Insightec-Txsonics, Ltd. Systems and methods for creating longer necrosed volumes using a phased array focused ultrasound system
US6494844B1 (en) * 2000-06-21 2002-12-17 Sanarus Medical, Inc. Device for biopsy and treatment of breast tumors
US6599245B1 (en) 2000-06-27 2003-07-29 Siemens Medical Solutions Usa, Inc. Ultrasound transmission method and system for simulating a transmit apodization
EP1299035B1 (en) 2000-07-13 2013-02-13 ReCor Medical, Inc. Thermal treatment apparatus with focussed energy application
US6641579B1 (en) 2000-09-29 2003-11-04 Spectrasonics Imaging, Inc. Apparatus and method for ablating cardiac tissue
US6758824B1 (en) 2000-11-06 2004-07-06 Suros Surgical Systems, Inc. Biopsy apparatus
US6618620B1 (en) 2000-11-28 2003-09-09 Txsonics Ltd. Apparatus for controlling thermal dosing in an thermal treatment system
US7914453B2 (en) 2000-12-28 2011-03-29 Ardent Sound, Inc. Visual imaging system for ultrasonic probe
US6540679B2 (en) 2000-12-28 2003-04-01 Guided Therapy Systems, Inc. Visual imaging system for ultrasonic probe
US6463510B1 (en) 2000-12-29 2002-10-08 Compaq Information Technologies Group, L.P. Apparatus for identifying memory requests originating on remote I/O devices as noncacheable
US20020087081A1 (en) 2001-01-04 2002-07-04 Manuel Serrano Method of mounting a transducer to a driveshaft
US20020111662A1 (en) 2001-02-09 2002-08-15 Iaizzo Paul A. System and method for placing an implantable medical device within a body
JP4227415B2 (en) 2001-03-28 2009-02-18 ヴァスキュラー・コントロール・システムズ・インコーポレーテッド Method and apparatus for detecting and ligating uterine arteries
US20030181900A1 (en) 2002-03-25 2003-09-25 Long Gary L. Endoscopic ablation system with a plurality of electrodes
US20020183739A1 (en) 2001-03-30 2002-12-05 Long Gary L. Endoscopic ablation system with sealed sheath
US6783524B2 (en) 2001-04-19 2004-08-31 Intuitive Surgical, Inc. Robotic surgical tool with ultrasound cauterizing and cutting instrument
US20030120270A1 (en) 2001-04-23 2003-06-26 Transurgical, Inc. Ablation therapy
US20030013972A1 (en) * 2001-05-29 2003-01-16 Makin Inder Raj. S. Treatment of lung lesions using ultrasound
US7846096B2 (en) 2001-05-29 2010-12-07 Ethicon Endo-Surgery, Inc. Method for monitoring of medical treatment using pulse-echo ultrasound
US7211044B2 (en) 2001-05-29 2007-05-01 Ethicon Endo-Surgery, Inc. Method for mapping temperature rise using pulse-echo ultrasound
US6921398B2 (en) 2001-06-04 2005-07-26 Electrosurgery Associates, Llc Vibrating electrosurgical ablator
US20020193781A1 (en) 2001-06-14 2002-12-19 Loeb Marvin P. Devices for interstitial delivery of thermal energy into tissue and methods of use thereof
AU2002316283B2 (en) 2001-06-19 2008-01-24 Medela Holding Ag System for a portable hands-free breast pump and method of using the same
US7035166B2 (en) * 2002-10-21 2006-04-25 Farsounder, Inc. 3-D forward looking sonar with fixed frame of reference for navigation
US7135029B2 (en) 2001-06-29 2006-11-14 Makin Inder Raj S Ultrasonic surgical instrument for intracorporeal sonodynamic therapy
US6666828B2 (en) 2001-06-29 2003-12-23 Medtronic, Inc. Catheter system having disposable balloon
US6932771B2 (en) 2001-07-09 2005-08-23 Civco Medical Instruments Co., Inc. Tissue warming device and method
CA2406684A1 (en) 2001-10-05 2003-04-05 Queen's University At Kingston Ultrasound transducer array
US6709397B2 (en) 2001-10-16 2004-03-23 Envisioneering, L.L.C. Scanning probe
EP1463454A1 (en) 2001-12-14 2004-10-06 Ekos Corporation Blood flow reestablishment determination
US7211055B2 (en) * 2002-01-15 2007-05-01 The Regents Of The University Of California System and method providing directional ultrasound therapy to skeletal joints
CN1671326A (en) 2002-01-15 2005-09-21 德米索尼克思有限公司 A wearable, portable sonic applicator for inducing the release of bioactive compounds from internal organs
EP1503685B1 (en) 2002-01-23 2012-10-31 The Regents of The University of California Implantable thermal treatment apparatus
IL148299A (en) 2002-02-21 2014-04-30 Technion Res & Dev Foundation Ultrasound cardiac stimulator
US6648839B2 (en) 2002-02-28 2003-11-18 Misonix, Incorporated Ultrasonic medical treatment device for RF cauterization and related method
US6887239B2 (en) 2002-04-17 2005-05-03 Sontra Medical Inc. Preparation for transmission and reception of electrical signals
US20030212331A1 (en) 2002-05-13 2003-11-13 Paul Fenton Ultrasonic soft tissue cutting and coagulation systems having multiple superposed vibrational modes
US20030212332A1 (en) 2002-05-13 2003-11-13 Paul Fenton Disposable ultrasonic soft tissue cutting and coagulation systems
US7066893B2 (en) 2002-06-06 2006-06-27 Ethicon Endo-Surgery, Inc. Biopsy method
US7063698B2 (en) 2002-06-14 2006-06-20 Ncontact Surgical, Inc. Vacuum coagulation probes
US20040006336A1 (en) * 2002-07-02 2004-01-08 Scimed Life Systems, Inc. Apparatus and method for RF ablation into conductive fluid-infused tissue
US7137963B2 (en) 2002-08-26 2006-11-21 Flowcardia, Inc. Ultrasound catheter for disrupting blood vessel obstructions
US6669638B1 (en) 2002-10-10 2003-12-30 Koninklijke Philips Electronics N.V. Imaging ultrasound transducer temperature control system and method
US6921371B2 (en) 2002-10-14 2005-07-26 Ekos Corporation Ultrasound radiating members for catheter
US6936048B2 (en) 2003-01-16 2005-08-30 Charlotte-Mecklenburg Hospital Authority Echogenic needle for transvaginal ultrasound directed reduction of uterine fibroids and an associated method
US7628785B2 (en) 2003-06-13 2009-12-08 Piezo Technologies Endoscopic medical treatment involving acoustic ablation
US7037306B2 (en) 2003-06-30 2006-05-02 Ethicon, Inc. System for creating linear lesions for the treatment of atrial fibrillation
US7008438B2 (en) 2003-07-14 2006-03-07 Scimed Life Systems, Inc. Anchored PTCA balloon
US7186252B2 (en) 2003-09-29 2007-03-06 Ethicon Endo-Surgery, Inc. Endoscopic mucosal resection device and method of use
US20050137520A1 (en) 2003-10-29 2005-06-23 Rule Peter R. Catheter with ultrasound-controllable porous membrane
US7833163B2 (en) 2003-12-10 2010-11-16 Siemens Medical Solutions Usa, Inc. Steering angle varied pattern for ultrasound imaging with a two-dimensional array
US7247141B2 (en) 2004-03-08 2007-07-24 Ethicon Endo-Surgery, Inc. Intra-cavitary ultrasound medical system and method
US20050228286A1 (en) 2004-04-07 2005-10-13 Messerly Jeffrey D Medical system having a rotatable ultrasound source and a piercing tip
US20050240123A1 (en) 2004-04-14 2005-10-27 Mast T D Ultrasound medical treatment system and method
US20050234438A1 (en) 2004-04-15 2005-10-20 Mast T D Ultrasound medical treatment system and method
US20050240124A1 (en) 2004-04-15 2005-10-27 Mast T D Ultrasound medical treatment system and method
US7494467B2 (en) 2004-04-16 2009-02-24 Ethicon Endo-Surgery, Inc. Medical system having multiple ultrasound transducers or an ultrasound transducer and an RF electrode
US8235909B2 (en) 2004-05-12 2012-08-07 Guided Therapy Systems, L.L.C. Method and system for controlled scanning, imaging and/or therapy
US20050267488A1 (en) 2004-05-13 2005-12-01 Omnisonics Medical Technologies, Inc. Apparatus and method for using an ultrasonic medical device to treat urolithiasis
US20050256405A1 (en) 2004-05-17 2005-11-17 Makin Inder Raj S Ultrasound-based procedure for uterine medical treatment
US7883468B2 (en) 2004-05-18 2011-02-08 Ethicon Endo-Surgery, Inc. Medical system having an ultrasound source and an acoustic coupling medium
US7951095B2 (en) 2004-05-20 2011-05-31 Ethicon Endo-Surgery, Inc. Ultrasound medical system
US20050261587A1 (en) 2004-05-20 2005-11-24 Makin Inder R S Ultrasound medical system and method
US7473250B2 (en) 2004-05-21 2009-01-06 Ethicon Endo-Surgery, Inc. Ultrasound medical system and method
US7695436B2 (en) 2004-05-21 2010-04-13 Ethicon Endo-Surgery, Inc. Transmit apodization of an ultrasound transducer array
US20050261588A1 (en) 2004-05-21 2005-11-24 Makin Inder Raj S Ultrasound medical system
US7474224B2 (en) 2004-09-08 2009-01-06 Smart Caregiver Corporation Patient monitor with magnetic disarming circuit
US7824348B2 (en) 2004-09-16 2010-11-02 Guided Therapy Systems, L.L.C. System and method for variable depth ultrasound treatment
US9011336B2 (en) 2004-09-16 2015-04-21 Guided Therapy Systems, Llc Method and system for combined energy therapy profile
US7393325B2 (en) 2004-09-16 2008-07-01 Guided Therapy Systems, L.L.C. Method and system for ultrasound treatment with a multi-directional transducer
US8535228B2 (en) 2004-10-06 2013-09-17 Guided Therapy Systems, Llc Method and system for noninvasive face lifts and deep tissue tightening
US20080071255A1 (en) 2006-09-19 2008-03-20 Barthe Peter G Method and system for treating muscle, tendon, ligament and cartilage tissue
US7530958B2 (en) 2004-09-24 2009-05-12 Guided Therapy Systems, Inc. Method and system for combined ultrasound treatment
US7758524B2 (en) 2004-10-06 2010-07-20 Guided Therapy Systems, L.L.C. Method and system for ultra-high frequency ultrasound treatment
US7530356B2 (en) 2004-10-06 2009-05-12 Guided Therapy Systems, Inc. Method and system for noninvasive mastopexy
ES2705758T3 (en) 2004-10-06 2019-03-26 Guided Therapy Systems Llc System for controlled heat treatment of human surface tissue
DE202005022028U1 (en) 2004-10-06 2012-07-09 Guided Therapy Systems, Llc Ultrasonic tissue treatment system
US20120016239A1 (en) 2004-10-06 2012-01-19 Guided Therapy Systems, Llc Systems for cosmetic treatment
JP2008522642A (en) 2004-10-06 2008-07-03 ガイデッド セラピー システムズ, エル.エル.シー. Method and system for beauty enhancement
US8133180B2 (en) 2004-10-06 2012-03-13 Guided Therapy Systems, L.L.C. Method and system for treating cellulite
US8663112B2 (en) 2004-10-06 2014-03-04 Guided Therapy Systems, Llc Methods and systems for fat reduction and/or cellulite treatment
US7666143B2 (en) 2004-12-14 2010-02-23 Siemens Medical Solutions Usa, Inc. Array rotation for ultrasound catheters
US8092475B2 (en) 2005-04-15 2012-01-10 Integra Lifesciences (Ireland) Ltd. Ultrasonic horn for removal of hard tissue
EP1875327A2 (en) 2005-04-25 2008-01-09 Guided Therapy Systems, L.L.C. Method and system for enhancing computer peripheral saftey
US20070016184A1 (en) 2005-07-14 2007-01-18 Ethicon Endo-Surgery, Inc. Medical-treatment electrode assembly and method for medical treatment
US8025672B2 (en) 2006-08-29 2011-09-27 Misonix, Incorporated Ultrasonic wound treatment method and apparatus
US9566454B2 (en) 2006-09-18 2017-02-14 Guided Therapy Systems, Llc Method and sysem for non-ablative acne treatment and prevention
US9241683B2 (en) 2006-10-04 2016-01-26 Ardent Sound Inc. Ultrasound system and method for imaging and/or measuring displacement of moving tissue and fluid
JP5975600B2 (en) 2007-05-07 2016-08-24 ガイデッド セラピー システムズ, エル.エル.シー. Method and system for coupling and focusing acoustic energy using a coupler member
JP2010526589A (en) 2007-05-07 2010-08-05 ガイデッド セラピー システムズ, エル.エル.シー. Method and system for modulating a mediant using acoustic energy
KR102147455B1 (en) 2008-06-06 2020-08-24 얼테라, 인크 Ultrasound treatment system
US8715186B2 (en) 2009-11-24 2014-05-06 Guided Therapy Systems, Llc Methods and systems for generating thermal bubbles for improved ultrasound imaging and therapy
EP2600937B8 (en) 2010-08-02 2024-03-06 Guided Therapy Systems, L.L.C. Systems for treating acute and/or chronic injuries in soft tissue
US8857438B2 (en) 2010-11-08 2014-10-14 Ulthera, Inc. Devices and methods for acoustic shielding

Patent Citations (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323077A (en) * 1980-03-12 1982-04-06 General Electric Company Acoustic intensity monitor
US4315514A (en) * 1980-05-08 1982-02-16 William Drewes Method and apparatus for selective cell destruction
US4646756A (en) * 1982-10-26 1987-03-03 The University Of Aberdeen Ultra sound hyperthermia device
US5080101A (en) * 1983-12-14 1992-01-14 Edap International, S.A. Method for examining and aiming treatment with untrasound
US5080102A (en) * 1983-12-14 1992-01-14 Edap International, S.A. Examining, localizing and treatment with ultrasound
USRE33590E (en) * 1983-12-14 1991-05-21 Edap International, S.A. Method for examining, localizing and treating with ultrasound
US4818954A (en) * 1986-02-15 1989-04-04 Karl Storz Endoscopy-America, Inc. High-frequency generator with automatic power-control for high-frequency surgery
US4984575A (en) * 1987-04-16 1991-01-15 Olympus Optical Co., Ltd. Therapeutical apparatus of extracorporeal type
US4986275A (en) * 1987-08-05 1991-01-22 Kabushiki Kaisha Toshiba Ultrasonic therapy apparatus
US5015929A (en) * 1987-09-07 1991-05-14 Technomed International, S.A. Piezoelectric device with reduced negative waves, and use of said device for extracorporeal lithotrity or for destroying particular tissues
US5095906A (en) * 1987-09-30 1992-03-17 Kabushiki Kaisha Toshiba Image processing system
US4932414A (en) * 1987-11-02 1990-06-12 Cornell Research Foundation, Inc. System of therapeutic ultrasound and real-time ultrasonic scanning
US5209221A (en) * 1988-03-01 1993-05-11 Richard Wolf Gmbh Ultrasonic treatment of pathological tissue
US5421338A (en) * 1988-03-21 1995-06-06 Boston Scientific Corporation Acoustic imaging catheter and the like
US5005580A (en) * 1988-04-22 1991-04-09 Kabushiki Kaisha Toshiba Destroying wave treatment apparatus
US5078144A (en) * 1988-08-19 1992-01-07 Olympus Optical Co. Ltd. System for applying ultrasonic waves and a treatment instrument to a body part
US5203333A (en) * 1989-05-15 1993-04-20 Kabushiki Kaisha Toshiba Acoustic wave therapy apparatus
US5095907A (en) * 1989-06-21 1992-03-17 Kabushiki Kaisha Toshiba Acoustic wave therapy apparatus
US5409002A (en) * 1989-07-12 1995-04-25 Focus Surgery Incorporated Treatment system with localization
US5311869A (en) * 1990-03-24 1994-05-17 Kabushiki Kaisha Toshiba Method and apparatus for ultrasonic wave treatment in which medical progress may be evaluated
US5514085A (en) * 1990-07-24 1996-05-07 Yoon; Inbae Multifunctional devices for use in endoscopic surgical procedures and methods therefor
US5304115A (en) * 1991-01-11 1994-04-19 Baxter International Inc. Ultrasonic angioplasty device incorporating improved transmission member and ablation probe
US5524620A (en) * 1991-11-12 1996-06-11 November Technologies Ltd. Ablation of blood thrombi by means of acoustic energy
US5601526A (en) * 1991-12-20 1997-02-11 Technomed Medical Systems Ultrasound therapy apparatus delivering ultrasound waves having thermal and cavitation effects
US5762066A (en) * 1992-02-21 1998-06-09 Ths International, Inc. Multifaceted ultrasound transducer probe system and methods for its use
US5882302A (en) * 1992-02-21 1999-03-16 Ths International, Inc. Methods and devices for providing acoustic hemostasis
US5485839A (en) * 1992-02-28 1996-01-23 Kabushiki Kaisha Toshiba Method and apparatus for ultrasonic wave medical treatment using computed tomography
US5624382A (en) * 1992-03-10 1997-04-29 Siemens Aktiengesellschaft Method and apparatus for ultrasound tissue therapy
US5759162A (en) * 1992-03-10 1998-06-02 Siemens Aktiengesellschaft Method and apparatus for ultrasound tissue therapy
US5295484A (en) * 1992-05-19 1994-03-22 Arizona Board Of Regents For And On Behalf Of The University Of Arizona Apparatus and method for intra-cardiac ablation of arrhythmias
US5733315A (en) * 1992-11-13 1998-03-31 Burdette; Everette C. Method of manufacture of a transurethral ultrasound applicator for prostate gland thermal therapy
US5391197A (en) * 1992-11-13 1995-02-21 Dornier Medical Systems, Inc. Ultrasound thermotherapy probe
US5620479A (en) * 1992-11-13 1997-04-15 The Regents Of The University Of California Method and apparatus for thermal therapy of tumors
US5743863A (en) * 1993-01-22 1998-04-28 Technomed Medical Systems And Institut National High-intensity ultrasound therapy method and apparatus with controlled cavitation effect and reduced side lobes
US5738635A (en) * 1993-01-22 1998-04-14 Technomed Medical Systems Adjustable focusing therapeutic apparatus with no secondary focusing
US5526815A (en) * 1993-01-29 1996-06-18 Siemens Aktiengesellschat Therapy apparatus for locating and treating a zone located in the body of a life form with acoustic waves
US5391140A (en) * 1993-01-29 1995-02-21 Siemens Aktiengesellschaft Therapy apparatus for locating and treating a zone in the body of a life form with acoustic waves
US6010531A (en) * 1993-02-22 2000-01-04 Heartport, Inc. Less-invasive devices and methods for cardiac valve surgery
US5897495A (en) * 1993-03-10 1999-04-27 Kabushiki Kaisha Toshiba Ultrasonic wave medical treatment apparatus suitable for use under guidance of magnetic resonance imaging
US5722411A (en) * 1993-03-12 1998-03-03 Kabushiki Kaisha Toshiba Ultrasound medical treatment apparatus with reduction of noise due to treatment ultrasound irradiation at ultrasound imaging device
US5603326A (en) * 1993-03-22 1997-02-18 Siemens Aktiengesellschaft Method and apparatus for displaying an image obtained by echo signals
US5402792A (en) * 1993-03-30 1995-04-04 Shimadzu Corporation Ultrasonic medical apparatus
US5860974A (en) * 1993-07-01 1999-01-19 Boston Scientific Corporation Heart ablation catheter with expandable electrode and method of coupling energy to an electrode on a catheter shaft
US5720287A (en) * 1993-07-26 1998-02-24 Technomed Medical Systems Therapy and imaging probe and therapeutic treatment apparatus utilizing it
US5873828A (en) * 1994-02-18 1999-02-23 Olympus Optical Co., Ltd. Ultrasonic diagnosis and treatment system
US5526822A (en) * 1994-03-24 1996-06-18 Biopsys Medical, Inc. Method and apparatus for automated biopsy and collection of soft tissue
US5596991A (en) * 1994-04-07 1997-01-28 Fuji Photo Optical Co., Ltd. Catheter type ultrasound probe
US5492126A (en) * 1994-05-02 1996-02-20 Focal Surgery Probe for medical imaging and therapy using ultrasound
US5522869A (en) * 1994-05-17 1996-06-04 Burdette; Everette C. Ultrasound device for use in a thermotherapy apparatus
US5746224A (en) * 1994-06-24 1998-05-05 Somnus Medical Technologies, Inc. Method for ablating turbinates
US5398690A (en) * 1994-08-03 1995-03-21 Batten; Bobby G. Slaved biopsy device, analysis apparatus, and process
US5743862A (en) * 1994-09-19 1998-04-28 Kabushiki Kaisha Toshiba Ultrasonic medical treatment apparatus
US5606975A (en) * 1994-09-19 1997-03-04 The Board Of Trustees Of The Leland Stanford Junior University Forward viewing ultrasonic imaging catheter
US5520188A (en) * 1994-11-02 1996-05-28 Focus Surgery Inc. Annular array transducer
US5628743A (en) * 1994-12-21 1997-05-13 Valleylab Inc. Dual mode ultrasonic surgical apparatus
US6246898B1 (en) * 1995-03-28 2001-06-12 Sonometrics Corporation Method for carrying out a medical procedure using a three-dimensional tracking and imaging system
US5873902A (en) * 1995-03-31 1999-02-23 Focus Surgery, Inc. Ultrasound intensity determining method and apparatus
US5626607A (en) * 1995-04-03 1997-05-06 Heartport, Inc. Clamp assembly and method of use
US6340352B1 (en) * 1995-04-06 2002-01-22 Olympus Optical Co., Ltd. Ultrasound treatment system
US5735280A (en) * 1995-05-02 1998-04-07 Heart Rhythm Technologies, Inc. Ultrasound energy delivery system and method
US6575969B1 (en) * 1995-05-04 2003-06-10 Sherwood Services Ag Cool-tip radiofrequency thermosurgery electrode system for tumor ablation
US6726677B1 (en) * 1995-10-13 2004-04-27 Transvascular, Inc. Stabilized tissue penetrating catheters
US5590657A (en) * 1995-11-06 1997-01-07 The Regents Of The University Of Michigan Phased array ultrasound system and method for cardiac ablation
US5895356A (en) * 1995-11-15 1999-04-20 American Medical Systems, Inc. Apparatus and method for transurethral focussed ultrasound therapy
US5735796A (en) * 1995-11-23 1998-04-07 Siemens Aktiengesellschaft Therapy apparatus with a source of acoustic waves
US5728062A (en) * 1995-11-30 1998-03-17 Pharmasonics, Inc. Apparatus and methods for vibratory intraluminal therapy employing magnetostrictive transducers
US5769086A (en) * 1995-12-06 1998-06-23 Biopsys Medical, Inc. Control system and method for automated biopsy device
US6071238A (en) * 1996-06-28 2000-06-06 Technomed Medical Systems Therapy probe
US6024718A (en) * 1996-09-04 2000-02-15 The Regents Of The University Of California Intraluminal directed ultrasound delivery device
US6063050A (en) * 1996-10-04 2000-05-16 United States Surgical Corp. Ultrasonic dissection and coagulation system
US5769790A (en) * 1996-10-25 1998-06-23 General Electric Company Focused ultrasound surgery system guided by ultrasound imaging
US6221014B1 (en) * 1996-11-22 2001-04-24 Richard Wolf Gmbh Device for tracking the focus position for a therapy apparatus
US6030344A (en) * 1996-12-04 2000-02-29 Acuson Corporation Methods and apparatus for ultrasound image quantification
US6241677B1 (en) * 1996-12-04 2001-06-05 Acuson Corporation Method and apparatus for ultrasound image quantification
US6193664B1 (en) * 1996-12-04 2001-02-27 Acuson Corporation Method and apparatus for ultrasound image quantification
US6071279A (en) * 1996-12-19 2000-06-06 Ep Technologies, Inc. Branched structures for supporting multiple electrode elements
US5873845A (en) * 1997-03-17 1999-02-23 General Electric Company Ultrasound transducer with focused ultrasound refraction plate
US6053868A (en) * 1997-04-24 2000-04-25 Sulzer Osypka Gmbh Apparatus for a cardiological therapy
US6024740A (en) * 1997-07-08 2000-02-15 The Regents Of The University Of California Circumferential ablation device assembly
US5893835A (en) * 1997-10-10 1999-04-13 Ethicon Endo-Surgery, Inc. Ultrasonic clamp coagulator apparatus having dual rotational positioning
US6050943A (en) * 1997-10-14 2000-04-18 Guided Therapy Systems, Inc. Imaging, therapy, and temperature monitoring ultrasonic system
US6071239A (en) * 1997-10-27 2000-06-06 Cribbs; Robert W. Method and apparatus for lipolytic therapy using ultrasound energy
US6013031A (en) * 1998-03-09 2000-01-11 Mendlein; John D. Methods and devices for improving ultrasonic measurements using anatomic landmarks and soft tissue correction
US6039689A (en) * 1998-03-11 2000-03-21 Riverside Research Institute Stripe electrode transducer for use with therapeutic ultrasonic radiation treatment
US6066123A (en) * 1998-04-09 2000-05-23 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of bioavailability by use of focused energy delivery to a target tissue
US6193709B1 (en) * 1998-05-13 2001-02-27 Olympus Optical Co., Ltd. Ultrasonic treatment apparatus
US6059731A (en) * 1998-08-19 2000-05-09 Mayo Foundation For Medical Education And Research Simultaneous side-and-end viewing underfluid catheter
US6042556A (en) * 1998-09-04 2000-03-28 University Of Washington Method for determining phase advancement of transducer elements in high intensity focused ultrasound
US6540700B1 (en) * 1998-10-26 2003-04-01 Kabushiki Kaisha Toshiba Ultrasound treatment apparatus
US6702745B1 (en) * 1999-01-21 2004-03-09 David Smythe 3D/4D ultrasound imaging system
US6206843B1 (en) * 1999-01-28 2001-03-27 Ultra Cure Ltd. Ultrasound system and methods utilizing same
US6340348B1 (en) * 1999-07-02 2002-01-22 Acuson Corporation Contrast agent imaging with destruction pulses in diagnostic medical ultrasound
US6210330B1 (en) * 1999-08-04 2001-04-03 Rontech Medical Ltd. Apparatus, system and method for real-time endovaginal sonography guidance of intra-uterine, cervical and tubal procedures
US6533726B1 (en) * 1999-08-09 2003-03-18 Riverside Research Institute System and method for ultrasonic harmonic imaging for therapy guidance and monitoring
US6352532B1 (en) * 1999-12-14 2002-03-05 Ethicon Endo-Surgery, Inc. Active load control of ultrasonic surgical instruments
US20030120306A1 (en) * 2000-04-21 2003-06-26 Vascular Control System Method and apparatus for the detection and occlusion of blood vessels
US6371903B1 (en) * 2000-06-22 2002-04-16 Technomed Medical Systems, S.A. Therapy probe
US6562033B2 (en) * 2001-04-09 2003-05-13 Baylis Medical Co. Intradiscal lesioning apparatus
US20040041880A1 (en) * 2002-08-30 2004-03-04 Canon Kabushiki Kaisha Recording apparatus

Cited By (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7806892B2 (en) * 2001-05-29 2010-10-05 Ethicon Endo-Surgery, Inc. Tissue-retaining system for ultrasound medical treatment
US9005144B2 (en) 2001-05-29 2015-04-14 Michael H. Slayton Tissue-retaining systems for ultrasound medical treatment
US9261596B2 (en) 2001-05-29 2016-02-16 T. Douglas Mast Method for monitoring of medical treatment using pulse-echo ultrasound
US20030018270A1 (en) * 2001-05-29 2003-01-23 Makin Inder Raj. S. Tissue-retaining system for ultrasound medical treatment
US7846096B2 (en) 2001-05-29 2010-12-07 Ethicon Endo-Surgery, Inc. Method for monitoring of medical treatment using pulse-echo ultrasound
US9962564B2 (en) 2001-08-29 2018-05-08 Accoustic Medsystems, Inc. Ultrasound device and method for treatment of a target nerve contained in intervertebral tissue
US20080108984A1 (en) * 2001-08-29 2008-05-08 Burdette Everette C Ultrasound device for treatment of intervertebral disc tisssue
US9302125B2 (en) 2003-06-10 2016-04-05 The Foundry, Llc Methods and apparatus for non-invasively treating atrial fibrillation using high intensity focused ultrasound
US20070027445A1 (en) * 2003-06-10 2007-02-01 Gifford Hanson S Methods and apparatus for non-invasively treating patent foramen ovale using high intensity focused ultrasound
WO2005000097A3 (en) * 2003-06-10 2005-05-19 The Foundry Inc Methods and apparatus for non-invasively treating atrial fibrillation using high intensity focused ultrasound
US20040260199A1 (en) * 2003-06-19 2004-12-23 Wilson-Cook Medical, Inc. Cytology collection device
US20050261611A1 (en) * 2004-05-21 2005-11-24 Makin Inder Raj S Ultrasound medical system and method
US7806839B2 (en) 2004-06-14 2010-10-05 Ethicon Endo-Surgery, Inc. System and method for ultrasound therapy using grating lobes
US20050277853A1 (en) * 2004-06-14 2005-12-15 Mast T D System and method for medical treatment using ultrasound
US9132287B2 (en) 2004-06-14 2015-09-15 T. Douglas Mast System and method for ultrasound treatment using grating lobes
US10183183B2 (en) 2007-04-13 2019-01-22 Acoustic Medsystems, Inc. Acoustic applicators for controlled thermal modification of tissue
US8597203B2 (en) 2010-03-30 2013-12-03 Siteselect Medical Technologies, Inc. Tissue excision device with a reduced diameter cannula
US8529466B2 (en) 2010-03-30 2013-09-10 Siteselect Medical Technologies, Inc. Tissue excision device with rotating stylet blades
US8597204B2 (en) 2010-03-30 2013-12-03 Siteselect Medical Technologies, Inc. Tissue excision device with an independent needle
US8597202B2 (en) 2010-03-30 2013-12-03 Siteselect Medical Technologies, Inc. Tissue excision device with a modified cutting edge
US8740809B2 (en) 2010-03-30 2014-06-03 Siteselect Medical Technologies, Inc. Tissue excision device with a retractable backhook
US8597201B2 (en) 2010-03-30 2013-12-03 Siteselect Medical Technologies, Inc. Tissue excision device with a flexible transection blade
US8535240B2 (en) 2010-03-30 2013-09-17 Siteselect Medical Technologies, Inc. Tissue excision device with a retracting stylet blade
US8444573B2 (en) 2010-03-30 2013-05-21 Siteselect Medical Technologies, Inc. Tissue excision device
US9226733B2 (en) 2010-03-30 2016-01-05 Siteselect Medical Technologies, Inc. Tissue excision device with an independent needle
US8597200B2 (en) 2010-03-30 2013-12-03 Siteselect Medial Technologies, Inc. Tissue excision device
US8529467B2 (en) 2010-03-30 2013-09-10 Siteselect Medical Technologies, Inc. Tissue excision device with a collapsible stylet
US8485988B2 (en) 2010-03-30 2013-07-16 Siteselect Medical Technologies, Inc. Tissue excision device
US20190015072A1 (en) * 2010-11-18 2019-01-17 Koninklijke Philips N.V. Medical device with forward and sideward ablation monitoring ultrasound transducers
US11707260B2 (en) * 2010-11-18 2023-07-25 Koninklijke Philips N.V. Medical device with forward and sideward ablation monitoring ultrasound transducers
US11896779B2 (en) 2012-08-15 2024-02-13 Acoustic Medsystems, Inc. MRI compatible ablation catheter system incorporating directional high-intensity ultrasound for treatment
EP2967705A4 (en) * 2013-03-13 2016-11-16 Covidien Lp Clamp ultrasound probe for lung surgery
CN105073045A (en) * 2013-03-13 2015-11-18 柯惠Lp公司 Clamp ultrasound probe for lung surgery
US10194933B2 (en) 2013-03-13 2019-02-05 Covidien Lp Clamp ultrasound probe for lung surgery
US20200384292A1 (en) * 2019-06-07 2020-12-10 The Board Of Trustees Of The Leland Stanford Junior University Pattern Interference Radiation Force (PIRF) neural stimulators

Also Published As

Publication number Publication date
JP2004528924A (en) 2004-09-24
WO2002096304A1 (en) 2002-12-05
EP1397075A2 (en) 2004-03-17
WO2002096504A3 (en) 2003-11-06
WO2002096505A3 (en) 2003-11-06
WO2002096508A9 (en) 2003-12-24
WO2002096502A3 (en) 2004-03-18
US20130226040A1 (en) 2013-08-29
US7473224B2 (en) 2009-01-06
WO2002096506A9 (en) 2004-05-13
AU2002312086B2 (en) 2007-06-14
WO2002096481A2 (en) 2002-12-05
US20030013960A1 (en) 2003-01-16
CA2448957A1 (en) 2002-12-05
EP1397070A4 (en) 2006-07-12
EP2289443A2 (en) 2011-03-02
EP1427343A4 (en) 2006-07-12
EP1397075A4 (en) 2006-07-19
EP1432355A4 (en) 2006-10-04
ATE494041T1 (en) 2011-01-15
ATE459293T1 (en) 2010-03-15
EP1397070A2 (en) 2004-03-17
US8333721B2 (en) 2012-12-18
WO2002096506A3 (en) 2003-10-30
WO2002096503A2 (en) 2002-12-05
EP1401530A4 (en) 2006-10-04
WO2002096502A9 (en) 2004-04-22
CA2449062A1 (en) 2002-12-05
US20030013971A1 (en) 2003-01-16
WO2002096507A2 (en) 2002-12-05
US20100312151A1 (en) 2010-12-09
WO2002096304A9 (en) 2004-07-22
EP1432355A2 (en) 2004-06-30
WO2002096508A8 (en) 2003-10-30
US20030018270A1 (en) 2003-01-23
CA2448906A1 (en) 2002-12-05
EP1397074A2 (en) 2004-03-17
US20030013972A1 (en) 2003-01-16
WO2002096506A2 (en) 2002-12-05
JP2004537350A (en) 2004-12-16
US20030069502A1 (en) 2003-04-10
EP1397073A2 (en) 2004-03-17
EP1427343A2 (en) 2004-06-16
DE60238838D1 (en) 2011-02-17
EP2289443B1 (en) 2016-04-20
WO2002096481A3 (en) 2003-04-17
EP2289443A3 (en) 2014-10-01
WO2002096504A9 (en) 2004-04-29
US7806892B2 (en) 2010-10-05
CA2449015A1 (en) 2002-12-05
WO2002096501A2 (en) 2002-12-05
ES2356808T3 (en) 2011-04-13
AU2002314816B2 (en) 2007-06-21
JP2004535860A (en) 2004-12-02
EP1397074A4 (en) 2006-07-12
CA2449012A1 (en) 2002-12-05
JP2004532689A (en) 2004-10-28
CA2449068A1 (en) 2002-12-05
WO2002096505A2 (en) 2002-12-05
US20030018266A1 (en) 2003-01-23
US20030032898A1 (en) 2003-02-13
JP2004532690A (en) 2004-10-28
EP1401530A2 (en) 2004-03-31
EP1397073A4 (en) 2006-07-12
WO2002096501A3 (en) 2004-03-11
WO2002096504A2 (en) 2002-12-05
WO2002096507A3 (en) 2003-11-20
JP2004532691A (en) 2004-10-28
WO2002096506A8 (en) 2003-05-15
DE60233401D1 (en) 2009-10-01
WO2002096503A3 (en) 2003-09-25
EP1397073B1 (en) 2009-08-19
WO2002096508A3 (en) 2003-07-24
WO2002096304A8 (en) 2004-04-29
EP1397074B1 (en) 2011-01-05
ATE439807T1 (en) 2009-09-15
US20030092988A1 (en) 2003-05-15
WO2002096508A2 (en) 2002-12-05
JP2004532686A (en) 2004-10-28
WO2002096502A2 (en) 2002-12-05
AU2002312085B2 (en) 2007-06-21
EP1397075B1 (en) 2010-03-03
US20030013970A1 (en) 2003-01-16
DE60235541D1 (en) 2010-04-15
JP2004530481A (en) 2004-10-07
CA2449568A1 (en) 2002-12-05
JP2004528925A (en) 2004-09-24
US9005144B2 (en) 2015-04-14
JP2004532688A (en) 2004-10-28
AU2002303862B2 (en) 2007-09-06

Similar Documents

Publication Publication Date Title
US9005144B2 (en) Tissue-retaining systems for ultrasound medical treatment
AU2002303862A1 (en) Ultrasound-based occlusive procedure for medical treatment
AU2002312085A1 (en) Tissue-retaining system for ultrasound medical treatment
AU2002314816A1 (en) Deployable ultrasound medical transducers
AU2002312083B2 (en) Treatment of lung lesions using ultrasound
AU2002314817A1 (en) Method for aiming ultrasound for medical treatment
AU2002312084A1 (en) Excisional and ultrasound medical treatment system
AU2002310089A1 (en) Faceted ultrasound medical transducer assembly
AU2002310114A1 (en) Staging medical treatment using ultrasound

Legal Events

Date Code Title Description
AS Assignment

Owner name: ETHICON ENDO-SURGERY, INC., OHIO

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MAKIN, INDER RAJ S.;REEL/FRAME:013411/0614

Effective date: 20020819

AS Assignment

Owner name: ETHICON ENDO-SURGERY, INC., OHIO

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SLAYTON, MICHAEL H.;BARTHE, PETER G.;REEL/FRAME:016615/0365

Effective date: 20050103

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION